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Abstract
In the first part of my PhD I explored the link between childbirth and mood
disorders in a retrospective sample of over 1500 parous women with mood dis-
orders, recruited as part of ongoing molecular generic studies.
Around two thirds of participants reported at least one episode of illness dur-
ing pregnancy or the postpartum. Women with bipolar I disorder reported an
approximately 50% risk of a perinatal major affective episode. Risks were lower
in recurrent major depression and bipolar II disorder at around 40%. The ma-
jority of perinatal episodes occurred within 4 weeks of childbirth. Episodes of
mania or psychosis had an earlier onset than those of depression. For bipolar II
disorder, onsets of psychiatric episodes were more spread out over the perinatal
period with more onsets in pregnancy and later in the postpartum. Moreover,
childbirth did not seem to be a specific trigger for the majority of perinatal
episodes of bipolar II disorder.
Primiparity was associated with postpartum mania/psychosis and unipolar post-
partum depression in women who experienced their first lifetime episode within
6 weeks postpartum. My findings raise the possibility of a relationship between
postpartum mood disorders and other disorders influenced by parity, such as
pre-eclampsia.
In the second part of my PhD I designed and piloted a prospective study aimed
i) to replicate and ii) to extend the findings on the retrospective sample, ex-
ploring the influence of a range of variables on the vulnerability to develop an
episode of severe illness in pregnancy or the postpartum. Over 14 months of
recruitment 19 women completed the follow-up assessment. To capture the clin-
ical complexity of bipolar disorder in pregnancy and the postpartum period very
large scale longitudinal studies are needed. These studies must be based on a
strong collaboration with the NHS.
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category for episodes occurring within 6 weeks after childbirth, while in the
clinical practice a 6 months interval is usually accepted. In general a manic or
affective psychotic episode occurring after childbirth.
Postpartum or postnatal (non psychotic) depression DSM-IV major de-
pressive episode without psychotic features occurring in the postpartum period.
Postpartum or postnatal or puerperal psychosis In my analyses DSM-IV
mania, or DSM-IV psychotic depression or DSM-IV mixed episode or cycloid
psychosis, defined as Brockington, with onset after delivery.
Primigravida A woman who is pregnant for the first time.
Primipara A woman who has given birth to only one child.
Probability or random sample: sample selected through probability sam-
pling. The sample is selected from a frame, that contains all the units of the
population under consideration (target population). Randomness does not im-
ply haphazardness.
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Introduction
Bipolar disorder is a protean term that indicates a spectrum of psychiatric
disorders characterised by periods of pathological mood elation, called mania.
Bipolar disorder is often a recurrent illness consisting in episodes of mania and
depression alternating with periods of well being. It has been estimated that
about 2-7% of women of childbirth age suffers from some form of bipolar disor-
der [1]. The boundaries between bipolar disorder and unipolar depression are
still controversial. If bipolar disorder and unipolar depression are conceptualised
in a continuum model, called the mood disorder spectrum, mood disorders are
the leading cause of disability worldwide, with unipolar depression ranking first
and bipolar disorder 6th among causes of years lived with disability [2].
Among psychiatric illnesses, bipolar disorder is most robustly associated with
childbirth [3]. However, the link between childbirth and mood spectrum disor-
ders is still poorly understood. The gap in knowledge is wider for the less severe,
but more prevalent, forms, such as postnatal bipolar depression and hypoma-
nia, that have been almost neglected by research and clinical practice [4], while
more severe forms have intrigued scientists for centuries, with mixed results.
Confusion in the clinical nosology of perinatal mood episodes has probably pre-
vented firm and consistent conclusions on the nature of the postpartum trigger.
Moreover, the research in this field relies mostly on arbitrary definitions of post-
partum disorders, while more evidence-based criteria are needed.
My PhD project sought to address these deficiencies. The 3-year project was
organised in 2 parts, that reflect the core structure of this thesis.
In the first part, I explored the link between childbirth and mood disorders
in a large retrospective sample of women with mood disorders. The nosol-
ogy of bipolar disorder is controversial and a lot of research efforts have
1
been spent in disentangling the relationship between unipolar and bipolar
mood conditions. I therefore investigated the childbirth trigger across the
entire mood disorder spectrum. I divided the sample with bipolar disor-
der in two groups, according to the Diagnostic and Statistical Manual of
Mental Disorders (DSM-IV) [5] criteria of bipolar I disorder (BD-I) and
bipolar II disorder (BD-II) and used a sample of women with recurrent
major depression (RMD) as a comparison group. The large samples anal-
ysed were already collected and my input involved: i) formulation of the
hypotheses, ii) selection of the samples, iii) data cleaning, iv) statistical
analyses, v) interpretation of the results.
In the second part, I designed and piloted a prospective study. Prospective
studies are the gold standard design of observational research. I sought
to test the feasibility and the validity of a study aimed to recruit a large,
well characterised sample of women with bipolar disorder preconception
or in early pregnancy and to monitor them through pregnancy and the
postpartum. The full-scale study was aimed i) to replicate and ii) to
extend the findings on the retrospective sample, exploring the influence of
a range of variables on the vulnerability to develop an episode of severe
illness in pregnancy or in the postpartum.
Outline of the thesis
This thesis is divided in 4 parts:
1. A background section in which I give an account of mood disorders and
their relationship with childbirth.
• In chapter 1 I attempt to elucidate the terminology used in the
thesis by giving a brief overview of the history and the controversies in
the definition and classification of mood disorders. The first chapter
is dedicated to the broad subject of mood disorders and psychiatric
nosology, because I think that the confusion in the terminology and
nosology of postpartum mood disorders is rooted on a deeper level in
the epistemic limitations of the study of mood disorders. Moreover,
I argue that the distinction between unipolar and bipolar disorder
is still not clear and that a sample of women with recurrent major
depression was therefore needed in the analyses I have conducted. I
2
finally introduce the current definitions of perinatal mood disorders.
• In chapter 2 I focus on the childbirth trigger. I critically review
the literature on the link between bipolar disorders and childbirth.
Many studies have investigated severe episodes of mania or psychotic
depression in the perinatal period, while little attention has been de-
voted to hypomania and bipolar depression. With few exceptions
[4, 6, 7], studies investigating postnatal depression have largely ne-
glected bipolar depressioin and have mainly focused only on unipolar
depression. Most of the literature on postnatal depression I present
is therefore based on unipolar perinatal depression.
• In chapter 3 I introduce mood disorders in pregnancy and the
postpartum, with particular emphasis on postpartum depression and
postpartum psychosis. These two conditions are the main topic of my
research and are extensively discussed throughout the entire thesis.
This chapter has a clinical focus on diagnosis, prognosis and treat-
ment. An in-depth discussion of the clinical issues in identifying and
treating perinatal mood disorders is beyond the scope of this thesis.
Here I provide a schematic overview on the clinical aspects of peri-
natal mood disorders. I particularly stress the diagnostic features
and the risk factors involved in the liability to postnatal episodes,
because they are key factors in the design of the prospective study
described in the third and last part of the thesis.
• I conclude the background section in chapter 4, where I summarise
the gaps in knowledge that have emerged in the previous chapters
and I formally state my research hypotheses.
2. A core section on the research I conducted on the existing retrospective
sample.
• In Chapter 5 I report the methodology of the research on the retro-
spective sample. I first describe the Mood Disorder Research Project,
from which the data were obtained, then I focus on the statisti-
cal methodology I employed. The Mood Disorder Research Project
database collects information on individuals who took part in differ-
ent sub-projects over a 20-year period. Although the main structure
of the dataset has remained unchanged, little variations in the in-
clusion criteria and in the variables assessed have occurred over the
3
years. In this chapter I provide an overview the methods of recruit-
ment and assessment of the participants in relation to the research
hypotheses. Different research hypotheses required sub-samples with
different characteristics. Given the complexity of my analytic plan, I
provide the reader with a flow-chart summarising the different inclu-
sion criteria for each analysis that I conducted. My major research
effort in the study of the retrospective sample was the statistical
analyses. Analysing retrospective data on reproductive events is a
complex task. Pregnancies from the same woman cannot be consid-
ered independent events and many covariates can bias the association
between bipolar disorder and the childbirth trigger. Moreover, as in
any clinical dataset, I had to deal with missing values. I therefore
dedicate the second part of chapter 5 to a general discussion of the
statistical methodology that I employed in the analyses of the ret-
rospective dataset. In chapter 5 I do not provide a detailed account
of the specific statistical methods that I have employed in different
analyses, because I describe them in the pertinent chapters along
with the results of the analyses.
• In chapters 6 to 9 I present the results of the analyses that I conducted
on the retrospective sample. As I largely discuss in the background
chapters, previous studies reported very heterogeneous estimates of
the rates of perinatal mood episodes (PNEs) and only few of them
reported on less severe episodes of hypomania and bipolar depression.
In chapter 6 I therefore estimate the rates of PNEs across the mood
disorder spectrum and explore potential differences across lifetime
diagnoses of BD-I, BD-II and RMD.
• One of the main current controversies in perinatal nosology is the
duration of the onset criterion. In chapter 7 I explore the time-to-
onset of perinatal mania, psychotic depression and both unipolar and
bipolar depression. I present the survival curves according to the phe-
nomenology of the perinatal episodes (mania, psychotic depression,
non psychotic depression) and according to the longitudinal course
of illness (bipolar vs unipolar depression, first vs second episode, first
vs second pregnancy). I also use the Cox proportional hazards model
methodology to establish which explanatory variables influenced the
latency between childbirth and onset of a postnatal episode.
• In chapter 8 I follow up the results gathered in chapter 6 and 7
4
and investigate the specificity of the childbirth trigger. The rates
of PNEs, in fact, need to be interpreted in the light of the longi-
tudinal life-course of mood disorders. First I report the estimates
for first lifetime episode in relation to childbirth, then the propor-
tion of women who experienced only perinatal episodes, without any
episodes outsides the perinatal period. Then I compare the rates of
episodes occurring in relation to childbirth with the rates of episodes
occurring at other times. Finally I test whether the childbirth trig-
ger is specific for postpartum psychosis or women who experienced
postpartum psychosis are also vulnerable to postnatal depression.
• In chapter 9 I introduce the intriguing hypothesis that a specific
childbirth trigger is related to first deliveries. The link to primipar-
ity may suggest relationships with other pregnancy related disorders
such as pre-eclampsia in which parity is known to play an important
role and lead to specific hypotheses about the nature of the postnatal
trigger. Here I use some of the results emerged in the previous chap-
ters and conduct separate analyses according to the time-to-onset of
the perinatal episodes and to the longitudinal lifetime course of the
disorders.
3. A section on the design and feasibility of a prospective study on bipolar
disorder in pregnancy and the postpartum.
• In chapter 10 I describe the methodology of the research protocol of
the study. I provide only a brief background, because I have already
discussed the clinical relevance of the bipolar trigger in the general
background section. The study was conducted as part of the Mood
Disorder Research Project, so my major effort was to integrate the
current research protocol with the one of the mood disorder research
project. Because the recruitment methods overlapped between the 2
studies, the reader can refer to chapter 5 for a detailed account of the
general recruitment methods. In this chapter I outline in detail the
assessment tools that I included in the protocol. Finally, I describe
the process of obtaining ethical approval.
• In chapter 11 I report the research outcomes of the pilot study.
Based on the findings of the pilot study, I report the estimates of the
sample size that should be needed to test the research hypotheses I
formulated in the research protocol. Finally I discuss the feasibility
5
of a large-scale study. The main focus of the chapter is the discussion
of the problems that I have encountered and of the limitations that
have emerged. Finally I propose some adjustment to the protocol in
order to optimise the resources.
4. The last section is dedicated to a general discussion.
Here I summarise the results of the analyses I conducted, discuss the
limitations to my approach and the implication of my findings for the
nosology and aetiology of the postpartum trigger. Finally, I propose some
suggestions for further research.
6
Part I
Background
7
Chapter 1
Epistemic issues in the
study of perinatal mood
disorders
“Irrespective of whether it is a clinician or a scientist who even-
tually unlocks the secrets of schizophrenia and bipolar disorder, they
are much more likely to succeed if the syndromes in question have
been accurately identified to begin with. ”
R. E. Kendell [8]
“The contradiction so puzzling to the ordinary way of thinking comes
from the fact that we have to use language to communicate our inner
experience, which in its very nature transcends linguistics.”
D.T. Suzuki [9]
I start my ’journey’ in understanding the childbirth trigger of mood episodes
with a general introduction to mood disorders, because I think that the con-
fusion in the study of postpartum mood disorders is rooted on a deeper level
in the epistemic limitations of the study of mood disorders. A discussion on
the epistemology of mood disorders is not academic sophistry. It is relevant for
both research and clinical practice, as its limitations have probably prevented
firm and consistent conclusions on the nature of the postpartum trigger. In
8
medicine, differently from other sciences such as physics, definitions need to be
explicit [10] 1 In this chapter and in the next I identify and discuss three related
problems - in order of complexity:
1. It is difficult to conceptualise emotions, because, as pointed out by Suzuki,
inner experience transcends linguistics. Scientific research in the emotions
has always been challenging and, in this field, the demarcation between
science and pseudo-science has always been flimsy. 2
2. Assuming that it is possible to define emotions and to explore them using
the scientific method, the concept of mood disorder introduces a further
level of complexity. The definition of disorder, in general, is not neat
and consistent. Again, this is not an academic/philosophical conundrum.
Scadding [10] emphasised the importance of this topic in a letter to the
Lancet about 50 years ago. He claimed that “To apply precise methods to
vague and ill-defined concepts is likely to perpetuate confusion, by lending
it an air of respectability, and to provide an example of what I call, borrow-
ing and adapting a phrase from A. N. Whitehead, the fallacy of misplaced
precision.”. In this chapter I first overview some of the current opinions
on the definition and criteria of disorder. Then I give a brief historical
account on the nosology of mood disorders. I particularly emphasise the
debate on the distinction between unipolar and bipolar disorders across
the mood disorders spectrum.
3. Assuming that there is an agreement on the logical construct of ’mood dis-
order’ (or ’bipolar disorder’), the link between mood disorders (or bipo-
lar disorder) and childbirth represents a further epistemic problem. In
this chapter I concentrate on the current definitions and classifications of
PNEs, while the next chapter is dedicated to a critical overview of the
literature on the postpartum trigger.
1Thomas Kuhn pointed out that “scientists don’t need to define concepts. Empirical
concepts, in fact, don’t need explicit definitions. Einstein, for example, did not have to invent
or even explicitly redefine space and time in order to give them new meaning within the
context of his work.” [11] Explicit definitions of empirical concepts are not only unnecessary,
but they would often hinder scientific progress.
2Although Popper’s critique of psychoanalysis is reductionistic and based on observations
dated a century ago, I think it is thought-provoking, as it may easily be applied to current
clinical research in psychiatry, especially to nosology. In “Science: Conjectures and Refuta-
tions ”Popper claims that a theory is scientific only if it is falsifiable and that the “clinical
observations which analysts naively believe confirm their theory cannot do this any more than
the daily confirmations which astrologers find in their practice ” [12]
9
1.1 What is an emotion?
In a book published in 1884 William James asked “What is an emotion? ”
[13]. Today, more than a century later, the definitions of emotions and feelings
are still heterogeneous and problematic. Contrary to the almost unambiguous
meaning given to concrete objects, the description and objectivation of feelings
and emotions have always been influenced by cultural differences, that act both
on a lexical and on a phenomenical level. An extensive discussion of emotions
goes beyond the scope of this thesis, so only some terminology used in this text
is presented and summarised in table 1.1.
Emotion, affect, feeling and mood are protean terms [14] with different etymo-
logical and cultural roots. A common etymological denominator is the shift
from meaning a physical act to a psychological experience. For example, as re-
ported in table 1.1, the term affect initially meant “to do something to”, “to act
on”and only later it gains a psychological meaning. Despite the longstanding
philosophical and scientific debate on the meaning and characteristics of these
terms, their characteristics are not unequivocally defined.
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1.2 Mood disorders
“But although accurate identification of the clinical syndrome is not
a necessary preliminary it undoubtedly increases the likelihood that
attempts to elucidate aetiology will be successful. ”
R. E. Kendell [8]
1.2.1 What is a disorder?
The definition of a disorder in epistemologically difficult and controversial and
the arguments range from metaphysics to science. A detailed debate over the
nature of psychiatric disorders is beyond the scope of my thesis. In table 1.2 I
summarise some of the most commonly used definitions and their consequences,
while I point the readers to Phillips at al 2012 [15] for a detailed discussion on
the epistemology of psychiatric disorders.
The definition of psychiatric disorder is crucial in the field of perinatal psy-
chiatry because there are several syndromic entities such as postpartum blues
and mother-infant relationship disorders that are not included in the current
diagnostic systems [20]. I return to the nosology of postpartum disorders in the
next section.
Psychiatric syndromes and disorders are currently systematised in discrete di-
agnostic categories, listed in the Diagnostic and Statistic Manual of Mental Dis-
orders (DSM) [5] and in the International Classification of Disorders (ICD) [21].
These diagnostic systems provide diagnostic criteria to establish the presence
of the psychiatric disorders listed. DSM, authored by the American Psychiatric
Association, and ICD, authored by the World Health Organisation, are widely
used in Western medicine. They provide both researchers and clinicians with
explicit diagnostic criteria, improving communication and enabling better diag-
nostic agreement [17]. However, the current discrete categorical approach is not
optimal, even according to the authors of DSM.3
For the work I present in this thesis I employed the DSM-IV definition of disor-
3“There is no assumption that each category of mental disorder is a completely discrete
entity with absolute boundaries dividing it from other mental disorders or from no mental
disorder”( [5], p. xxii)
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der, that embraces both nominalistic and essentialistic positions and defines a
mental disorder as either A) a “clinically significant behavioural or psychological
syndrome or pattern ”associated with disability, distress, or “with a significantly
increased risk of suffering death, pain, disability, or an important loss of free-
dom ”or as B) a manifestation of a behavioural, psychological, or biological
dysfunction. This definition accounts for the socio-cultural context and does
not include culturally sanctioned beliefs and behaviours or conflicts that are
“primarily between the individual and society”. 4
In my research I use the concept of disease-entities as classified in DSM-IV,
bearing in mind Jaspers’s observations. Jaspers pointed out that the concept
of mental disorders is a Kantian idea, i.e. an unending object that cannot be
reached. However, it shows a fruitful research direction and is a true point of
orientation for individual empiric research. 5
The discussion on the validity and utility of the diagnosis of postpartum episodes
is central for this thesis. Unfortunately, the concept of validity and utility
are themselves controversial. In table 1.3 I provide several possible criteria
that have been proposed to establish the validity of psychiatric diagnoses. The
main limitation of these validators is that they consider psychiatric diagnoses
as separate nosological entities. It has been pointed out by a number of authors
[17] that the categorical approach in which categories do not overlap is not in
agreement with the evidence from clinical and non clinical studies.
1.2.2 Conceptualisation of mood disorders
The conceptual heterogeneity that characterises emotion, affect, feeling and
mood aﬄicts also the definition and conceptualisation of their pathological coun-
terparts. In the past two centuries psychiatry has relatively neglected disor-
ders of affectivity in comparison to disorders of thinking. According to Berrios
1985 [14], the lack of emphasis on feelings reflects “earlier views on the subor-
dinate role played by the emotions in the definition of man”.
4The website of DSM-5 Task Force proposed a revised definition of a men-
tal disorder, in which the symptoms reflect “a disturbance in the psychologi-
cal, biological, or developmental processes underlying mental functioning ”- see
http://www.dsm5.org/proposedrevisions/pages/proposedrevision.aspx?rid=465
5“Die Idee der Krankenheitseinheit ist [..] eine Idee im Kantischen Sinne: der Begriff
einer Aufgabe, daren Ziel zu erreichen unmo¨glich ist, da sas Ziel in der Unendlichkeit liegt;
die uns aber trotzdem die fruchtbare Forschungsrichtungen weist und due ein waherer Orien-
tierungspunkt fur empirische Einzelforschung bedeutet” [22]
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In the current Western psychiatric framework, an alteration of the mood can
indicate:
• A symptom: a change from the normal experience noticed by the subject
and usually caused by a disorder. Mood symptoms are pervasive mood
states, extreme manifestations along an axis from happiness to sadness.
A condition of extreme pathological low mood is called depression, while
a condition of extreme elevated mood is called mania.
• An episode or a syndrome, characterised by different combinations of signs
and symptoms. In the modern classification systems episodes of major
mood disorders are usually labeled as major depression, (hypo)mania or
mixed episodes. Mood episodes can present with or without psychotic
features.
• A disorder. In this thesis I use the term mood disorder to label the longi-
tudinal/lifetime diagnoses of recurrent major depression and bipolar dis-
order.
In this thesis I deal with a number of concepts such as melancholia, cycloid,
bipolar spectrum. The vast majority of terms and concepts used to define and
describe mood disorders are antecedent to and not always in agreement with
the current diagnostic systems, so I provide here some historical notes and I
briefly explore current controversies.
I have already mentioned that the terms ’depression’ and ’mania’ are currently
used to describe both extreme mood states (symptoms) and complex mood dis-
orders (syndromes). In the current categorical diagnostic systems, the overlap
between a symptom and a syndrome is not necessary.
For example, in both DSM-IV [5] and ICD-10 [21] depressed mood is not a
necessary criterion for a major depressive episode. However, this view is not
unanimously accepted. Stefanis and Stefanis [25], for example, considered de-
pressed mood as a necessary symptom for a depressive syndrome and criticised
the concept of depressio sine depressione. On the other hand, depressed mood
may be present outside a major depressive episode in the context of other syn-
dromes or, less frequently, as an isolated symptom.
Similarly, mania describes a pathological elevation of mood, but in DSM-IV a
manic episode is characterised not necessarily by elevated and expansive mood.
The diagnostic criterion of mood in mania can be fulfilled also by irritable mood.
Hypomania is a milder, but still clinically significant, elevation of mood. The
presence of hypomania is sufficient to make a diagnosis of bipolar disorder ac-
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cording to DSM-IV, but not according to ICD-10, which labels as bipolar only
disorders characterised by a history of both full-blown mania and depression.
The concept of melancholia is etymologically rooted in the theory of the
’four humors’ of Alcmaeon of Crotona and the pre-Hippocratic Greek physi-
cians and literally means ’black bile’ (μελανχολια). Until the 20th century the
term melancholia defined a periodic mood disorder with both manic and depres-
sive episodes. Melancholia was often described as a severe illness, characterised
by psychosis, psychomotor disturbance and vegetative signs. Mood was often
reported as manic or mixed (depressive and manic features together) or rapidly
switching from mania to depression (Falret’s folie circulaire). Later, melan-
cholia has generally been considered the ’biological’ type of depression. Since
the introduction in the third edition of DSM (1980), melancholia has been a
specifier for a major depressive episode (in the context of either a lifetime diag-
nosis of major depressive disorder or bipolar disorder). According to DSM-IV
melancholic features are: ahnedonia, lack of mood reactivity, the low mood is
subjectively different from grief or loss, severe weight loss or loss of appetite,
psychomotor disturbance (agitation or bradykinesia), early morning awakening
and worse mood in the morning and excessive guilt.
However, in the recent years many authors have argued that melancholia should
be treated as a nosological entity separated from major depression. It is of in-
terest that it has been proposed to include postpartum depression together with
psychotic depression and manic depression in a new separate diagnostic cate-
gory of melancholia [26].
The concept of bipolar disorder is rooted in the classic pre-Hippocratic pe-
riod [27]. However, Hippocrates was the first who described systematically
melancholia and mania as biologically determined diseases. Hippocratic descrip-
tions of mania and melancholia included not only what we labeled as depression
and mania, but also mixed states and psychotic states.
In the first century after Christ by Aretaeus of Cappadocia linked mania and
melancholia for the first time6. However, at the beginning of the 19th century
mania and melancholia were still conceptualised as two different syndromes.
The father of the modern concept of bipolar disorder is probably the French psy-
chiatrist Jean-Pierre Falret, who, in the 19th century, described the circulaire,
6“melancholia is the beginning and a part of mania . . . The development of a mania is
really a worsening of ..[melancholia] rather than a change into another disease. . . In most
of them (melancholics) the sadness became better after various lengths of time and changed
into happiness; the patients then developed a mania” [27]
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an illness characterised by periodical episodes of mania and melancholia alter-
nated with periods of well-being [28]. The term folie circulaire was introduced
to the German speaking psychiatry by Karl Kahlbaum in 1863 as circula¨res
Irresein [29]. At the end of the 19th century, Emil Kreapelin unified, not with-
out a certain skepticism, the circula¨res Irresein with depressive illness, labelling
the unified syndrome as manisch-depressives Irresein (manic-depressive insan-
ity) [30].
The current distinction between unipolar and bipolar disorders is rooted in
the German psychiatry of the beginning of 20th century. Carl Wernicke dif-
ferentiated unipolar mania or depression from manic-depressive insanity [31].
Karl Kleist was the first to use the term bipolar, labelling manic-depressive
insanity and atypical cycloid psychoses as zweipolig(bipolar) in contraposition
to einpolig(unipolar) mania and depression [27]. However, the distinction be-
tween unipolar and bipolar disorders was internationally recognised only in the
1960s. [32]
Recent evidence from clinical, epidemiological and molecular studies have chal-
lenged the current clear-cut unipolar-bipolar distinction [33]. Several studies
have found that hypomanic symptoms are common in a substantial propor-
tion of subjects suffering from a unipolar depressive episode [34]. On the other
side, there are increasing evidence that bipolar depressive episodes and unipo-
lar depressive episodes (that currently share the same diagnostic criteria and
nosology) are not overlapping clinical entities.
The nosological boundaries of bipolarity have been expanded through the emerg-
ing concept of a clinically relevant broad bipolar spectrum. This term has
been conceptualised as a clinical continuum ranging from affective tempera-
ments to DSM-IV BD-I (a manic episode with or without a history of depression)
and encompassing depression with history of spontaneous hypomanic episodes
(DSM-IV, BD-II), cyclothymic depressions (BD-II and a half ), antidepressant-
associated hypomania (bipolar III disorder) and hyperthymic depressions (bipo-
lar IV disorder) [35]. The term cyklothymie (cyclothymia) was firstly used
by Kahlbaum to describe a mild form of bipolar disorder (a “partielle See-
lensto¨rungen ”, a partial mental disorder) characterized by highs and lows [36].
This view on cyclothymia is currently internationally accepted and recognised
by ICD-10 and DSM-IV. However, in the German speaking psychiatry, although
increasingly rare, cyclothymia can be used according to Schneider’s meaning,
indicating a full mental disorder, overlapping with the manic-depressive illness.
Affective temperaments and their role in mood disorders are still controversial.
The modern concept of affective temperaments is rooted in the German descrip-
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tive tradition. Kraepelin described four fundamental states (’grundzusta¨nde’):
depressive, manic, irritable and cyclothymic 7. Kretschmer expanded Krae-
pelin’s notion of premorbid behavioural patterns to embrace the whole range
of temperamental variants in the population. He theorised that psychoses “are
only rare exaggerated editions of large wide-spread groups of healthy constitu-
tions [that] have a genetic basis ” [38]. Schneider regarded hyperthymic and
depressive psychopathic personalities as extremes in a statistical sense, which
represented much more than simply the underlying foundations of mood disor-
ders [39]. In recent years there has been a rejuvenation of interest in the concept
that certain affective temperaments may represent formes frustes or endophe-
notypic8 manifestations of vulnerability to bipolar spectrum disorders. Akiskal
et al postulated that temperamental dysregulation might constitute the link be-
tween predisposing familial-genetic factors and affective illnesses such as bipolar
disorder [42]. They defined affective temperament as emotional reactivity
that embraces both affective liabilities and assets and includes five dimensions
of dysthymia, hyperthymia, cyclothymia, irritability and anxiety.
Recent advances in molecular genetics have provided new insights in the def-
inition of the spectrum boundaries and challenged the still-in-use Kreapelian
dichotomy between dementia praecox and manic-depressive insanity [43]. The
bipolar spectrum can thus be extended to psychotic mood disorder, schizoaffec-
tive disorder, laying on a continuum with schizophrenia .
Despite Kreapelin’s observations of subjects with clinical features that lied be-
tween manic-depressive insanity and dementia praecox, the first systematic stud-
ies on schizoaffective disorders are dated more than 60 years later [44]. Cur-
rently, the definition of schizoaffective disorder, bipolar type is controversial and
its boundaries with bipolar disorder are very labile. Recent advance in molecu-
lar genetics has provided new important insight. Employing different definitions
of schizoaffective disorder, bipolar type, Craddock et al in two different studies
found that common variations at receptors within the gamma-aminobutyric acid
system were associated with susceptibility to schizoaffective, bipolar type, when
Research Diagnostic Criteria were applied [45, 46]. The methodology employed
in these studies represented a shift of paradigm from a hypothesis driven de-
scriptive approach to a data-driven, iterative approach [47] and is an important
7temperaments“on the one hand frequently accompany the ”free“intervals between attacks,
on the other hand characterise the manic-depressive temperament in such cases also in which
the full development of the malady is absent ” [37]
8Akiskal et al, for example used the term behavioural phenotype to indicate traits that
“best tap the familial-genetic diathesis of BD-II” [40]. The term endophenotype differed here
from the more rigorous definition and use proposed by Walters and Owen [41]
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tool for a new definition of psychiatric disorders.
In discussing postpartum episodes in relation to childbirth, cycloid psychosis
is a recurring concept. Pfuhlmann et al [48] reported that about half of episodes
of postpartum psychosis meet Leonhard’s criteria for cycloid psychosis.
The term cycloid psychosis is not included explicitly in the current diagnostic
systems. However, many characteristics of cycloid psychosis are met by the
diagnostic categories of acute polymorphic psychotic disorders, with or without
symptoms of schizophrenia, F-23 in ICD-10 and brief psychotic disorder, 298.8
in DSM-IV, although in both cases the episode has to last less than 1 month.
As many other concepts described in this chapter, the concept of cycloid psy-
chosis is rooted in the German psychiatric tradition. Initially the term was
used by Karl Kleist to label a form of psychosis that was not included in the
Kraepelian dichotomy dementia praecox - manic-depressive illness [49] and that
in many cases presented as an acute psychotic illnesses similar to schizophre-
nia, but with the episodic course of manic-depression. There is a paucity of
information on the diagnostic validity of cycloid psychosis, however, it has been
claimed that it is a separate nosological entity with longitudinal diagnostic sta-
bility [49]. Over the years two nosological positions have been alternating: the
first supporting the view that cycloid is not a separate nosological entity and
the second supporting the independence of cycloid psychosis from schizophre-
nia and bipolar disorder. Cycloid psychoses are phasic disorders with complete
remission after each episode. Patients usually present with polymorphic clinical
symptomatology that overlaps the symptomatology of organic psychoses. Karl
Leonhard [50] described three characteristic forms of presentation: hyperkinetic-
akinetic motility psychosis, excited-inhibited confusion psychosis and anxiety-
happiness psychosis. In the database I analysed, episodes of cycloid psychosis
were recorded and rated according to Perris and Brockington criteria [51]. These
criteria were employed also by Kendell et al [52] in a milestone paper on post-
partum disorders. I therefore list them in table 1.4.
The uncertainty in the definition of bipolar disorder(s) and in the limits of the
bipolar spectrum influenced not only the design of my research, but also my lex-
ical choices in this thesis. Expressing uncertainty around definitions is tedious
(especially for the reader), but necessary. I use here the term bipolar/mood dis-
orders to underline that, although the focus of the discussion is bipolar disorder,
the boundaries between unipolar and bipolar mood disorders are unknown and
probably not neat. I use the term bipolar depression to indicate an episode
of DSM-IV major depression in subjects who have previously experienced a
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Table 1.4: Perris and Brockington criteria for cycloid psychosis
1. Acute psychosis, not related to the drug use, to brain injury,
with first onset between 10-50 years.
2. Sudden onset with rapid change from health to a full-blown
psychosis within few hours/days
3. At least four of the following must be present:
i) Confusion, mostly expressed as perplexity or puzzlement
ii) Mood-incongruent delusions, mostly persecutory
iii) Hallucinations, often related to themes of death
iv) Pan-anxiety
v) Deeper feelings of happiness or ecstasy, most often with a reli-
gious coloring
vi) Motility disturbances of an akinetic or hyperkinetic type
vii) particular concern with death
viii) significant mood swings in the background that justify a di-
agnosis of affective disorders
4) Symptoms may change frequently during an episode and show
bipolar characteristics.
manic/hypomanic/mixed episode.
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1.3 Nosology of perinatal mood episodes
Contrary to pregnancy, the postpartum has been historically recognised as a
period of great liability for psychiatric disorders and great emphasis has always
been put on episodes occurring after childbirth.
Postpartum mood disorders are typically divided into three categories: the baby
blues, postnatal depression and postpartum psychosis.
Baby blues are common after childbirth. Often depressive and hypomanic
symptoms occur together, with mood swings ranging from elation to
sadness, insomnia, tearfulness, crying spells, irritability, anxiety, and de-
creased concentration. Despite the inconsistency of the data in the current
literature, it has been estimated that around 30-80% of women experience
mood swings after delivery. Symptoms develop within a week postpar-
tum and resolve within 2 weeks. Postpartum mood swings do not require
treatment and there are many controversies as to their pathological rele-
vance. However, they have been associated with subsequent postpartum
depression and affective vulnerability (for a review on baby blues please
see [53]). As I have already mentioned, in my research I used the DSM-IV
criteria of disorder. Baby blues is not included in DSM-IV nor in ICD-10.
Moreover, following the DSM-IV definition of what is a disorder reported
above, baby blues does not significantly increase risk of suffering death,
pain, disability, or an important loss of freedom nor there are solid evi-
dence of behavioural, psychological, or biological dysfunction. Therefore,
I did not investigate baby blues in my research
The term postpartum depression refers to the development of a depressive
episode following childbirth and may form part of a bipolar or, more usu-
ally, a unipolar disorder. In contrast to baby blues, postpartum depression
can last for months or even years and can result in significant impairment
with severe long-term consequences for the mother and the entire family.
Postpartum psychosis is the most severe form of postpartum mood disorder.
Although the disorder is not easy to define, the core feature is the acute
onset of a manic, depressive or mixed affective psychosis in the immediate
postpartum period. It is a psychiatric emergency. The epidemiology of
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psychosis occurring after childbirth has changed over time and still changes
over countries. Brockington [54] distinguished between three forms of
postpartum psychosis:
1. Organic psychosis - including post-eclamptic and infective psychosis.
With the introduction of antenatal care, this form has become rare
in Western countries. I discuss the differential diagnosis of organic
psychosis in chapter 3
2. Psychogenic psychosis is usually characterised by delusions and is
associated with severe stress.
3. Bipolar/cycloid psychosis is currently the most common in the West-
ern countries and is the object of this thesis. So, when I use the term
postpartum or postnatal psychosis, I refer to this form.
Neither the term nor the concept of postpartum psychosis are present in DSM-
IV or ICD-10. Figure 1.1 compares the modern classification of postpartum
psychotic disorders with the clinical-historical concept of postpartum psychosis.
According to Brockington, “the influence of ICD and DSM on postpartum psy-
chosis has been adverse ”and “has depressed research and the provision of the
services ”. DSM-IV severe manic episodes without psychotic features may be
labeled as postpartum psychosis. On the contrary, chronic psychotic illness,
such as schizophrenia, affecting the postpartum period, but with an onset be-
fore delivery are generally not considered episodes of postpartum psychosis. I
use the term postpartum psychosis to define an episode of mania or affective
psychosis occurring in the puerperium. I specify the length of the postpartum
period in each analyses I discuss/ perform.
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Postpartum psychosis 
DSM-IV psychotic mania  
Psychotic depression 
Psychotic mixed episode 
Brief (<1month) psychotic 
episode 
Cycloid 
 
Schizophreniform 
disorder 
DSM-IV non psychotic 
mania? 
Figure 1.1: Postpartum psychosis in DSM-IV. Disorders included in the current
DSM-IV postpartum onset specifier in grey. Postpartum psychosis includes also
cycloid psychosis and schizophreniform disorders. However, episodes of cycloid
that last more than a month are excluded by the current postpartum onset
specifier. Similarly schizophreniform disorders are not covered by the onset
specifier and cycloid is not a term employed by the DSM-IV. On the contrary,
DSM-IV severe manic episodes without psychotic features may be labeled as
postpartum psychosis.
Before describing the current nosology of perinatal disorders in ICD-10 and in
DSM-IV I briefly list previous definitions in table 1.5, because they have been
used in many studies that I report in the next chapters.
Although the approach to perinatal episodes is different in ICD-10 and DSM-IV,
both assume that perinatal mood episodes are not separate nosological entities:
postpartum depression and postpartum psychosis are not recognised as separate
conditions.
DSM-IV has a course specifier - with postpartum onset which can be applied to
a major depressive, manic, or mixed episode; or to brief psychotic disorder with
an onset within 4 weeks after childbirth. The postpartum onset specifier cannot
be applied to any other psychiatric diagnosis. Hypomania is excluded from the
onset specifier, although, it has recently been argued that postpartum hypoma-
nia is clinically relevant and that the next version of DSM should consider a
revision of the postpartum onset specifier to include it. Similarly, postpartum
psychoses which are cycloid (and last more than a month) or schizophreniform
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are not covered by the onset specifier (figure 1.1).
In ICD-10 the category Mental and behavioural disorders associated with the
puerperium, not elsewhere classified (code F53) should be used only when un-
avoidable and includes only mental disorders associated with the puerperium
(commencing within 6 weeks of delivery) that do not meet the criteria for dis-
orders classified elsewhere9. Alternatively, disorders occurring within 6 weeks
after childbirth, can be coded by adding to the presenting psychiatric episode
code a second code (0.993 - mental diseases and diseases of the nervous system
complicating the puerperium).
Current diagnostic systems do not allow episodes in pregnancy or later in the
postpartum to be linked to childbirth. However, rather than the 4 or 6 weeks
cut-off, a 6 month or 1 year postpartum period is commonly used in clinical
practice. The exact length of time that the term postpartum denotes is contro-
versial and is the main topic of chapter 7. The current definitions of perinatal
onset in DSM-IV and in ICD-10 are, in fact, essentially arbitrary and more
evidence-based criteria are needed.
Although pregnancy has thought to be a period of emotional well being, there
is evidence, at least for depression that episodes are at least as frequent as at
other time. Women with bipolar disorder face very difficult decisions about
pregnancy: many of drugs used to keep them well are known teratogens, that
is they can cause birth defects in children if taken in pregnancy. As I discuss
in detail in the next chapter, euthymic women who discontinue antidepressant
treatment during pregnancy have a five time higher risk of relapse than those
who maintain drug [56]. Women with bipolar disorder have an even higher
risk of recurrence in pregnancy, especially mixed recurrences. Discontinuation
of treatment, especially if abrupt, is highly associated with the onset of a new
episode in pregnancy, with more than 85% of women who discontinued mood
stabilising therapy developing a new episode, versus only 37% in the group who
continued therapy.
9“This classification should be used only for mental disorders [..] that do not meet the
criteria for disorders classified elsewhere [..] either because insufficient information is available,
or because it is considered that special additional clinical features are present which make their
classification elsewhere inappropriate” [55]
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1.4 Summary
In this chapter I have explored some of the difficulties in the definition and
nosology of mood episodes occurring in relation to childbirth. Confusion in the
definitions of emotions and in the classification of mood disorders in general
has probably had a negative impact on research into perinatal mood disorders
(figures 1.2-4). The current categorical diagnostic systems do not consider peri-
natal disorders as separate nosological entities. There is no difference between
episodes occurring after delivery or outside the puerperium. There is a neat dif-
ference between bipolar and unipolar disorders with no continuity between the
two categories (figure 1.2). Episodes of hypomania, that are common in post-
partum period, or cycloid/schizophreniform psychosis that have been associated
with childbirth in the past are neglected by the current categorical diagnostic
systems.
Postpartum episodes are not always recurrences of mood disorders occurring
outside the perinatal period. Episodes neglected by DSM-IV such as cycloid
psychosis and schizophreniform disorders are included, either as recurrence of
a lifetime bipolar disorder, or as distinct entities, with no recurrences outside
the puerperium. Postpartum depression can be either a recurrence of RMD or
bipolar disorder or an isolated episode (figure 1.3). However, a first depressive
episode after childbirth has been associated with an increased risk of a bipolar
diathesis (please see [7] discussed in chapter 2)
One of the aim of this thesis was to explore different definitions of perinatal
mood episodes and to compare them with current diagnostic criteria. I investi-
gated a range of mood episodes and of definitions of puerperium to see whether
the evidence support the current classifications.
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Figure 1.2: Postpartum illness and mood disorders: PNEs as part of the
unipolar-bipolar dichotomy. The current approach to postnatal mood episodes
in DSM-IV is shown: there is no difference between episodes occurring after
delivery or outside the puerperium. There is a neat difference between bipolar
and unipolar disorders with no continuity between the two categories.
Figure 1.3: Postpartum episodes are not always recurrences of mood disorders
occurring outside the perinatal period. Episodes neglected by DSM-IV such as
cycloid psychosis and schizophreniform disorders are included, either as recur-
rence of a lifetime bipolar disorder, or as distinct entities, with no recurrences
outside the puerperium. Postpartum depression can be either a recurrence of
RMD or bipolar disorder or an isolated episode. However, a first depressive
episode after childbirth has been associated with an increased risk of a bipolar
diathesis (please see [7] discussed in chapter 2)
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Figure 1.4: PNEs as part of the mood/bipolar disorder spectrum. Mood
episodes are all part of a same nosological entity: the bipolar/mood disorder
spectrum. Postnatal hypomania, that is currently neglected by DSM-IV, is
included.
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Chapter 2
Childbirth as a trigger for
episodes of mood disorder
In the previous chapter I overviewed the complexity and the limitations that
hinder the study of bipolar/mood disorders and introduced the debate on the
nosological status of PNEs. In this chapter I expand the discussion on the child-
birth trigger and critically review the literature on the following main research
questions:
1. Is the perinatal period a period of increased risk of onset of bipolar/mood
disorders? Is the risk similar across mood spectrum disorders?
2. Is the perinatal period a period of increased risk of recurrence of bipo-
lar/mood disorders? Is the risk similar across mood spectrum disorders?
3. What period of time should be covered by the postnatal onset criterion?
Should pregnancy be included?
These research questions were the main topic of my analyses on the Mood Dis-
order Research Project dataset.
As proposed by Kendell [52], quantitative studies on the effect of childbirth on
psychiatric morbidity need to meet three methodological requirements: 1. an
epidemiological sample 2. accurate information on women from the same pop-
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ulation who do not develop any psychiatric disorders, despite the exposition to
pregnancy and childbirth. 3. a large sample. Although many studies have been
conducted over the years on bipolar disorder in pregnancy and the postpartum
(table 2.1), only few meet Kendell’s criteria. Therefore I dedicate an extensive
part of this chapter to large register based studies. Large registry studies con-
ducted in Scandinavia have given a major contribution to the topics approached
in this chapter. In both Denmark and Sweden every resident is identified by
a unique identification number that is used as personal identifier across all na-
tional registers. National registers include basic demographic information, but
also medical information on admissions, diagnoses and treatment. Thanks to
the unique identification number, register based studies have linked information
contained in different registers in order to explore the link between childbirth
and mental disorders.
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Table 2.1: Studies reporting the rates of perinatal episodes in mood
disorders.2
First Au-
thor,Year
C
o
u
n
t
r
y
S
a
m
p
l
i
n
g
Sample characteristics T
i
m
e
w
i
n
d
o
w
S
t
a
t
i
s
t
i
c
O
u
t
c
o
m
e
N %
Kendell 1987
[52]
UK E Pregnancies in women with prior
history of manic or circular ill-
ness
90 days postpar-
tum
Incidence Psychiatric admissions 30 21.4
Blehar 1998
[57]
US G Parous women with prior history
of BD-I
Lifetime preva-
lence
Severe emotional dis-
turbance
186 „ 50
Viguera 2000
[58]
US,
Italy
C Pregnant women with prior his-
tory of BD-I, BD-II
Pregnancy Incidence Mania, or hypomania,
or MDE
42 52.4
24 weeks post-
partum
20 70
Jones
2001 [59]
UK G Pregnancies in women with BD-
I, or schizoaffective disorder,
bipolar type
6 weeks postpar-
tum
Incidence Mania or psychosis 313 26
Continued on next page
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Table 2.1 – Continued from previous page
First Au-
thor,Year
C
o
u
n
t
r
y
S
a
m
p
l
i
n
g
Sample characteristics Time window Statistic Outcome N %
Parous women with prior history
of BD-I or schizoaffective disor-
der, bipolar type
Pregnancy Lifetime preva-
lence
Any DSM-IV affective
episode
152 7.2
6 weeks postpar-
tum
Mania or psychosis 38.2
MDE or anxiety disor-
ders
12.5
Freeman
2002 [60]
US C Parous women with prior history
of BD-I or BD-II
Postpartum Lifetime preva-
lence
Any DSM-IV mood
episode
30 67
Eberhard-
Gran
2004 [61]
Norway E Pregnancies in women with prior
history of depression
Pregnancy-12
months post-
partum
Incidence EPDS ą9 156 14.1
Cohen 2006
[56]
US C Pregnant women with prior his-
tory of MDD
Pregnancy Incidence MDE 201 43
Payne 2007
[62]
US G Parous women with prior history
of BD-I
1 month post-
partum
Lifetime preva-
lence
Mood symptoms a 514 22
Continued on next page
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Table 2.1 – Continued from previous page
First Au-
thor,Year
C
o
u
n
t
r
y
S
a
m
p
l
i
n
g
Sample characteristics Time window Statistic Outcome N %
Parous women with prior history
BD-II
83 22.9
Parous women with prior history
MDD
1283 20.3
Harlow 2007
[63]
Sweden E 1st time pregnant women with
prior history of BD-I
90 days postpar-
tum
Incidence Hospitalization 786 8.5
Pregnancy For BD 1.4
Viguera 2007
[64]
US C Pregnant women with prior his-
tory of BD-I or BD-II
Pregnancy Incidence MDE 89 38.2
Hypomania 16.9
Mania 6.7
Munk-Olsen
2009 [65]
DenmarkE 1st time pregnant women with
prior history of BD
90 days postpar-
tum
Cumulative in-
cidence
Hospital re-admission 22
1st time pregnant women with
prior history of MDD
1 year postpar-
tum
„ 5
Colom 2010
[66]
Spain C Parous women with prior history
of BD-I or BD-II
4 weeks postpar-
tum
Lifetime preva-
lence
MDE 66 50
Continued on next page
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Table 2.1 – Continued from previous page
First Au-
thor,Year
C
o
u
n
t
r
y
S
a
m
p
l
i
n
g
Sample characteristics Time window Statistic Outcome N %
Mania or mixed
episode
16.7
Viguera 2011
[6]
US,
Italy
C Parous women with prior history
of BD-I
6 months post-
partum
Lifetime preva-
lence
DSM-III/IV Mania or
Mixed episode
7.9
DSM-III/IV MDE 19.2
Psychosis 1.9
Parous women with prior history
of BD-II
6 months post-
partum
DSM-IV hypomania 2.3
DSM-III/IV MDE 28.7
Parous women with prior history
of MDD
6 months post-
partum
DSM-III/IV MDE 16.1
2s By asking: Have you ever had any severe emotional problems within a month of childbirth? Abbreviations: BD: bipolar disorder: BD-I bipolar disorder,
type I: BD-II: bipolar disorder, type II, C: Clinical, DSM: Diagnostic and Statistical Manual of Mental Disorders, E: epidemiological, EPDS: Edinburgh Postnatal
Depression Scale, G: genetic family study; MDD: major depressive disorder, MDE: major depressive episode.
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2.1 Are there pregnancy or delivery specific trig-
gers for the onset of bipolar/mood disor-
ders?
Although the study by Kendell (1987) [52] was the first large systematic study
meeting the above methodological criteria, it did not discriminate between first
admissions and readmissions, and so I don’t discuss it in this section. Two
studies conducted on the Danish registries in recent years have investigated the
risk of a first psychiatric episode in relation to childbirth in the general pop-
ulation. By linking information on the Danish Civil Registration system with
information on the Danish Psychiatric Central Register, researchers were able
to follow-up the entire Danish population for many years (Terp et al from 1973
until 1993 [67] and Munk-Olsen et al from January 1973 to 2005 [68]).
Terp et al (1998) [67] compared the rates of hospital admission within 3
months after childbirth with those in the general Danish female population, in-
cluding parous and non parous women. The incidence for psychosis between 2
days and 3 months after delivery was 0.45/1000 deliveries. It is worth noting
that women admitted within 1 day of delivery were not included in the nomi-
nator. The highest risk of first admission was found for bipolar disorder (ICD-8
codes 296-19, 296-39 - relative risk = 6.82 95% CI 4.22-10.42). The highest risk
was for bipolar episodes occurring in the first month postpartum, while the risk
was lower and more spread out across the first 3 months in women with unipolar
depression (ICD-8 codes 296.09, 296.29).
Munk-Olsen et al (2006) [68] employed a different reference group, compar-
ing rates of admission in women during pregnancy and in the first 11 months
after childbirth with rates of admission in women who had given birth 11 to
12 months prior. The selection of a reference group of mothers presented an
advantage compared to the choice of the general female population as in Terp et
al [67]. In fact, risk factors involved in the onset of a mental disorder may influ-
ence also the likelihood of becoming a mother (selection into parenthood). They
found, in fact, different patterns of admission between parent and non parent,
with a strong interaction between age, parenthood and risk of admission. With
the exception of pregnancies in early years (before 26 years of age), women with
children had fewer psychiatric admissions than those without children. This
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hypothesis was corroborated by a subsequent study on the same registries [69],
that found that those who suffered with more severe disorders were less likely
to become parents.
Although separate analyses were conducted on women giving birth to a second
live-born child, the focus of the research was primiparae with a live-born child
. The findings on hospital admissions are reported in figure 2.1.
Compared to admissions 12 months postpartum, there was an increased risk
of admission for bipolar disorder in the first 2 months postpartum, but not in
pregnancy or later in the postpartum. Similarly to Terp et al [67], the increased
risk of admission with unipolar disorders was lower and persisted in the first 5
months postpartum. Pregnancy had a protective effect with a decreased relative
risk of onset. The postpartum risk was only modestly increased for less severe
episodes that did not require admission.
Several caveats need to be considered in the interpretation of the results of Terp
et al [67] and Munk-Olsen [68] :
• In both studies, conducted on overlapping samples, diagnoses were made
according to the ICD criteria. Therefore, they included ’mental and be-
havioural disorder associated with the puerperium, not elsewhere classi-
fied’. This is a composite category and it is possible that atypical forms
of affective psychosis have been included in this category. Moreover, a
study conducted on the same Danish Psychiatric Central Register [70] on
the concordance between ICD-8 and ICD-10 found that the categories of
bipolar and unipolar disorders in ICD-10 are broader and more compre-
hensive compared to those in ICD-8.
• Analyses of medical registries provided robust evidence on severe episodes,
which required hospital admission. However, less severe episodes that
required outpatient contact were not investigated by Terp [67]. Although
Munk-Olsen [68] included separate analyses on outpatient contacts, it is
still possible that women with less severe episodes may have not sought
help in the health care system.
• Register studies, in general, rely on diagnoses made by clinicians in clinical
settings without using the diagnostic instruments and procedures usually
employed by researchers.
• Another problem that may lead to an underestimate of perinatal bipolar
episodes is related to the current nosology of mood disorders. Bipolar
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Figure 2.1: Risks of first-time hospital admission 0 to 12 months postpartum
among primiparae in Munk-Olsen 2006 [68]. The top graph displays the rate of
admission per 1000 person-years in pregnancy and the postpartum in primiparae
without a previous psychiatric history and with a live birth. The bottom graph
displays the relative risk of illness by period groups (pregnancy, first month,
second month) compared with women who had given birth 11 to 12 months
prior. I used Excel to draw the graphs. Abbreviations:UD: unipolar depression,
BD: bipolar disorder, F53: mental and behavioural disorder associated with the
puerperium, not elsewhere classified, for unipolar depression only 3-5 months,
d:days, mo:months
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depression is usually a ’longitudinal’ diagnosis, made in subjects who are
currently experiencing a depressive episode and who have a history of at
least one manic episode. Thus, women experiencing depression as first
lifetime episode are all initially labelled as unipolar. However, a study
conducted on the same registries estimated that about 14% of women
with first-time psychiatric contact during the first postpartum month for
any type of mental disorder excluding bipolar disorder converted to a
bipolar diagnosis within a 15-year follow-up period [7] compared to 4% of
women with a first contact at other times. The risk was highest for ad-
missions within 14 days postpartum (risk ratio adjusted for first diagnoses
and family history of psychiatric illness =2.53 (95% CI 1.57-4.07) The as-
sociation was stronger for hospital admission than for outpatient contacts.
In summary, despite some limitations, the studies conducted on the Danish
registries provide robust evidence of an increased risk of psychiatric hospital
admission in the first month postpartum, especially in primiparae with bipolar
disorder.
2.2 Is the perinatal period a period of increased
risk for a recurrence of bipolar/mood disor-
ders?
2.2.1 Registry based studies
The first large study meeting the quality criteria listed above was conducted
by Kendell et al (1987) [52] on the Edinburgh Psychiatric Case Register and
Scottish maternity discharge data. Rates of psychiatric admission/contact in
pregnancy and within 2 years after delivery were compared with the average
admission rate of the same group of women two years before childbirth, using
women as their own control group. Kendell et al [52] identified 486 women
who had a psychiatric admission before their first delivery. Across psychiatric
diagnoses, bipolar disorder (including mania and cycloid psychosis defined as
in [51]) had the highest risk of readmission in the first 3 months after childbirth
with 21.4% of deliveries affected. This study used diagnoses made according
to the ICD-9 diagnostic criteria and differentiated between depressed manic-
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depressive illness (ICD-9 296.3) and depressive neurosis (ICD-9 300.4)3. It
found that, although the risk of admission for depressed manic-depressive ill-
ness was 13.3%, lower than the risk for mania or cycloid, but still higher than
the risk for other disorders, including depressive neurosis (1.9%). Overall the
risk of manic-depressive psychosis after childbirth was significantly higher than
for any other psychiatric disorder (p=0.00008).
Terp et al [67], investigating clinical diagnoses made according to ICD-8 cri-
teria, found much lower relative risks of readmission across all diagnoses than
Kendell et al [52]. For bipolar manic depressive psychoses the relative risk was
only moderately increased (1.86, 95% CI 1.43-2.39) between 2 and 28 days and it
was even decreased between 29 and 91 days (0.38, 95%CI 0.25-0.56). For unipo-
lar manic depressive psychoses the relative risk was not significantly different
between 2 and 28 days (0.81, 95%0.48-1.28) and was moderately decreased be-
tween 29 and 91 days (0.65, 95% CI 0.44-0.92).
These contrasting results probably reflect the different reference groups chosen
(the entire Danish female population in Terp et al [67] vs women acting as their
own control in Kendell et al [52]). Both approaches have some limitations that
need to be considered in the interpretation of the results. The choice of Terp
et al [67] to include the entire female population as control group implied that
the chances of becoming a mother were the same among women with mental
disorders and women in the general Danish population (i.e. the authors did not
consider what Munk-Olsen et al [68] called selection into parenthood). However,
Laursen and Munk-Olsen [69] found in an overlapping sample that fertility was
significantly impaired in women with psychiatric disorders. Using the Danish
general female population as a reference, they found that the incidence rate
of becoming a mother for the first time was significantly lower in women with
unipolar depression (incidence rate ratio =0.57; 95% CI 0.55, 0.60) and even
lower in those with bipolar disorder (incidence rate ratio =0.36; 95% CI 0.33,
0.40). Due to a similar mechanism of selection into parenthood, Kendell et al [52]
estimates may be inflated. Kendell et al [52], in fact, used as denominator the
same women 2 years before pregnancy. It is possible, however, that women who
are well have more chances of getting pregnant and thus that the period before
pregnancy is a period in which the rates of admission are lower than other times.
3Depression precipitated by events in a person’s life. Chronic affective disorder charac-
terised by either relatively mild depressive symptoms or marked loss of pleasure in usual
activities. It is not a synonym of DSM-IV or ICD-10 dysthymia. See [71] for a discussion and
critique to the the current views on neurotic depression
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Terp et al [67] supported this thesis by finding in the Danish sample that the
admission rate before pregnancy (i.e. the reference group of the Scottish study)
was significantly reduced in comparison to the admission rate in the general
population (relative risk=0.08; 95% CI 0.07-0.09). The comparison between
these two studies exemplifies a recurrent problem in studies investigating the
link between childbirth and mental health: the choice of control groups can
have dramatic consequences not only in the magnitude of the effect (here 10-
fold lower in Terp et al [67] than in Kendell et al [52]) but also on the direction
of the effect (here decreased risk for unipolar depression in Terp et al [67] and
increased in Kendell et al [52]).
Two studies conducted in the last decade have acknowledged these limitations
and used parous women in the general population as control group. The first
study was conducted on the Nationwide Swedish Hospital Discharge and
Medical Birth registers [63]. Similarly to Kendell et al [52] and Terp et
al [67], the length of observation in the postpartum period was 3 months. Dif-
ferently from the previous studies only primiparae were included. The overall
incidence rate of admission for any psychiatric disorders was similar to the inci-
dence reported in Terp et al [67], at around 0.1% of deliveries. The age-adjusted
recurrence rate for admission with bipolar disorder in the postpartum was 8.5%
(95% CI 6.22-10.70). Interestingly, and in contrast with previous findings, Har-
wol et al [63] reported more than twice as high rates of hospital readmission for
schizophrenia (21.7%). Jones et al [72] pointed out that this marked discrep-
ancy with previous studies may be due to several methodological factors. First,
despite using diagnoses made according to ICD criteria as Kendell et al [52]
and Terp et al [67], Harwol et al [63] did not separate unipolar manic-depressive
illness from bipolar manic-depressive illness. As shown in the previous 2 studies
and confirmed by a subsequent research [65], the risk of readmission for bipolar
manic-depressive illness is at least 2-fold the risk for unipolar manic-depressive
illness. Moreover, hospital readmissions in women with chronic psychoses such
as schizophrenia may not be due to a new episode with acute onset within 3
months after childbirth but to other reasons such as necessity of assessing the
parenting skills or close monitoring of women, with attempts to prevent an ex-
acerbation by admission at the early signs of symptoms.
The most recent study was again a study conducted on the Danish registries.
It investigated the hospital readmission during the first year after a live-born
delivery. This study confirmed the interaction between parenthood and recur-
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rences, with non parous women having significantly more recurrences than the
parous counterparts. In this study primiparae with the same diagnosis who
gave birth 6 to 11 months earlier were the reference group. The rates of re-
currence in bipolar women were similar to those reported in previous studies
at about 22%. The risk of readmission in the bipolar group was more than 8
times higher than the risk for any other disorder and maximised between 10
and 19 days postpartum (relative risk= 37.22; 95% CI, 13.58-102.04). In this
study rates of readmission for unipolar depression were not intermediate be-
tween bipolar disorder and other mental disorders such as in the Scottish study
and in Terp et al [67], but were lower than those for schizophrenia. The different
risk profile for unipolar depression between studies may reflect the differences
between ICD-8/ICD-9 and ICD-10 in the classification of unipolar depressive
disorders. In ICD-10, in fact, the category neurotic depression was omitted and
replaced mainly by the diagnoses of dysthymia but also by recurrent depression
and depressive episode [73]. The inclusion of formerly labelled neurotic depres-
sions in ICD-10 unipolar depression group is likely to underestimate the risk of
recurrence in women with unipolar manic depressive illness.
In summary, there is solid evidence from register based studies that the risk of
a hospital readmission for bipolar disorder is the highest among psychiatric dis-
orders and it is significantly increased in the first month postpartum compared
to other times. However, register-based studies have major limitations: i) they
don’t question the reliability of diagnosis -that relies on the opinion of clinicians,
rather than on research instruments and methodologies and ii) are not able to
investigate mental disorders that do not require admission to a public hospi-
tal. The issue of bipolar depression has not been explored by register studies,
probably because it is difficult to examine, probably because it requires hospital
admission less frequently than mania. Interestingly, a clinical study found that
the majority of patients (57%, 34/60) referred for treatment resistant unipolar
postpartum depression suffered from bipolar disorder [74]. For these reasons,
clinical studies may provide further insights in the perinatal trigger.
2.2.2 Clinical prospective studies
The gold-standard for clinical studies aiming to estimate the rates of postpartum
recurrence is a longitudinal design in which women with bipolar/mood disorders
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are assessed and followed-up in pregnancy to establish the risk factors for a re-
currence and after childbirth to see whether they have developed an episode of
illness of not. Viguera et al [64] conducted an observational clinical cohort study
on 89 women with DSM-IV bipolar disorder in pregnancy who were euthymic at
conception. In this study the follow-up period was limited to pregnancy and no
information was provided on episodes after childbirth. The recurrence rate of
any episode of bipolar disorder in pregnancy was 71%, with women discontinuing
the mood stabilising therapy at twice as high risk of a recurrence than those who
continued the therapy. Moreover, about 3 in 4 (74%) episodes were depressive
or mixed4, with only 1 in 4 women having a clear cut manic/hypomanic episode.
The same research group conducted a similar study on recurrent major depres-
sion and found that 43% of women had a relapse in pregnancy [56]. Similarly
to bipolar disorder, women who discontinued their medication had a increased
risk of relapse compared to those who didn’t (hazard ratio= 5.0; 95% CI 2.8-9.1;
pă 0.001).The high rates of recurrence in pregnancy seem to be in contrast with
the results of the register-based studies discussed above, in which pregnancy was
protective against a relapse. However, the latter clinical studies assessed also
less severe episodes, that did not require hospitalisation and reported only the
raw rates, without comparing them with the rates in the postnatal period or
at other times. Moreover the academic tertiary setting is not representative of
the entire population at risk and may include only most severe cases. Both
studies limited the sample to women who received a medical treatment prior to
pregnancy and who then discontinued it or not. However, women with bipolar
disorder or recurrent major depression who are well are not necessarily in con-
tact with the services or taking any therapy. So the results of both studies may
be inflated by the selection of particularly severe patients with highly recurrent
illness. Unfortunately, Cohen reported the length of illness, the average num-
ber of episodes, the type of course of illness of the participants, but not other
indicators of severity and it was impossible to establish if women with a more
severe course were selected. However, it seems the case for the bipolar sample
in Viguera et [64] where about 1 in 2 participants had an onset of the disorder
before the age of 15 and about 30% reported more than 1 episode/year of illness
4In this paper it is not clear what criteria were used to define a mixed states. The DSM-IV
criteria are : A. The criteria are met both for a manic episode and for a major depressive
episode (except for duration) nearly every day during at least a 1-week period B. The distur-
bance is sufficiently severe to cause marked impairment, or to necessitate hospitalisation to
prevent harm to self or others, or there are psychotic features. C. The symptoms are not due
to the direct physiological effects of a substance or a general medical condition (pregnancy is
not considered a general medical condition!) [5] However, it is very unlikely that Viguera et
al [64] used DSM-IV criteria, that are narrow and exclude BD-II
43
and about 40% reported prior rapid cycling.
2.2.3 Clinical retrospective studies
Given the paucity of informations from longitudinal studies, I also discuss 2 ret-
rospective studies conducted again by Viguera et al [6, 58] on overlapping sam-
ples (that included also data from the longitudinal sample described above [64]).
In the first study [58] the authors compared the rates of recurrence after lithium
discontinuation in women who discontinued the therapy during pregnancy and
in those who discontinued it outside the perinatal period. Rates of recurrence
in pregnant women (52%) were similar to rates of recurrence in non-pregnant
women (58%) during the first 40 weeks after lithium discontinuation, while post-
partum recurrences were about 3 times more frequent than recurrences during
an equivalent period of time for non-pregnant women (70% versus 24%). Inter-
estingly, in accordance with the longitudinal study described above [64], depres-
sive and mixed-dysphoric episodes were significantly more common among preg-
nant/postpartum women than in non-gravid subjects (63.16% versus 37.50%,
p=0.02). More recently Viguera et al conducted a retrospective study on 1,162
women with DSM-IV BD-I (479 pregnancies/283 women), BD-II (641/338), or
RMD (1,132/541) who were treated in three tertiary academic settings spe-
cialised in perinatal mood disorders [6]. The study derived several measures to
assess the risk of recurrence. In the bipolar disorder group (either BD-I or BD-
II), 23% of participants reported an episodes during pregnancy and 52% in the
postpartum period, defined as within 6 months after childbirth. The rates were
lower for unipolar depression, with 4.6% reporting an episode during pregnancy
and 30% in the postpartum. In addition to the retrospective design, this study
had the same limitations of the previous studies conducted by Viguera [58,64].
It could also be argued that the conclusions are not generalizable because the
sample was drawn from tertiary academic settings. Moreover, the definition
and validity of ’mixed states’ used by Viguera were not clear. The DSM-IV
criteria for a mixed states implied a full-blown manic episode and thus mixed
states should not occur in women with BD-II. However, mixed states affected
3.5% of women in the BD-II group during pregnancy and 22.5% after childbirth.
Moreover, none of the participants with RMD or BD-II reported psychosis.
In summary, in women with bipolar disorder recurrences following childbirth
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are significantly more common than at other times. With the exception of
Harlow et al [63], studies found that bipolar disorder has the highest risk of
recurrence across psychiatric disorders. Clinical studies investigating the symp-
tomatology of the recurrences found that mixed and depressive episodes were
more prevalent than mania. There is no evidence that pregnancy is a specific
trigger for mood episodes. The high rates of recurrences in pregnancy observed
by clinical studies are probably associated with the high rates of women discon-
tinuing the medications during pregnancy.
2.3 What period of time should be covered by
the postnatal onset criterion? Should preg-
nancy be included?
I have already discussed the current definition of postpartum onset in chapter 1.
Here I summarise the evidence from registry and clinical studies on the length
of the postpartum period. The studies I examined in the previous sections have
all consistently reported an increased risk of hospital admission within the first
month after childbirth. Results on a longer length of time after childbirth are
controversial, but all univocally report a lower risk compared to the first month
after delivery.
Less recent studies [75, 76] used a 6 months postpartum criterion. Kendell et
al in the Scottish registry study [52] found that, although the admission rate
maximised in the first month, it was still higher than before pregnancy for 2
years after delivery and proposed a 3 months criterion.
A lot of debate has been generated on whether there is a lucid interval between
delivery and the onset of postpartum psychosis5.
Paffenbarger [76] reported that only one third of women with postpartum psy-
chosis had the onset in the first week postpartum and less than 70% of women
with postpartum psychosis had an onset within 4 weeks. On the opposite side,
Brockington et al [77] and Heron et al [78] argued against a lucid interval. In a
clinical retrospective study conducted on women with a history of postpartum
mania or affective psychosis within 4 weeks postpartum 6 73% of participants
5I use the term postpartum psychosis because the studies I discussed are antecedent to
the DSM-IV and ICD-8 classifications and used different diagnostic criteria for ’postpartum
psychosis’
6This sample was part of the Mood disorder research project
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recalled the first manic symptom within 3 days postpartum and about 95%
within the first 2 weeks. The results are, however, not generalizable, as women
were recruited as part of a project on bipolar disorder and the majority of them
suffered from both perinatal and non perinatal recurrences. It is an important
limitation, because, as argued in a review based on follow-up studies by Chau-
dron and Pies [79], although the majority of episodes of postpartum psychosis
occur in women with bipolar disorder, this is not the case for all episodes.
Bergink et al recently conducted a prospective study on a small cohort (n=57)
of women admitted to a mother and baby unit for postpartum psychosis 7,
without a history of bipolar disorder or psychosis outside the postpartum pe-
riod [80]. For 45 patients this was the first psychotic episode. Although a
previous history of postpartum disorders had no effect on time of onset, there
were significant differences according to the polarity of mood symptoms. Pa-
tients without depression had a significantly earlier onset of psychosis (median
= 7 days; interquartile range = 4-10) than patients with psychotic depression
(median=18 days; interquartile range = 7-21). Unfortunately the groups were
very small (only 7 women had prominent depressive psychotic features) and
solid conclusions cannot be drawn. Moreover, as in Heron et al [78], women
who had an episode of psychosis later in the postpartum were not included
in the studies and thus it was not possible to determine whether a 1 month
postpartum criterion was too narrow. However, a similar pattern was reported
in previous studies that found that women with manic episodes were admitted
more quickly than those with depressive psychosis [81–83].
There is a lack of information on the time-to onset of bipolar depression. In
registry studies that considered only unipolar depression, the definition of de-
pressive episodes varied significantly and may be in part responsible for the
lack of consistent results. Insights on the length on the postpartum period in
RMD are provided by a family study conducted on the Mood Disorder Research
Project dataset. Forty et al [84] studied 120 sibling pairs with RMD and found
that the familiality for postpartum depression maximised when a postpartum
definition of 6-8 weeks was applied. One of the major aims of my research was
to partially fill this gap in knowledge on bipolar postpartum depression and
on whether lifetime diagnosis made any difference in the time-to onset between
unipolar and bipolar depression.
7defined as DSM-IV depressive disorder with psychotic features, mania with psychotic
features, mixed episode with psychotic features, psychotic disorder not otherwise specified
(NOS), or brief psychotic disorder with onset within 4 weeks after delivery
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2.3.1 Pregnancy
Registry based and clinical studies found that pregnancy was a ’protective’ pe-
riod with a reduced risk of new onset disorders and recurrences. A prospective
clinical study found high recurrence rates in pregnancy in women who discon-
tinued the medications [64]. However, the high recurrence rates in pregnancy
were similar to the rates of recurrences in women who discontinued the ther-
apy outside the perinatal period. Moreover, in a retrospective clinical study
Viguera et al [6] reported that the postpartum/pregnancy risk ratio in unipolar
depression was higher (3.68, 95% CI=3.16-4.30) than that in BD-II (1.68, 95%
CI=1.20-2.01) and in BD-I (1.52, 95% CI=1.15- 2.03). Although there is no
consistent evidence of an increased risk of bipolar/mood episodes in pregnancy,
I analysed in my research also information on pregnancy onset for a reason of
completeness and clinical utility. Depression in pregnancy, in fact, could be less
prevalent than depression in the postpartum period, but, there is increasing
evidence that it has long-term negative consequences on the offspring. The lon-
gitudinal, community-based South London Child Development Study followed
up until the age of 16, 25 children who were exposed to maternal depression
in utero and 95 who were not. Antenatal depression was associated with an
about 4-fold increased risk of maltreatment in the offspring, not necessarily
perpetrated by the mother. Although antenatal depression was not associated
with subsequent psychopathology in the offspring, children who were exposed
to depression in utero and who were also maltreated had a 12 times greater risk
of developing psychopathology than the non exposed counterpart [85].
2.4 Summary
In this chapter I have reviewed the literature on the childbirth trigger of episodes
of mood disorders. For women who have never suffered from any mental dis-
orders, the first month postpartum is a period of increased risk of hospital
admission for mania or affective psychosis. Similarly, for women who have a
previous history of bipolar disorder, the first month postpartum is a period of
increased risk of hospital readmission. The majority of studies reported that the
association with childbirth shows some specificity for bipolar disorder. Postpar-
tum non bipolar episodes in women with no psychiatric history are associated
with an increased risk of further episodes of bipolar disorder. Although there is
a lot of evidence on the association between childbirth and admission for ma-
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nia, there is a paucity of information on less severe episodes. Moreover, lack of
consensus on the terminology used to defined postpartum episodes and on the
reference groups has led to some inconsistencies.
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Chapter 3
Clinical characteristics of
perinatal mood episodes
In the previous chapters I overviewed some of the epistemic and nosological diffi-
culties that raise when we investigate perinatal mood disorders. In this chapter
I provide a schematic overview on the clinical aspects of postnatal depression
and postpartum psychosis in bipolar disorder. I particularly stress the diagnos-
tic features and the risk factors involved in the liability to postnatal episodes,
because they were key factors in designing the prospective study that I discuss
in chapters 10 and 11.
3.1 Postpartum psychosis
3.1.1 Aetiology and pathophysiology
A range of factors has been suggested to increase vulnerability to postpartum
psychosis:
Genetic factors There is robust evidence that the vulnerability to the trig-
gering of affective psychosis by childbirth aggregates in families and may
define a genetically relevant subtype of bipolar disorder [59,86]. Evidence
from family studies suggests that episodes of postpartum psychosis are a
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marker for a more familial form of bipolar disorder [87] and that a specific
vulnerability to the puerperal triggering of bipolar disorder is familial [59].
Evidence from a linkage study indicated the possible location of a suscep-
tibility gene on chromosome 16 [86]. Particular candidate genes, such as
those involved in the serotoninergic [88,89], hormonal [90,91], and inflam-
matory pathways [92], have been also investigated.
Obstetric risk factors An increased risk of postpartum psychosis has been re-
ported with primiparity, pregnancy and delivery complications, caesarean
section, female baby and shorter gestation period. However, findings are
consistent only for primiparity [93]. The bias that women with a severe
postpartum episode may be less likely to go on to have further children
is unlikely to be the sole, or even the main, explanation [93]. Given that
there is little evidence of an association between postpartum psychosis
and psychosocial factors, the possibility remains that the effect of primi-
parity is, at least in part, due to biological differences between first and
subsequent pregnancies. It is of particular interest the overlap with other
pregnancy related disorders, such as pre-eclampsia, that have also been
reported to occur more frequently in first pregnancies. Hormonal, im-
munological and other biological differences between first and subsequent
pregnancies are therefore interesting targets for further investigation into
the aetiology of postpartum psychosis. This is the main topic of chapter
9.
Changes in medications Women with bipolar disorder often come off mood
stabilizers, such as lithium, preconception or in early pregnancy because
of concerns over toxicity to the foetus. A survival analysis comparing
women with bipolar disorder who stopped taking lithium because of preg-
nancy compared with age-matched non-pregnant women who discontin-
ued lithium for other reasons, reported similar rates of recurrence during
the first 40 weeks after lithium discontinuation for both groups. How-
ever, among subjects who remained stable over the first 40 weeks after
lithium discontinuation, postpartum recurrences were 2.9 times more fre-
quent than recurrences in non-pregnant women during weeks 41-64 (70%
versus 24%) [58]. Thus, the increased risk of recurrence following child-
birth for women with bipolar disorder does not appear to be merely a
result of stopping mood-stabilizing medication.
Hormonal factors The lack of evidence implicating psychosocial factors and
consideration of the abrupt onset during a time of major physiological
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change suggest that biological, possibly hormonal, factors are important.
The role of several hormones (including estrogens, progesterone, prolactin,
follicular stimulating hormone and luteinizing hormone) has been consid-
ered, but the evidence pointing to hormones in the aetiology of postpartum
psychosis is predominantly circumstantial.
Sleep deprivation A plausible hypothesis is that the sleep deprivation of de-
livery and the immediate postpartum period is responsible for puerperal
triggering of illness. Sleep loss can effectively trigger the onset of mania
in people with bipolar disorder and sleep loss is, of course, common for
new mothers. In a small study flawed by many methodological limitation
(chart review with no direct measure of sleep, and use of a healthy con-
trol without psychiatric history rather than a comparison group of at-risk
women), Sharma et al found that postpartum psychosis was associated
with longer duration of labour and and nighttime delivery. In the group
of women with postpartum psychosis insomnia was the most frequent and
usually the earliest symptom [94].
3.1.2 Prevention
Screening for risk factors
In addition to a history of bipolar disorder or postpartum psychosis, other risk
factors for postpartum psychosis include having a first-degree relative who has
experienced postpartum psychosis and having a first-degree relative with bipolar
disorder [95].
For women who themselves have a history of mood disorder, particularly bipolar
disorder, a family history of a severe postpartum episode is very important and
may indicate a risk in excess of 50%.
For women who have themselves not suffered with psychiatric illness, it is not so
clear that a family history is relevant with a risk of postpartum psychosis in low
single figures. While this represents a considerable increase on the population
risk of around 1 in 1000, it is unclear whether extensive efforts to identify women
who are well but with a family history is a worthwhile strategy. It is not in
doubt, however, that family history is an important consideration in women
with a personal history of bipolar disorder.
Because of the relapsing and remitting nature of bipolar disorder, women at
high risk are often currently well and not in contact with mental health services
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and will fail to recognise the serious risks of the situation. Thus, all women
should be screened for known important risk factors at their antenatal booking
visit. Protocols should be put in place to ensure that women at potential risk
receive a formal risk assessment and management plan [95].
Management of women at high risk
Women at high risk of postpartum psychosis need very careful care before con-
ception, throughout pregnancy and during the postpartum period. The high
risk of illness in the weeks following delivery in a woman with a history of bipo-
lar disorder must be recognised both by healthcare professionals and by the
woman herself.
Preconception The possibility of future pregnancy should be considered in
all women with bipolar disorder who are of childbearing age. The risks of illness
following childbirth should be discussed with women and the importance of
seeking help emphasised. Decisions about continuing or stopping medications
before, or during, pregnancy are difficult and should be the result of a detailed
and individualised risk analysis [95]. Although there are significant concerns
about the teratogenic effects of the medications used to treat bipolar disorder,
the risks of stopping medication must also be considered. Data suggest that
women with bipolar disorder who stopped medication during pregnancy were
more than twice as likely to experience a recurrence than those who remained
on medication [64].
During pregnancy and after childbirth Perhaps the most important as-
pect of care is to maintain close contact and review during the perinatal period.
Women at high risk, even if they are well, should be referred in pregnancy for
psychiatric assessment and monitored regularly for at least 3 months follow-
ing delivery. Psychiatric services should have priority care pathways for preg-
nant and postpartum women and care by multiple psychiatric teams should be
avoided [96]. It may also be important to address other avoidable factors that
may increase risk - such as decreasing general levels of stress and paying atten-
tion to sleep in late pregnancy and the early postpartum weeks. For women
with a history of bipolar disorder who have been off medication in pregnancy
the introduction of prophylactic medication in the immediate postpartum pe-
riod should be considered. Some evidence exists for the use of lithium in this
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context, but the few studies have been open and retrospective and there are
practical problems with reaching therapeutic levels quickly to cover the period
of risk. These issues have led some perinatal psychiatrists to use typical or
atypical antipsychotics as prophylaxis [97].
3.1.3 Diagnosis
Examination
The distinctive clinical features include sudden onset and rapid deterioration.
The vast majority of episodes has its onset within 2 weeks of delivery, with
over 50% of symptom onsets occur on days 1-3 [98]. The clinical picture often
changes rapidly, with wide fluctuations in the intensity of symptoms and severe
swings of mood. Common symptoms and signs include: 1) A wide variety
of psychotic phenomena such as delusions and hallucinations, the content of
which is often related to the new child. 2) Affective (mood) symptoms, both
elation and depression. 3) Disturbance of consciousness marked by an apparent
confusion, bewilderment or perplexity.
Differential diagnosis
• Primary cerebral or systemic disease (e.g. eclampsia or infection) should
be excluded. The misattribution to psychiatric disorder has led to a num-
ber of deaths in new mothers [96].
• Exogenous toxic substances or hormones: History of therapeutic use and/or
abuse of known causative substances or hormones, other symptoms and
signs specific to the substance or substances involved should be investi-
gated. Urine drug screen may be positive in substance abuse and identifies
the substance taken, although it is not definitive for drug misuse.
• Other psychiatric disorders of the puerperium:
– Minor mood disorders (mood swings)
– Postpartum depression
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The tendency for all postpartum episodes to be labeled as postnatal depression
can lead to suboptimal care and, in some cases have dramatic consequences on
mothers and babies. The last Confidential Enquiries into Maternal Deaths in
the United Kingdom reported that 8 out of 11 women, who committed suicide
after suffering for postpartum psychosis, were initially diagnostisized as suffer-
ing for anxiety or mild depression or adjustment disorder [96]. Any psychotic
symptoms, particularly delusions or hallucinations, substantially increase risk
for both mother and child. The woman should be referred for a same day
emergency appointment so that a detailed risk assessment can be carried out.
3.1.4 Treatment
Hospital admission
Postpartum psychosis is a psychiatric emergency. The clinical picture may mis-
lead, quickly become extremely severe and vary significantly from hour to hour.
Patients are usually admitted for treatment. Even women with the most sup-
portive of families are likely to require hospital admission. The National Insti-
tute for Health and Clinical Excellence (NICE) guidelines 23 recommend that
women within a year of childbirth should be offered admission to a specialist
mother and baby unit, however, the provision of services across the United King-
dom is patchy and for the majority of women there is no option of admission
with her baby [99].
Pharmacological treatment
A range of psychotropic medication may need to be employed. The treatment
used depends on a number of factors, including the symptoms that the woman
experiences, her level of disturbance and her previous response to medication.
For many women the severity of the illness does not allow breastfeeding. If
breastfeeding is being considered, factors in the baby such as prematurity and
systemic illness should be considered in addition to the particular properties
of the medication itself. Limited data suggest that the use of lithium during
breastfeeding is not as problematic as once thought but it tends to be avoided
because of the risk of toxicity in the infant.
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3.1.5 Prognosis
The short-term prognosis for postpartum psychosis is generally good. However,
women need to be counselled about the risks they run of a further puerperal
or non-puerperal episode. This will include discussing the need for longer-term
mood stabilising medication and other measures that can reduce the risk of
recurrence. Despite the high risk of recurrence following further deliveries, many
women make the decision to become pregnant again and it is our strongly held
view that women with PP, or indeed bipolar disorder more generally, should not
be told that they should not have children.
Risk of non-puerperal recurrences
There is a paucity of information on rates of non-puerperal recurrences. Robert-
son et al [100] found that, following the index episode of postpartum psychosis,
62% of women experienced at least one non-puerperal affective episode of ma-
nia, depression or hypomania during a median period of observation of 9 years
from recovery.
Complications
Neglect of the baby Referral to safeguarding teams should not be routine,
but should take place as the result of a risk assessment. Extra vigilance
and care are required in these cases, as it may increase the risk of deteri-
oration in the mother’s mental health and suicide [97].
Infanticide Infanticide is a very rare complication. The past two Confidential
Enquiries into Maternal Deaths in the United Kingdom didn’t report any
infanticide in mothers suffering from postpartum psychosis .
Suicide According to the Eight Report of the Confidential Enquiries into Ma-
ternal Deaths in the United Kingdom, psychosis was the most common
diagnosis in woman who committed suicide after childbirth [96].
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3.2 Postpartum depression
There is a paucity of evidence on bipolar depression. However, the topic cannot
be neglected, given the high rates of depressive recurrences in the perinatal
period in bipolar disorder. The data reported in this section are mostly based
on unipolar samples. The few studies on bipolar depression are reported in the
last paragraph.
3.2.1 Aetiology and pathophysiology
The aetiology of postpartum depression is poorly understood but is likely to
involve an interaction between psychological, social, and biologic factors. For
non psychotic episodes of major depression, a specific relationship with child-
birth has been challenged [101]. It has been argued that depression is no more
common following childbirth, that the clinical presentation is no different from
that for depression occurring at other times, and that the treatment options are
the same. However, a proportion of women with postpartum depression may be
vulnerable to a specific puerperal trigger.
Hormonal factors No major differences in the hormonal profile of women
who develop postpartum depression have been reported [102]. However, it
has been suggested that women who become depressed postpartum may
have an abnormal sensitivity to the normal physiologic changes of child-
birth [103].
Exaggerated immune response It has also been suggested that the inflam-
matory response after labor and delivery may be exaggerated in women
who develop postpartum depression [104].
Genetic factors Vulnerability to postpartum depression within 8 weeks of de-
livery may be familial [84]. For women without a personal history of
major depression, however, the importance of a positive family history is
less clear [105]. An Australian twin study reported that genetic factors
accounted for 26% to 49% of variance in postpartum depressive symp-
toms [106]. A study suggested that genetic variation on chromosomes 1q
and 9p might increase susceptibility to broadly defined postpartum mood
symptoms in a sample of women with both unipolar and bipolar disor-
der [107].
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Sleep disruption A strong association between infant sleep patterns, maternal
fatigue, and new-onset depressive symptoms in the postpartum period has
been suggested. Therapeutic interventions to reduce sleep deprivation in
the early weeks postpartum have been tried [108].
Previous psychiatric history A previous history of psychiatric illness, either
in pregnancy or lifetime, has been strongly associated with postpartum de-
pression. Postpartum depression is more likely to occur in patients with
a history of previous depression or anxiety [105, 109–112]. Discontinuing
psychopharmacological treatments increases the risk of postpartum de-
pression in patients with depression or a bipolar disorder [58]. Women
who experience prenatal depression have about a fivefold increased risk of
developing postpartum depression [113], while women who experience pre-
natal anxiety have a threefold increased risk [113].Two longitudinal studies
also found that hypomanic symptoms at day 3 predicted depressive symp-
toms at 6 weeks postpartum [114,115].
Psychosocial factors There is a strong association between recent life events
and postpartum depression. In the presence of clear psychosocial adver-
sity and mild to moderate postpartum depression, the risk of subsequent
depressive episodes depends on the persistence of the adverse circum-
stances [116]. Emotional and instrumental supports have been negatively
correlated with postpartum depression [105, 109, 112, 117, 118] while per-
ceived social isolation was strongly predictive of depression in the postpar-
tum period in a sample of black women with low incomes [119]. Marital
problems during pregnancy and the lack of a supportive partner have been
found to moderately increase the risk of postpartum depression [112]. Low
income, financial strain, unemployment, and low social status have a small
but significant predictive effect on postpartum depression [112,119].
3.2.2 Prevention
Intensive professional postpartum support individually targeted at at-risk moth-
ers may be beneficial. Although the evidence base is small, it may be appro-
priate to offer antidepressant prophylaxis to some women with a strong history
of depression [116]. Current guidelines, however, do not recommend psychoso-
cial interventions routinely as part of prenatal and postpartum care [99]. An
argument can be made for a lower threshold for access to psychological ther-
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apies during pregnancy and the postpartum period arising from the changing
risk-benefit ratio for psychotropic medication at this time.
Management of women at risk
Advice about future risk should be tailored to the individual patient [116]. It is
important to give relevant information to women with an existing mental illness
who are planning a pregnancy or are pregnant, as well as to those women who
develop an episode during pregnancy or the postpartum period [99]. This should
include the impact of the disorder and its treatment on both the woman herself
and her baby and a full discussion of the risks and benefits of medication [99].
3.2.3 Diagnosis
Screening
Suspected mild and moderate depression can be assessed and managed in pri-
mary care. Depression should routinely be sought in all women in the perinatal
period [99,120]. Risk factors should be identified.
The Bromley Postnatal Depression Scale [121], the Edinburgh Postnatal De-
pression Scale [122], and the Postpartum Depression Screening Scale [123] are
self-reported measures specifically designed to screen for depression in the post-
partum period. The Edinburgh Postnatal Depression Scale had been most
widely studied. It has been psychometrically tested extensively in postpar-
tum women and used throughout the world. Sensitivity and specificity of cutoff
points showed marked heterogeneity between different studies. Sensitivity re-
sults ranged from 34% to 100% and specificity from 44% to 100%. The cutoff
score of ą12 has an overall positive predictive value of 57% and negative pre-
dictive value of 99%. Other tools such as the Beck Depression Inventory [124]
may have value but require further research [125]. These screening tools should
be used to identify women who need further clinical assessment.
The United Kingdom National Institute for Health and Clinical Excellence
[99, 120] recommends that healthcare professionals (including midwives, obste-
tricians, health visitors, and general practitioners) should ask 2 questions to
identify possible depression (Whooley questions), at the woman’s first contact
with primary care, at her first prenatal appointment, and postnatally (usually
at 4 to 6 weeks and 3 to 4 months).
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US guidelines stress the importance of routinely assessing patients for depres-
sion but do not provide a definitive recommendation as to how patients should
be screened and which tools should be used [120].
Symptoms
Patients may present with a history of depressed mood, anhedonia, weight
changes, sleep disturbance, psychomotor problems, low energy, excessive guilt,
loss of confidence or self-esteem, poor concentration, or suicidal ideation [126].
Depressed mood is to a degree that is abnormal for the person, present for most
of the day, and largely uninfluenced by circumstances.
There is evidence of a relationship between postpartum depression and obsessive-
compulsive symptoms, particularly unwanted intrusive thoughts of hurting the
newborn [127]. In one study of 37 women with postpartum depression, 57%
reported obsessional thoughts, of which 95% had an aggressive content. The
most frequent content of the aggressive thoughts was causing harm to their
newborns or infants. The presence or number of obsessional thoughts or com-
pulsions was not related to severity of the depressive episode [128]. In another
study, of the 41% of women with postpartum depression who reported aggres-
sive obsessive thoughts, 5% had actually acted in an aggressive way toward
their child. However, it must also be noted that the prevalence of aggressive
thoughts among postpartum women without depression is 6.5% [129]. Psychotic
symptoms occurred in 4% of episodes in one study [130]. These include halluci-
nations, delusions, confused and disturbed thoughts, and a lack of insight and
self-awareness. They can substantially increase risk of self-harm or harm to the
baby, particularly if the delusions or hallucinations relate to the baby.
Physical exam is required to assess the patient’s general medical status but does
not reveal any specific features of depression. However, examination of the skin
may reveal stigmata of trauma, self-injury, or drug use.
• Minor mood disturbance (postpartum blues or baby blues, mood swings)
• Postpartum psychosis. Any psychotic symptoms substantially increase the
risk of self-harm or harm to the baby, particularly delusions or hallucina-
tions that relate to the baby. The core feature of postpartum psychosis
is the acute onset of a manic or depressive psychosis in the immediate
postpartum period. Postpartum psychosis is a psychiatric emergency and
can develop rapidly into a very severe condition.
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• Internistic conditions, such as anemia and thyroid dysfunctions.
3.2.4 Treatment
Guidelines recommend a stepwise approach to the treatment of postpartum de-
pression [99], although it is important that women with severe illness receive
appropriate treatment quickly rather than working through various levels of
treatment. Treatment can be effectively organised via primary care.
Referral to specialist mental health services is reserved for patients with suici-
dal ideation, thoughts of harming the child, severe disease, and/or features that
raise suspicion of bipolar illness. Before treatment decisions are made, health-
care professionals should discuss with the patient the absolute and relative risks
associated with treating and not treating the mental disorder in relation to
breastfeeding, the evolutionary risk of the illness and the impact on the mother-
child relationship.
For a woman who develops mild or moderate depression1 during the postpartum
period, the following should be considered [99,126]:
• Self-help strategies (guided self-help, computerised cognitive behavioural
therapy, or exercise)
• Brief cognitive behavioural therapy or interpersonal psychotherapy
• Antidepressants are recommended if the patient declines psychological
therapy, if it is unavailable or does not work, or if the woman has a prior
history of severe depression [99,126].
For a woman who develops a severe postpartum depressive episode or a moderate
postpartum depressive episode with a prior history of severe depression, the
following should be considered [99,126]:
• Cognitive behavioural therapy or interpersonal psychotherapy
1Depression is defined as mild, moderate, and severe as follows: Mild: few if any symptoms
more than the number required for diagnosis of depression with minor functional impairment.
Moderate: more than the required number of symptoms for diagnosis of depression with
greater intensity and moderate impairment in functioning. Severe: many more symptoms
than required for diagnosis of depression with intense functional impairment [5]
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• Antidepressant therapy if preferred by the patient
• Combination treatment if there is no, or a limited, response to psycholog-
ical or drug treatment alone.
The local availability of psychological therapies is an important factor when
determining which treatment to offer, as waiting times can be lengthy. It is
vital to treat women with severe illness promptly, which often necessitates the
use of antidepressant drugs [99,126].
Non-pharmacologic therapy
A Cochrane meta-analysis of 10 trials of psychological and psychosocial inter-
ventions [98] concluded that peer support and non-directive counselling, cog-
nitive behavioural therapy, psychodynamic psychotherapy, and interpersonal
psychotherapy are all effective in postpartum depression. Women requiring
psychological treatment should be seen for treatment quickly, ideally within 1
month of initial assessment [99].
Pharmacologic therapy
Specific evidence for the pharmacologic management of postpartum depression
is limited [116]. Antidepressants are often prescribed for postpartum depression
according to the same principles delineated for other types of major depressive
disorder, despite a limited number of controlled studies. However, in breast-
feeding women the risk-benefit balance of antidepressant drugs is altered, and
psychological therapies are therefore preferred if possible [99]. If antidepressant
therapy is given, patients require close mood monitoring in case a hypomanic
or manic episode is triggered.
Treatment depends on the patient’s preference, previous responses to treat-
ment, local availability of psychological therapies, the severity of the illness,
and the risks involved. Certain antidepressants are considered safer than oth-
ers in breastfeeding women, but in general the long-term outcomes for babies
exposed to maternal antidepressant treatments are unknown.
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Emerging Therapies
A Cochrane review on oestrogens and progestins for preventing and treating
postpartum depression suggests that synthetic progestins may be used with
significant caution in the postpartum period and that oestrogen therapy may be
of modest value [131]. However, oestrogens have not been rigorously evaluated,
and further research is warranted, given the increased risk of thromboembolism
associated with their use.
3.2.5 Prognosis
Differing definitions of postpartum depression across studies make it difficult to
interpret prognostic information. Outcomes depend on the severity and nature
of the symptoms. Episodes of postpartum depression last 3 to 6 months on
average, but a few women remain depressed at 1 year [116].
Risk of further episodes
Women with a first episode of postpartum depression have a higher risk of sub-
sequent postpartum depression (41% vs. 18%) but a lower risk of depression
outside the postpartum period (38% vs. 62%).
In the presence of clear psychosocial adversity and mild to moderate postpartum
depression, the risk of subsequent depressive episodes depends on the persistence
of the adverse circumstances [116]. If the adversity was a discrete life event, such
as the breakdown of a relationship, and has been resolved, then the risk of future
postpartum depression may be low. However, the risk of future episodes in this
situation depends not only on the life event itself but also on a wide range of
patient-specific psychological and biologic factors [116].
Early-onset depression (within the first 6-8 weeks), severe depression, and de-
pression with bipolar or psychotic symptoms suggest the presence of a specific
puerperal trigger, and the risk of subsequent postpartum episodes may be higher
in these patients [100].
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Complications
Impaired bonding with infant A strong correlation exists between postpar-
tum depression and impaired interaction and bonding between mother
and infant. Avoiding or impaired bonding with the baby, a lack of feeling
of attachment toward the infant, and a sense of numbness are important
features to consider. Impaired maternal-infant bonding has a negative im-
pact on infant development and may also affect later child development.
It also adds to the mother’s sense of shame and guilt. Infant exposure
to maternal depression has been shown to have negative consequences be-
haviourally, cognitively, and emotionally. Affected infants demonstrate
restricted facial expression and fewer interests. Treatment of maternal
depression reduces depression, anxiety, and disruptive behaviour in the
child, whereas no treatment results in worsening of these symptoms. Co-
morbidity with a personality disorder increases the risk of dysregulated
infant behaviour [132].
Neglect of the baby, maltreatment or infanticide Situational and environ-
mental factors might increase or decrease risk. Any history of attempted
suicide or harm to the baby, any psychotic symptoms substantially in-
crease risk, particularly delusions or hallucinations that relate to the baby.
In these cases, the patient should be referred for a same-day emergency
appointment so that a detailed risk assessment can be carried out [116].
Suicide is much more common than infanticide in new mother with severe
psychiatric disorders. A preliminary assessment of the risks of suicide
can be made by assessing the current mental state and any situational
and environmental factors that might increase or decrease risk [116]. Also
in these cases, the patient should be referred for a same-day emergency
appointment so that a detailed risk assessment can be carried out.
3.2.6 Postpartum depression in bipolar disorder
Postpartum depression most often occurs in the context of a unipolar depres-
sive illness. However, episodes of mood disorder following childbirth are very
common in women with bipolar disorder, and a small proportion of postpar-
tum depressive episodes are bipolar. The consequences of missing a diagnosis of
bipolar disorder can be particularly serious, as treatment with antidepressants
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may precipitate mania, a mixed state, or rapid cycling, and thereby increase the
risk for admission to a psychiatric hospital [4]. It has been reported that 54%
of 56 outpatients seen consecutively with the referral diagnosis of postpartum
depression were re-diagnosed as having a lifetime diagnosis of a bipolar disor-
der [133]
Screening should include questions about a family history of bipolar disorder.
Atypical features [5] , racing thoughts, and psychotic symptoms during a de-
pressive episode should raise suspicion of a bipolar disorder [4].
In addition to asking questions about high mood and related symptoms in the
history, questionnaires can also be used. There is no screening instrument
designed specifically for use before or after delivery in women with bipolar
disorder [134]. Self-reported measures used to screen for bipolar disorder in
the general population include the Altman Self-Rating Mania Scale [135], the
Highs [115], the Mood Disorder Questionnaire [136], and the Screening Assess-
ment of Depression-Polarity [137]. Although no screening tool has been defini-
tively shown to be superior [138], the Mood Disorder Questionnaire [4,138] and
Highs [4] are the most promising tools and have already been studied in peri-
natal populations. The Mood Disorder Questionnaire incorporates all pertinent
information included in the other scales with the addition of an assessment
of irritability and impulsive behaviour. Once the risk of bipolar disorder is
recognised, it is necessary to follow up with a more comprehensive psychiatric
assessment.
Insufficient research has been conducted on the treatment of postpartum bipolar
depression, so definitive recommendations cannot be made [4].Treatment with
antidepressants should be avoided, as it has been associated with a highly un-
stable course of illness. Mood stabilisers may pose a risk to the baby during
breastfeeding. Specialty consultation with a psychiatrist familiar and comfort-
able with managing mood disorders during and following pregnancy is recom-
mended.
In summary, bipolar depression following childbirth is an important but ne-
glected topic. I extensively investigate depression in bipolar disorder throughout
the thesis.
64
Chapter 4
Summary and objectives
“The problems of language here are really serious”
Werner Heisenberg [139]
There is very strong, clear and consistent evidence of a specific relationship be-
tween bipolar disorder and childbirth. New mothers in the general population
are over 23 times more likely to be admitted with an episode of mania in the
first postpartum month [68]. A previous history of admission with bipolar is
associated with an even larger increased risk of postpartum admission (rela-
tive risk 37.2) [65]. Women with bipolar disorder have at least a 1 in 4 risk of
suffering a severe recurrence following delivery. Women with bipolar disorder
and a previous personal or family history of a severe postpartum episode are at
particularly high risk with more than 1 in 2 deliveries affected [95].
Despite the high prevalence of less severe forms of illness, the study of postpar-
tum bipolarity beyond postpartum psychosis has been largely ignored [4, 140].
Misdiagnosis of bipolar depression as major depressive disorder during the post-
partum period appears to be common and the consequences particularly seri-
ous [74]. Treatment with antidepressants, in fact, may precipitate mania, a
mixed state, or rapid cycling and thereby increase the risk for psychiatric hos-
pitalisation.
Although a number of potential risk factors for postpartum triggering have been
established, the work to date has been in retrospective samples and has not ex-
amined a number of potential factors that are likely to be involved.
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In summary, the link between bipolar disorders and childbirth has firmly been es-
tablished only for severe psychotic episodes, while there is no robust evidence for
less severe, but more prevalent forms. Even for severe episodes, risk factors and
mechanisms underpinning the relationship between bipolar episodes/disorders
and childbirth are poorly documented. My PhD project sought to address these
deficiencies. The project revolved around the childbirth trigger of bipolar dis-
order. The uncertainty in the definitions and classification of mood disorders
(within and outside the perinatal period) was the major conundrum in my re-
search, so much attention was paid in exploring possible models to conceptualise
perinatal episodes of bipolar disorder.
Aims of the PhD project were:
• To investigate in a large existing dataset perinatal bipolar episodes and
to compere them with those in women suffering with RMD. I focussed my
analyses on
Rates of perinatal episodes I estimated the lifetime prevalence, the
incidence during and after each pregnancy and the morbidity risk.
Then I explored differences between lifetime diagnoses of BD-I, BD-
II and RMD.
Timing of onset of episodes in pregnancy and within 6 months post-
partum. I estimated and compared survival curves across types of
episode (mania, non psychotic depression, psychotic depression) and
lifetime diagnoses (BD-I, BD-II and RMD).
Specificity of the postpartum trigger I explored the lifetime course
of mood disorders in relation to the episodes occurring after childbirth
and tested the hypothesis that childbirth is not a specific trigger and
episodes occur after delivery only by chance.
Link between parity and PNEs and its potential implications for the
aetiology and nosology of perinatal mood disorder. I estimated the
rates of PNEs across types of episode (mania and psychotic depres-
sion, non psychotic depression) and lifetime diagnoses (BD-I, BD-II
and RMD), explored the influences of potential biases and compared
the rates between first and subsequent pregnancies.
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• To design and pilot a prospective study aimed to recruit a large, well char-
acterised sample of women with bipolar disorder preconception or in early
pregnancy and to monitor them through pregnancy and the postpartum.
The aims of the full blown prospective study were:
– to establish the proportion of women who suffer a severe episode of
psychiatric illness
– to characterise the clinical features of episodes occurring in the post-
partum
– to explore the influence of a range of variables on the vulnerability to
develop an episode of severe illness in pregnancy or the postpartum
The aims of the pilot study were:
• to establish the effectiveness of the recruitment methods
• to test the adequacy of the assessment tools
• to estimate the variability in the outcomes to calculate the sample size
• to assess the feasibility of the large scale study and to modify the current
research protocol in order to increase the chance of success in recruiting
and following-up women
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Part II
Perinatal mood episodes in
a large dataset of women
with mood disorders
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Chapter 5
Methods
In this chapter I first describe the recruitment and assessment of participants
included in the Mood Disorders Research Project database, then provide a brief
overview of the principal statistical methods employed in the analyses.
5.1 The Mood Disorder Research Project
The retrospective data that I analysed were drawn from the Mood Disorder
Research Project database. The Mood Disorder Research Project is jointly run
by the University of Birmingham (Dr Lisa Jones and Dr Katherine Gordon-
Smith) and Cardiff University (Professor Nick Craddock, Dr Ian Jones and Dr
Liz Forty). The Mood Disorders Group - called also the Bipolar Disorder Re-
search Network (BDRN - see bdrn.org) - has extensive experience of recruiting
large numbers of individuals with unipolar and bipolar disorder for clinical and
genetic studies and has collected data on more than 6000 people with mood
disorders over a 20-year period.
The database collected information on individuals who took part in different
sub-projects (figures 5.1, 5.2 and 5.3). Although the main structure of the
dataset remained unchanged, a number of variations in the inclusion criteria
and in the variables assessed have been occurred over the years (table 5.1).
As stated in the background section, a clear-cut distinction between bipolar
and unipolar disorders is currently controversial. Thus, although this thesis
is focused on bipolar disorder in relation to pregnancy and postpartum, I in-
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cluded in the analyses a sample of women with RMD to explore differences and
similarities between unipolar and bipolar disorder. Strategies of ascertainment
and duration of recruitment differed across sub-studies, thus in my analyses the
sample sizes of the BD-I, BD-II and RMD group differed (figures 5.2 and 5.3).
12
77
28
0
17
2
12
5
69
57
12
Psychosis-mood disorders study
Postnatal depression study
Unipolar depression family study
Postnatal psychosis study
Bipolar disorder family study
Unipolar depression association study
Bipolar disorder association study
proportion
0.0 0.1 0.2 0.3 0.4 0.5 0.6 0.7
Figure 5.1: Distribution of participants according to study in which they have
originally been recruited. The numbers on the left refer to number of participant,
while the bars display the proportions. Only parous women with bipolar I
disorder, bipolar II disorder or recurrent major depression and a history of
mood disorder prior to menopause were included in the present analyses. If
multiple members from the same family took part to the project, only probands
(index cases) were included, i.e. only one member for each family was included.
5.1.1 Recruitment
Participants were recruited using both systematic and non-systematic recruit-
ment methods (figure 5.4). In the current analyses, 26 % of the sample was
recruited systematically. No differences emerged in the rates of broadly de-
fined perinatal episodes between systematically and not systematically recruited
women (χ2 = 0.56, df = 1, p-value = 0.45).
Systematic recruitment Systematic recruitment involved the identification
of participants through screening of community mental health teams across
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1995 2000 2005 2010
BD-GWAS
BD family study
Postpartum depression study
Postpartum psychosis study
Studies on the relationship mood - psychosis
UD- GWAS
UD family study
Date at interview
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Figure 5.2: Distribution of participants by project, year of inclusion and life-
time diagnosis. Each symbol represents one participant. Information on date
of interview was missing for 794 women in the BD-GWAS project, 110 in the
BD family study, 36 in the postpartum depression study, 122 in the postpartum
psychosis study, 7 in the study on the relationship between mood and psychosis,
180 in the UD-GWAS and 43 in the UD family study. Symbols colours reflect
lifetime diagnoses of DSM-IV BD-I (red), BD-II (purple), RMD (blue). Ab-
breviations: BD: bipolar disorder, GWAS: genome wide association study, UD:
unipolar depression
72
1985 1990 1995 2000 2005 2010 2015
0.
00
0.
10
0.
20
0.
30
Year of interview
D
en
si
ty
BD-I
BD-II
RMD
Figure 5.3: Kernel density plot of participants by year of interview and lifetime
diagnosis. A kernel density estimate is a good graphical summary of the shape
of the data, in which each observation xi is replaced by a copy of the function kpq
shifted so that it is centred at xi, and scaled by a factor h called ’bandwidth’. The
function kpq has got the following characteristics: i) kpxq ě 0 @ x, ii) ş´88 kpxqdx
iii) k is concentrated around 0. Differently from the previous graph, this one
does not display the count of participants, but the proportion of participants
recruited by year and by lifetime diagnosis. From the graph it can be inferred
that the overrepresentation of women with BD-I was due to a longer time of
recruitment and to a more intensive recruitment in more recent years. Women
with RMD were recruited intensively over a shorter period of time. The majority
of women with BD-II were recruited in recent years.
the United Kingdom (UK). At the discretion of the responsible medical
officer, all participants deemed suitable for inclusion were invited to par-
ticipate. More than 20 Mental Health Trusts and Boards throughout the
UK were involved in the recruitment and the recruitment was supported
by the Mental Health Research Network (http://www.mhrn.info/).
Non-systematic recruitment Participants were recruited non-systematically
via the media (television, press, radio and internet) and via patient sup-
port organisations (Bipolar UK and Action on Puerperal Psychosis). I
provide here a description of Bipolar UK and Action on Puerperal Psy-
chosis because I have been in contact with them for the recruitment of
participants in the longitudinal study I describe in chapter 10 and 11.
Bipolar UK (former MDF The Bipolar Organisation) Bipolar UK
is the only England & Wales based charity aimed to specifically
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Bipolar UK
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Figure 5.4: Distribution of participants according to method of recruitment.
The numbers on the left refer to number of participant, while the bars display
the proportions. Only parous women with BD-I, BD-II or RMD and a history
of mood disorder prior to menopause were included in the present analyses. If
multiple members from he same family took part to the project, only probands
(index cases) were included, i.e. only one member for each family was included.
Abbreviations: APP: action on postpartum psychosis, CMHT: community men-
tal health team
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support individuals suffering from bipolar disorder, their families
and carers. Explicit objectives of the charity are to promote “the
improvement of treatments and services to promote recovery ”and
to “develop partnerships with other organisations concerned with
mental health ”(http://www.bipolaruk.org.uk/). Bipolar UK was
established in 1983 and currently provides support to over 65,000
people/year (data from http://www.bipolaruk.org.uk/history-of-the-
charity.html). Pendulum is the magazine published quarterly by
Bipolar UK and provides also evidence-based information.
There is a close collaboration between Bipolar UK and BDRN. In
2010 BDRN hosted a national conference for Bipolar UK at the Uni-
versity of Birmingham Medical School, with around 350 delegates
from all over UK taking part (http://bdrn.org/?p=648). Moreover,
Professor Nick Craddock and Dr. Ian Jones have collaborated with
Bipolar UK and written for the Pendulum magazine, providing sci-
entific contributions.
Action on Postpartum Psychosis Action on Postpartum Psychosis (APP)
is a charity based in UK and a network of women who have expe-
rienced postpartum psychosis. An explicit objective of APP is to
“facilitate research into all aspects of postpartum psychosis ”. APP
was set up by Professor Ian Brockington and Mrs. Jackie Benjamin in
1996 in Birmingham and currently has about 600 members through-
out the UK including a number of women worldwide. Today, APP
is run by a team of women who have experienced postpartum psy-
chosis, clinicians and researchers from the University of Birming-
ham and Cardiff University. Dr. Ian Jones is the current chair of
APP. APP publishes the annual APP magazine with information
about research and events. The magazine contains adverts and up-
dates on the BDRN study. The previous and current editions of the
magazine are available for free at http://www.app-network.org/news-
events/newsletters/.
5.1.2 Inclusion criteria
All participants were aged 18 years or over and provided written informed con-
sent after complete description of the study.
Participants were excluded from the original studies if they: i) had a lifetime
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diagnosis of intravenous drug dependency; ii) had only experienced affective
illness as a result of alcohol or substance dependence; and iii) had only experi-
enced affective illness secondary to medical illness or medication.
The major depression studies aimed to recruit a sample of participants with
clear-cut unipolar depression. Thus, in addition to the general criteria, indi-
viduals in the recurrent major depression group were excluded if they i) had a
first or second degree relative with a clear diagnosis of bipolar affective disorder
or schizophrenia, schizotypal disorder, persistent delusional disorder, acute and
transient psychotic disorders or schizoaffective disorder, or ii) had ever experi-
enced mood incongruent psychosis or psychosis outside of mood episodes.
Participants were included in the current analyses if they i) had a lifetime diag-
nosis of DSM-IV BD-I, BD-II or RMD and ii) were parous, having given birth
to at least one live child.
As I was interested in mood disorder episodes in the reproductive years, women
were excluded from the current analyses if they reported an age of onset in the
post-menopausal period. A cut-off of 50 years old was set, according to the
mean European age at menopause [141].
The analyses presented in the next chapters were conducted on different sub-
samples, according to the research hypothesis that was tested. Figure 5.5 pro-
vides a flow chart aimed to help the reader throughout the different research
hypotheses.
5.1.3 Assessment
Team members involved in the interview, rating and diagnostic procedures were
all research psychologists or psychiatrists.
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Interview
Subjects, who agreed to take part, were interviewed in a place convenient for
them, usually their own house. The interview lasted about an hour and a half
and included:
• The life chart for the systematic collection of retrospective information
about the course of illness, life events and treatment. An example of life
chart is given in figure 5.6.
• The Schedules for Clinical Assessment in Neuropsychiatry (SCAN)
are a set of semi-structured clinical interviews developed by the World
Health Organization and widely used to assess and diagnose psychiatric
disorders among adults [142]. The approach is bottom-up and no diagnosis-
driven frames are applied in grouping the symptoms, with each symptom
assessed in its own right. The Mood Disorder Research Project interview
contained the sections on mania, depression and psychosis. Each section
contains obligatory general questions about symptoms of that particular
section, followed by more specific questions to be answered if the general
questions were affirmative or if the interviewer has got doubts. The rat-
ing is done by comparing the answers given by the interviewee with the
definitions of the symptoms given in a glossary. The definitions in the
glossary largely follow Jasper’s criteria [22]. In my research I considered
episodes rather than symptoms. Possible rating for episodes according to
the SCAN interview are: current episode, representative episode, in which
symptoms were more severe, lifetime ever. Although SCAN alone can be
used to produce a DSM-IV or a ICD-10 diagnosis, in the Mood Disorder
Research Project other sources of information were jointly employed.
• Details of family history of mental disorders
• Information about lifetime history of PNEs of illness.
• Participants recruited more recently were also asked pregnancy by preg-
nancy questions about the relationship of episodes of illness to childbirth.
If the participant consented, part of the interview was audio recorded for con-
sistency and training purposes.
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Age	  30,	  ﬁrst	  pregnancy,	  
2nd	  day	  a3er	  delivery	  
Admi8ed	  to	  hospital	  
Treated	  with	  Olanzapine	  
10mg	  and	  Lithium	  900	  mg	  
Lithium	  900	  mg	  
Age	  32,	  Stop	  
lithium	  because	  
weight	  gain	  
Lithium	  900	  mg	  
Mixed	  episode,	  Admi8ed	  
to	  day	  hospital	  a3er	  2	  
months	  
Treated	  with	  Olanzapine	  
10mg	  and	  Lithium	  900	  mg	  
	  
Figure 5.6: Example of a life chart. Although systematic, the collection of
information did not follow the graphic and the structured approach of Leverich
and Post [143]
Questionnaires
Participants were left with a set of questionnaire, which took around half an
hour to be completed. Questionnaires included measures of:
• Current mood (Beck Depression Inventory and Altman Self-Rating Mania
Scale)
• Life events prior to onset (Brief Life Events Questionnaire) and childhood
life events (Coddington Life Events Questionnaire)
• Personality and temperament (Eysenck Personality Questionnaire, Tem-
perament Evaluation of the Memphis, Pisa, Paris, and San Diego. Auto-
questionnaire)
• Alcohol and substaces use
However, in my analyses I used only information collected during the interview.
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Case notes review
Psychiatric case-notes were available for 78% of participants and were also re-
viewed.
Estimate of lifetime diagnosis and clinical variables
Based on the information collected during the interview, in the questionnaires
and by reviewing the case-note, best-estimate lifetime diagnoses were made ac-
cording to DSM-IV, ICD-10 and key clinical variables, such as age at onset and
number of episodes, were rated. In cases where there was doubt, diagnostic and
clinical ratings were made by at least two members of the research team blind
to each other’s rating. Inter-rater reliability was formally assessed using 20
cases. Mean kappa statistics 1 were 0.85 for DSM-IV diagnoses and ranged be-
tween 0.81 and 0.99 for other key clinical categorical variables; mean intra-class
correlation coefficients were between 0.91 and 0.97 for key clinical continuous
variables.
5.2 Analytical strategies
“[..] to deal with uncertainty successfully we must have a kind of
tentative humility. We need a lack of hubris to allow us to see data
and let them generate, in combination with what we already know,
multiple alternative working hypotheses. These hypotheses are then
modified as new data arrive. The sort of humility required was well
described by the famous Princeton chemist Hubert N. Alyea, who
1Kappa statistic is a quantitative measure of agreement between observers. It is calculated
as the standardised difference between the observed agreement po and the agreement that
would be expected to be present by chance alone pe.
k “ po ´ pe
1´ pe
where
po “ concordantobservations
totalobservations
and
pe “ n1m1
n2
` n0m0
n2
is the expected agreement with m1 and n1 the positive results in the observers m and n and
m0 and n0 the negative results in the observers m and n. Kappa assumes values between -1
and 1. With negative values indicating agreement less than chance, 0 agreement as expected
by chance and positive values agreement more than chance and 1 perfect agreement.
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once told his class, ’I say not that it is, but that it seems to be; as
it now seems to me to seem to be.’ ”
Howard Wainer [144]
Analysing retrospective data on reproductive events is a complex task. In this
chapter I discuss the principal statistical methods I employed in the analy-
ses of the retrospective dataset. I do not provide here a detailed account of
the specific statistical methods that I used in the different analyses, because I
describe them in the appropriate chapters along with the results of the analyses.
Analyses were performed using R version 2.13.0 (Copyright 2011 by The R
Foundation for Statistical Computing). Graphics were also produced with R.
When an unusual type of graph is presented, explanations are provided in the
caption.
Methodology and results are reported according to the statistical guidelines of
the British Medical Journal2 and of the STROBE project 3. These guidelines
recommend to prefer confidence intervals for effect sizes to p-values when report-
ing the results of comparisons. However, I calculated and report also p values,
as the majority of papers I reviewed relayed their conclusions on p values. In
accordance to the STROBE and BMJ guidelines, I emphasise that the results of
my analyses need to be interpreted in the light of the following considerations,
sometimes dismissed in medical research: i) percentages where the denominator
is small (for example less than twenty) are of little value ii) a lack of significance
is not an evidence of no effect and iii) odds ratios instead of relative risks should
be calculated as a measure of effect when retrospective information is analysed
(such in the case of my analyses).
5.2.1 Estimates
Figure 5.7 summarises the estimates I report in the next chapters. In the back-
ground section I argued that the choice of the reference group (i.e. the denom-
inator in the ratios) has been a major source of bias and heterogeneity across
studies. So, in my research I paid special attention to the choice of the refer-
ence groups. I chose a 99% confidence interval (99%CI) estimator instead of
the usual 95% because I wanted to have greater confidence that my estima-
2http://bmjopen.bmj.com/site/about/guidelines.xhtml
3http://www.strobe-statement.org/index.php?id=available-checklists
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tions contained the population parameters. Confidence intervals for estimates
were imputed using the Clopper-Pearson exact4 method (function exactci in
the package PropCIs [147]). The Clopper-Pearson exact method relies on the
assumption of a binomial distribution. There are several algebraically identical
formulae to calculate the Clopper-Pearson confidence intervals, including:
Bpα{2;x, n´ x` 1q ă θ ă Bp1´ α{2;x` 1, n´ xq (5.1)
where x is the number of successes, n is the number of trials, and Bpp; v, wq is
the pth quantile from a beta distribution with shape parameters v and w. 5 I
chose the Clopper-Pearson exact method because it is one of the most commonly
used. It is accurate when np ą 5 or np1´ pq ą 5.
5.2.2 Comparative analyses
The comparative analyses I conducted are summarised on table 5.2. I tested
more than one hypothesis simultaneously, incurring in problems of multiple
testing. 6 In fact, I investigated many variables (presence of PNE, time of onset
of PNE, order of pregnancy, lifetime diagnosis etc) and grouped participants
in many ways (by lifetime diagnosis, by pregnancy outcome, by having a first
lifetime episode in the perinatal period etc). Although I had to control for
multiple comparisons, it is “cleary impractical, if not impossible to control errors
to a small level over the entire set of potential comparisons ” [150].
4The term exact refers to the fact that the estimate is based directly on the cumulative
probabilities of the binomial distribution rather than any approximation to the binomial
distribution [145]. Neyman pointed out that “exact probability statements are impossible in
the case of the binomial distribution ”. [146]
5The beta distribution is a family of continuous probability distributions defined on the
interval [0, 1] parametrized by two positive shape parameters, denoted by v and w, that appear
as exponents of the random variable and control the shape of the distribution
6For a comprehensive overview on multiple comparisons I used two text books: [148,149]
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Table 5.2: Summary of the comparative analyses presented in the
thesis8
SUBJECT C
H
A
P
T
E
R
SAMPLE Ho NOTES N
I
N
D
H
0
N
n
I
N
D
H
0
Parous women with a life-
time diagnosis of either BD-
I, BD-II or RMD & with
first mood episode before
menopause &
Lifetime prevalence of
PNE
6 Randomly recruited BD-I
(N=1100), BD-II (N=314),
RMD (N=396)
no difference in lifetime prevalence of
PNE between BD-I, BD-II and RMD
1 3
Morbidity risk of PNE 6 as above no difference in morbidity risk of PNE
between BD-I, BD-II and RMD
1 3
Pregnancy incidence of
PNE
6 Pregnancy by pregnancy ratings
available BD-I (N=828, Np=1718),
BD-II (N=272, Np=598), RMD
(N=327, Np=809)
no difference in incidence of PNE be-
tween BD-I, BD-II and RMD
1 3
Continued on next page
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Table 5.2 – Continued from previous page
SUBJECT C
H
A
P
T
E
R
SAMPLE Ho NOTES N
I
N
D
H
0
N
N
I
N
D
H
0
Time of onset in BD-I 7 583 post BD-I No difference between time of onset of
M, BD-I pD and BD-I npD
1 3
Time of onset of npD 7 678 perinatal /584 post npD No difference in time of onset of npD
between BD-I, BD-II and RMD
1 3
First lifetime episode
in the postpartum
8 History of broadly defined PNE
BD-I (N=887), BD-II (N=237),
RMD (N=314)
Proportion of women with lifetime on-
set in the perinatal period is similar
across mood disorders
1 NA
Specificity of the child-
birth trigger in relation
to lifetime course
Multiparae with ě 5years of obser-
vation after 1st impairment and i)
history of PP and BD-I (N=239)
or ii) history of PND and BD-I
(N=166) or iii) history of PND and
BD-II (N=88) or iv) history of PND
ad RMD (N=154)
rates of episodes occurring outside the
perinatal period per year are similar to
the rates of deliveries affected
analysis conducted sep-
arately for each lifetime
diagnosis and for PP and
PND in BD-I
4 NA
Continued on next page
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Table 5.2 – Continued from previous page
SUBJECT C
H
A
P
T
E
R
SAMPLE Ho NOTES N
I
N
D
H
0
N
N
I
N
D
H
0
Concordance between
PNE
8 Pregnancy by pregnancy ratings
available, BD-I, 2 live births and
ě 1 delivery affected by post-
partum/mania/psychosis within 6
weeks (N=146)
The proportion of women experiencing
2 PNE of different polarity is similar to
the proportion of women experiencing
2 episodes of the same polarity
1 NA
Parity and PNE 9 Multiparae with at least one preg-
nancy affected BD-I (N=183), BD-
II (N=93), RMD (N=159)
Proportion of first pregnancies affected
by PP/PND similar to the propor-
tion of second pregnancies affected by
PP/PND.
@ lifetime diag-
nosis,and @ onset
groups1
123 NA
Parity PNE 9 Multiparae with at least
one pregnancy affected BD-
I (N=183), BD-II (N=93), RMD
(N=159)
as above, but by lifetime onset (post-
partum v other times)
secondary to the previ-
ous analyses
23 NA
8Abbreviations: BD-I bipolar I disorder, BD-II bipolar II disorder, RMD recurrent major depression,ti time-to-onset, M mania, pD psychotic depression,
npD non psychotic depression, 1 first perinatal period, 2 second perinatal period, PP: postpartum psychosis defined as DSM-IV mania or DSM-IV psychotic
depression or, cycloid psychosis, defined according to [51] preg: in pregnancy, post: postpartum, IND: independent, nIND:not independent, H0 null hypothesis,
1 in pregnancy, within 6 weeks postpartum, between 6 weeks and 6 months postpartum, 2maximum number of possible analyses, but only those promising at the
exploratory analyses were conducted, 3 number of analyses actually conducted, on the basis of previous significant findings
86
Multiple testing
Three major multiple testing problems arose from my analytic plan:
1. Multiple independent analyses . It is the set of minimal hypotheses
that did not imply the truth of any other hypothesis in the set.
2.Hierarchical sets Some hypotheses were components of others (for exam-
ple, in the parity analyses, the hypotheses tested on the subgroups of
multiparous with at least a pregnancy affected were a subgroup of the
hypotheses tested on the general sample).
3. Pairwise comparisons For each analysis in which I rejected the null hy-
pothesis I examined the differences between pairs of groups (post hoc
analyses).
The main problem was to establish the number of K independent hypotheses
I tested, or, looking from another prospective, the number of families of hy-
potheses (i.e. set of hypotheses to treat as a family and for which errors were
controlled jointly) and how many hierarchical sets I had. Moreover, different
independent hypotheses were tested on overlapping, but not identical datasets.
So a unique one step correction for all analyses I performed would have been
too conservative.
Once I determined the number K independent hypotheses, I calculated a cor-
rected P value using the Bonferroni correction. The Bonferroni method is the
most user-friendly single step approach to correct for multiple testing. However
it has got its limitations: i) it is counter-intuitive, because the interpretation of
findings depends on the number of other tests performed, ii) the general null hy-
pothesis that all the null hypotheses are true is rarely of interest, iii) it is highly
conservative, with a high probability of rejecting the alternative hypothesis of
an effect when it is true (i.e. high probability of committing a type 2 error).
For correlated multiple tests the Bonferroni correction is inappropriate, be-
cause of the reasons explained above. I therefore used a two-steps approach .
Initial global comparisons between groups (BD-I, BD-II and RMD) were per-
formed using the analysis of variance for normally distributed variables and the
non parametric Kruskall-Wallis analysis of variance for continuos variables that
were not normally distributed. For categorical variables I employed contingency
tables and χ2 statistics. If groups were not homogenous at the Bonferroni cor-
rected P value, I run further analyses and, according to the characteristics of
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the variables, I used:
• the least significant difference - Tukey’s method when variables were nor-
mally distributed and groups were of similar size,
• the least significant difference - Scheffe’s method when variables were nor-
mally distributed, but groups differed in size
• for non parametric continuous variables I used rank sums and calculated
the standard error as
padj “ pKpK ` 1q2
where K is the number of groups (in this case 3)9
• for categorical variables I used the function fisher.multcomp from the
package RVAideMemoire.
Logistic regression
I used logistic regressions for many inferences10. Logistic regression is a gen-
eralised linear model for binary response variables, based on the logit transfor-
mation of a proportion. As a response variable I used PNEs, classifying each
observation as a success (having a PNE) or a failure (not having a PNE). The
definition of PNE varied across analyses and could include only certain subtype
of PNEs.
In logistic regression models the odds for a participant with independent vari-
ables specified by X is
P pXq
1´ P pXq
where, in my analyses, P denotes the probability of a PNE (the definition of
PNE varied across analyses). Thus, an odds is the probability that a PNE
occurred over the probability that it did not occur. In the logit function the
parameters α and βi can be interpreted in terms of log odds. The odds ratio is
the ratio between two odds and the probabilities in the odds ratio are all defined
9I derived the formula from [148], Chapter 9, Distribution-Free and Robust Procedures
pages 242-247
10Almost all the analyses I conducted were on categorical data. As a main reference book
I used [151]
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as risks. In the case of logistic regression
RORX1,X2“ oddsforX1
oddsforX0
“ e
α`ř βiX1i
eα`
ř
βiX0i
(5.2)
5.2.3 Dealing with dependent measures
Multiple deliveries from one individual could not be considered independent ob-
servations. In order to compare differences in rates of deliveries affected across
diagnostic groups, I used the Mantel-Haenszel methodology for repeated mea-
surements data. The null hypothesis of no partial association between lifetime
diagnosis and perinatal episode was that the occurrence of PNEs (response vari-
able) was distributed at random with respect to the factor levels (i.e. lifetime
diagnoses), for each of the stratum levels indexed by 1st, 2nd, 3rd, 4th pregnancy.
I was interested in the extent to which the null hypothesis could be rejected in
favour of the hypothesis that the distribution of PNEs differed in nonspecific
patterns across diagnoses. Thus, the general association Mantel-Haenszel test
statistic (GA) was employed (for a general overview of Mantel-Haenszel meth-
ods, see [152]).
Similarly, in the multivariate analyses I took into account possible within sub-
ject effects. I used a generalized mixed model approach (package lme4 [153]),
introducing a parameter that identified each subject (random effect). If deliver-
ies from the same woman were independent events, the variance of the random
effect should be zero. This null hypothesis was tested with the Wald Z statistic
test.
If in the mixed models the variance of the random effect was close to zero, uni-
variate comparisons were performed using contingency tables and χ2 statistics
or Fisher Exact test for categorical variables, t-test for normally distributed
quantitative variables and non-parametric rank tests for those not normally dis-
tributed. When in the mixed models the variance of the random effect was close
to zero, the random effect was dropped from the final model and a generalized
linear model was fitted (function glm).
In case of multiple imputed datasets, the function containing a within subject
effect was modelled by using the specification logit.mixed in the zelig com-
mand [154] (see the section on multiple imputations below).
Mixed effect models for survival analyses using the Cox method are discussed
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in chapter 7.
5.2.4 Dealing with missing values
Missing values are common in medical research and a vast literature has been
produced on the topic. Missing values are usually classified according to the
cause of missingness:
Missing completely at random (MCAR) : missing values are equally and
randomly distributed across the dataset. MCAR data cause loss of power,
but do not influence the inferences, because missing values in cases have
the same characteristics of missing values in controls.
Missing at random (MAR) : missing values are associated with certain
known factors. However, these factors are not necessarily measured in
the experiment. In this case, to obtain unbiased inferences, analyses need
to be corrected for the variable responsible of the missing values.
Missing Not at Random (MNAR) : the causes of missingness cannot be
related to any variable known by the researcher. This is the most damaging
cause of missingness.
Graham & Donaldson [155] simplified this classification, according to the causes
of missingness:
Accesible, in which the causes of missingness are known and have been mea-
sured (this category included MCAR and part of the MAR, where infor-
mation for the responsible factor are available)
Inaccessible, in which the causes of missingness have not been measured.
In my analyses I investigated the presence of accessible factors. However, the
most common scenario is that both accessible and inaccessible factors account
for missing data. I therefore used multiple imputations techniques to handle
missing data. Multiple imputation replaces each missing value/missing cell with
M values in the dataset/data matrix and creates M complete data sets. The
M complete sets obtained through multiple imputations contain the same ob-
served values of the original data set, while missing values there replaced with
a distribution of M imputations that reflect:
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• the natural variability in the missing values. The imputed values, in fact,
are estimated on the basis of the variables correlated with the missing
data and causes of missingness
• the uncertainty about the estimation by creating M different datasets
that contain different versions of the missing values and then observing
the variability between missing values.
I chose multiple imputation over other techniques for the following reasons:
• It minimises the detrimental effect of inaccessible mechanisms [155];
• It produces better inferences than list-wise deletion. Excluding cases with
missing values using a list-wise deletion process would lead not only to
loss of power and of valuable information that was partially collected for
these cases, but also to biased inferences;
• It has been shown to be robust for not normally distributed variables;
• It performs well in the presence of high rates of missing data;
• It is an intuitive method and a package was available in R.
I used multiple imputations in all analyses involving variables with missing val-
ues, with the exception of the time-to-onset coded as a continuous variable
in weeks, because i) the distribution violated the assumption of normality, ii)
transformations to normality didn’t work and iii) the difference between the
distribution of imputed values and the actual values was too large (see below
for an explanation of the diagnostic techniques).
Amelia II [156], the statistical package I used to compute multiple imputation,
in fact, requires two assumptions: i) multivariate normality ii) data MAR. Thus,
I first checked whether there were factors that could have been accounted for
the pattern of missingness and whether the normality assumption was met, then
I used Amelia II to replace missing values using multiple imputations. Using
the amelia function, I imputed priors and bounds to improve the imputations.
A detailed description of the theory behind Amelia II computation of missing
values is beyond the scope of this thesis. In addition to the Amelia II reference
guide [156], I referred to [157] as a general reference guide on missing data.
Here I explain in very lay terms only the terminology and the formulae that
are necessary to interpret the results. I focus on the Expectation-Maximization
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Dataset with missing values 
Is listwise 
deletion a 
good idea? 
YES 
Perform 
analysis after  
deleting cases 
with missing 
values   
MULTIPLE IMPUTATION WITH AMELIA II 
•  Amelia assumes that continuous variables are normally distributed. Is 
it the case? If not, transform the variable. 
•  Create a model that includes predictor variables, on which the 
imputed values will be created 
 
NO 
Bootstrap the data to simulate the uncertainty of the estimation  
EM algorithm to  to find the mode of the posterior for the 
bootstrapped data 
Imputation of Dmiss from its distribution conditional on Dobs and 
the draws of a linear regression with parameters that can be 
calculated directly from the complete-data parameters.  
ANALYSIS OF THE IMPUTED DATASETS 
Analyses are performed separately on each dataset, as it was the 
original dataset  
COMBINING THE RESULTS (Zelig package) 
Figure 5.8: Flow chart of the multiple imputations process
(EM) algorithm, rather than on the bootstrap step, because this is a key con-
cept to understand not only the results, but also possible problems rising from
the imputations algorithm.
Expectation-Maximization (EM) algorithm
Given a density function fpx | Φq that is is governed by the set of parameters
Φ and a data set of size N, supposedly drawn from this distribution, i.e., X “
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x1, ...,xN, the likelihood function
fpX | Φq “
Nź
i“1
fpxi | Φq “ gpΦ | X q (5.3)
The likelihood is a function of the parameters Φ where X is fixed.
The aim of the maximum-likelihood estimation problem is to find the Φ that
maximizes g
The EM algorithm is a iterative method of finding this maximum-likelihood
estimate of the parameters Φ of an underlying distribution from a given data
set when the data is incomplete or has missing values.
An incomplete dataset implies 2 sample spaces: Y and X and a many Ñ one
mapping from y Ñ ypxq from X to Y, with x being the complete data and y
the observed data, x is known only to lie in X pyq. In other words, the subset of
X is determined by the equation x “ ypxq. Let fpx | Φq be a family of sampling
densities depending on the parameters Φ and gpx | Φq its corresponding family
of sampling densities. The complete-data fp... | ...q is related to the incomplete-
data gp... | ...q by the function [158]11
gpx | Φq “
ż
X pyq
fpx | Φqdx (5.4)
As the term suggests, the EM algorithm is an iterative process that consists on
a iteration step followed by a maximization step. The aim of the EM algorithm
is to find the values of Φ that maximises gpx | Φq. There are many possible
complete data specifications fpx | Φq that generate gpy | Φq given the incomplete
data specification gpx | Φq.
E-step The EM algorithm first finds the expected value of the complete-data
log-likelihood loggpX ,Y | Φq with respect to the unknown data Y given the
11The paper is wrongly cited in the seminal paper on Amelia II. Although the paper by
Dempster et al [158] is the seminal paper on EM algorithm, I also refer here to the Gentle
tutorial by Bilmes [159]
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observed (constant) data X and the current parameter estimates:
QpΦ,Φpi´1qq (5.5)
where Φpi´1q are the current (constant) parameters estimates that are used to
evaluate the expectation and Φ are the new parameters that are optimized to
increase Q. Φ is a normal variable while Y is a random variable governed by
the distribution fpy | X ,Φpi´1qq.
M-step M-step maximizes the expectation computed in the first step.
Φpiq “ arg max
Φ
QpΦ,Φpi´1qq (5.6)
where arg max is the argument of the maximum, i.e. the set of values of Φ for
which the function QpΦ,Φpi´1qq attains its maximum value.
These two steps are repeated as necessary. Each iteration increases the log-
likelihood and the algorithm is guaranteed to converge to a local maximum of
the likelihood function.
Diagnostics
I inspected the multiple datasets with graphical methods of overimputations
and overdispersion diagnostic.
Overimputation involves sequentially treating each of the observed value as
if it was missing. Hundreds imputed values for that ’missing value’ are created.
Then by plotting observed values over imputed values (for that missing value)
it is possible to inspect whether the observed values fall within the region where
it would have been imputed if it had been missing. It was possible to compute
overimputations only for one continuos variable at time. I report two examples
of overimputation diagnostics from the Amelia II reference guide [156] in figure
5.8.
94
> overimpute(a.out, var = "tariff")
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Figure 8: An example of the overimputation diagnostic graph. Here ninety percent
confidence intervals are constructed that detail where an observed value would have
been imputed had it been missing from the dataset, given the imputation model.
The dots represent the mean imputation. Around ninety percent of these confidence
intervals contain the y = x line, which means that the true observed value falls
within this range. The color of the line (as coded in the legend) represents the
fraction of missing observations in the pattern of missingness for that observation.
Our overimputation diagnostic, shown in 8, runs this procedure through all of
the observed values for a user selected variable. We can graph the estimates of
each observation against the true values of the observation. On this graph, a y = x
line indicates the line of perfect agreement; that is, if the imputation model was a
perfect predictor of the true value, all the imputations would fall on this line. For
each observation, Amelia also plots 90% confidence intervals that allows the user to
visually inspect the behavior of the imputation model. By checking how many of
the confidence intervals cover the y = x line, we can tell how often the imputation
model can confidently predict the true value of the observation.
Occasionally, the overimputation can display unintuitive results. For example,
diﬀerent observations may have diﬀerent numbers of observed covariates. If covari-
31
Figure 5.9: Examples of overimputations diagnostic.The vertical lines represent
the 90% confidence intervals detail where an observed value would have been im-
puted if it had been missing from the dataset, given the imputation model.The
dots represent the mean imputation. The colour of the line (as coded in the
legend) represents the fraction of missing observations in the pattern of missing-
ness for that observation.The regression line x “ y indicates perfect agreement,
(all the true observed values fall on this line). By checking how many of the
confidence intervals cover the regression line, I can see how often the imputation
model can confidently predict the true value of the observation. In part A, the
majority of confidence intervals fall on the regression line and there is less than
20% of covariates missing for each value imputed. In part B, the observations
with fewer covariates observed (in red) have a higher variance across imputed
values. The example is taken from [156]
Overdispersion diagnostic is used to make sure that the imputations do not
depend on the starting values. The EM algorithm is deterministic. Thus, the
point in the parameter space where it starts can impact where it ends. However,
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this is irrelevant when the likelihood has only one mode. If the EM algorithm
has problems finding a global maximum, starting values can effect imputations.
In this scenario, the algorithm recognise the starting values as the maximum,
unaware that there is a global maximum farther away. So, by running the EM
algorithm from multiple, dispersed starting values, I checked that the EM chains
converged. Convergence is a good sign (i.e. a well behaved likelihood), because
it means that the algorithm recognises the global maximum.12. The diagnostic
tracks the convergence of M EM chains which start from various overdispersed
starting values. I report two examples of overdispersion diagnostic from the
Amelia II reference guide [156] in figure 5.10. The parameter space of the
imputation model is high-dimensional. However, the plot can track no more
than 2 principle components and their change over the iterations of the EM
algorithm. Thus, the plot is a lower dimensional summary of the convergence
and is subject to all the drawbacks of summaries.
Analyses of the multiple imputed datasets
First I analysed each imputed dataset as it was a primary completed dataset.
Then, I analysed multiple imputed datasets. The imputations used by the mul-
tiple imputation method are conditional draws rather than conditional means.
They therefore provide valid estimates for a wide range of estimands, if the im-
putation model is good [157]. The combined estimate for any parameter θ over
M imputed datasets is
θ¯M “ 1
M
Mÿ
m“1
θˆm (5.7)
The variability associated with this estimated has two components: the average
within-imputation variance,
W¯M “ 1
M
Mÿ
m“1
Wm (5.8)
and the between-imputation component,
B¯M “ 1
M ´ 1
Mÿ
m“1
pθˆm ´ ¯θM q2 (5.9)
12For a in depth mathematical explanation of the convergence properties of the EM algo-
rithm, I referred to [160]
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However, for matter of brevity I report for each estimate only the total variability
associated with θ¯M ,
TM “ W¯M ` M ` 1
M
BM (5.10)
When possible, I used the Zelig package [161] to calculate these estimates. I
run mixed regression models with logit.mixed [154] if a random effect was
required, otherwise I computed logistic regressions with logit [162].
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Figure 5.10: Examples of overdispersion diagnostic. Part A All chains converge
to the same point, and thus starting values are not affecting the EM algorithm.
On the left the x- axis represents the iteration number of the chain. The y-axis
represents movement in the (very high dimensional) parameter space. The plot
shows the movement of the chain on the y-axis over time (given by the iteration
number on the x-axis). The black horizontal line is the point where the first
EM chain converges. Thus, we are checking that the other chains converge close
to that horizontal line. On the right: Two dimensional parameter space using
the first two principal components of the end points of the EM chains. The
distance between iterations is marked by the distance between arrowheads on
each chain. The convex hull indicates the point of convergence for the first
EM chain. The hull is scaled to be within the tolerance of the EM algorithm.
Thus, we should check that the other chains end up in this hull. Part B: a
problematic EM algorithm, where chains are converging to one of two different
modes, depending upon the starting value. The example is taken from [156]
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Chapter 6
Rates of perinatal episodes
across the bipolar/mood
disorder spectrum
In the background section I argued that, i) although lot is known on severe
postnatal mood episodes, the literature presents some discrepancies and that ii)
the gap in knowledge is wider for the less severe, but more prevalent, forms, that
have been almost neglected by research and clinical practice. In this chapter I
move beyond the rates of postpartum psychosis in BD-I, to examine the occur-
rence of a wider range of PNEs in BD-I, BD-II and RMD. I first estimate the
lifetime rates, the morbidity risk, the rates in relationship to each pregnancy of
PNEs. I then explore differences in rates across the unipolar-bipolar spectrum.
6.1 Methods
6.1.1 Inclusion criteria
Recruitment and assessment of participants have been already described in chap-
ter 5.
Participants were included in the current analyses if they i) had a lifetime di-
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agnosis of DSM-IV BD-I or BD-II or RMD and ii) had at least one full term
delivery. Some participants in the mood disorder project dataset were recruited
specifically due to a history of severe postpartum illness. Including these women
would have inflated the rates of postpartum episodes, as, by definition, they
were ill in the postpartum period. I therefore excluded women from the current
analysis who were recruited on the basis of having a postpartum episode. The
inclusion criteria were met by 1810 parous women, 1100 with BD-I, 314 with
BD-II and 396 with RMD.
Participants recruited more recently (N= 1427) were also asked pregnancy by
pregnancy questions about the relationship of episodes of illness to childbirth.
I was therefore able to report lifetime rates of perinatal episodes in the whole
sample, and report rates per delivery in a majority (78.8%) of women.
6.1.2 Assessment
Lifetime occurrence of perinatal episodes
For the lifetime PNE rating I employed three overlapping and hierarchical def-
initions of perinatal episode:
Narrow definition History of at least one episode of mania / hypomania,
or mixed episode or affective psychosis all with onset within 6 weeks of
delivery
Intermediate definition History of at least one episode meeting narrow cri-
teria or major depressive episode with onset within 6 weeks of delivery
Broad definition History of any major mood disorder with onset in pregnancy
or within 6 months of delivery.
Women were rated on a lifetime basis into the narrowest category that applied
for any of their pregnancies. The 6-week onset cut-off is consistent with previous
studies [84], includes both DSM-IV and ICD-10 definitions of the postpartum
period, and was chosen as a compromise between very narrow (onset within 1
or 2 weeks) and very wide (onset within 6 months) definitions that have been
used in previous studies of postpartum episodes.
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Pregnancy by pregnancy ratings
For women with pregnancy by pregnancy information the following episodes
were rated, according to DSM-IV criteria: mania/mixed episode, hypomania,
major depression with psychotic symptoms, and non-psychotic major depres-
sion. Time-to-onset of PNEs was also recorded. However in this chapter I
report the estimates for a broad definition of the perinatal period, including
episodes occurring in pregnancy and within 6 months after childbirth. Then,
in the next chapter I explore the rates of deliveries affected by mood episodes
employing survival curves to address the issue of the time of onset.
6.1.3 Analytic plan
Estimation of rates and morbidity risk of perinatal episodes
I calculated interval estimates for
• Lifetime prevalence of PNEs, defined according to the narrow, intermedi-
ate and broad definition described above;
• Morbidity risk of broadly defined PNEs;
• Incidence rates of PNEs occurring in pregnancy or within 6 months after
childbirth.
Estimation of the morbidity risk The lifetime prevalence of PNEs under-
estimates the lifetime morbid risk of PNEs, as at the time of the assessment
some participants who had not experienced any episodes in relation to child-
birth will go on to have further pregnancies and PNEs. The morbidity risk of
PNEs is the probability (expressed as percentage) that a woman with a diagno-
sis of mood disorder will develop a PNE if she survives and has children through
the entire period at risk (in this case represented by the distribution of the age
at first PNE). To obtain an indirect approximation to disease expectancy, the
Stro¨mgren’s method was employed. The Stro¨mgren’s estimator is defined as:
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SO ´MR “ Ařn
i“1Dpaiq
(6.1)
where ai is the age at the time of the interview and Dpaiq is the corresponding
conditional probability of being affected by age ai, given that an individual is
affected. The Stro¨mgren’s denominator sums the proportion of risk for onset
that the individual has experienced, rather than the proportion of risk period
time. It assumes that the conditional age-at-onset distribution for affected in-
dividuals (i.e. age at first PNE) is known and it is normally distributed (see
figure 6.1).
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(b) Index plot of the sorted values
Figure 6.1: Age at onset of first PNE, N=383, mean 26.6 years, sd 5.37, range
16-41. PNE was defined as any mood episode occurring in pregnancy or within
6 months after childbirth. Age at onset did not differ across lifetime diagnostic
groups (df= 1, F= 0.025, p=0.9) or between perinatal mania (N=58, mean
28.3, sd 4.95) and perinatal depression (N=169, mean 26.5, sd 5.34, t=-1.4284,
p=0.16)
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Comparative analyses
I tested the null hypotheses that there were no differences between BD-I, BD-
II and RMD in i) lifetime prevalence; ii) morbidity risk; iii) incidence rates of
PNEs.
Because I tested 3 independent hypotheses, I set the level of significance for
the independent analyses testing to p=0.05/3=0.017. This significance level is
consistent with the conservative approach used above for estimations.
The Mantel-Haenszel methodology for repeated measurements data was used
to compare differences in rates of deliveries affected by a PNE across diagnostic
groups.
6.2 Results
Demographic and clinical characteristics of the sample are shown in table 6.1.
As explained in detail in chapter 5, women with BD-I were overrepresented be-
cause of the ascertainment strategy and the duration of each sub-study from
which the samples were drawn. The focus of the bipolar disorder recruitment
was in mental health services, where it is more likely to identify individuals with
BD- I than BD-II. The studies recruiting bipolar probands were also longer than
the study recruiting RMD. Women with BD-I, BD-II and RMD had similar age
at interview and age at first pregnancy. Age at onset of mood disorder (defined
as first episode of mood disorder resulting in significant impairment), number of
pregnancies and number of deliveries significantly differed across lifetime diag-
nostic groups. Women with BD-II reported a significantly earlier age at onset
than women with either BD-I or RMD (Tukey multiple comparisons of means:
p ă 0.001 and p ă 0.001 respectively). The BD-I group had significantly fewer
deliveries than the BD-II group (Wilcoxon rank sum test with continuity cor-
rection W = 127534.5, p = 0.007) and than the RMD group (Wilcoxon rank
sum test with continuity correction W = 147729.5, p = p ă 0.001).
6.2.1 Lifetime occurrence of perinatal illness
I examined the lifetime occurrence of three definitions of PNE (table 6.2, figures
6.2 and 6.3). Although the narrow definition of PNE was predominantly found
in women with BD-I, under the broad definition more than 23 of women in all
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three diagnostic groups reported at least one episode of illness during pregnancy
or postpartum. With the broad definition of PNE, there were not significant
differences across lifetime diagnostic groups (χ2= 6.03, df = 2, p = 0.05).
Table 6.2: History of PNEs in women with mood disorders. Hierarchical def-
initions of perinatal episode: i)Narrow: an episode of mania / hypomania, a
mixed episode or an affective psychosis all with onset within 6 weeks of delivery
ii) Intermediate: those women meeting the narrow criteria plus those with a
history of an episode of major depression with onset within 6 weeks of delivery
iii) Broad: a history of an episode of any major mood disorder with onset in
pregnancy or within 6 months of delivery.
LIFETIME
DIAGNOSIS
BD-I BD-II RMD
HISTORY
OF PNEs
N % 99%CI N % 99%CI N % 99%CI
Narrow 338 30.7 27.2-34.4 30 9.5 5.8-14.6 0 0.0-0.1
Intermediate 595 54.1 50.2-58.0 141 45 37.6-52.3 179 45.2 38.7-51.8
Broad 768 69.8 66.1-73.3 231 74 66.7-79.7 258 65.1 58.7-71.2
6.2.2 Morbidity risk of perinatal episodes
Using the Stro¨mgren’s estimator, the morbidity risk for broadly defined PNEs
didn’t differ across lifetime diagnoses and was 72.3% (99%CI 68.7%-75.2%) in
the BD-I group, 76.6% (99%CI 69.8%-82.6%) in the BD-II group and 67.2%
(99%CI 60.7%-73.3%) in the RMD group (figure 6.4).
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Figure 6.3: Lifetime perinatal episodes in parous women with mood disorder.
Hierarchical definitions of perinatal episode: i) Narrow: an episode of mania
/ hypomania, a mixed episode or an affective psychosis all with onset within
6 weeks of delivery ii) Intermediate: those women meeting the narrow criteria
plus those with a history of an episode of major depression with onset within 6
weeks of delivery iii) Broad: a history of an episode of any major mood disorder
with onset in pregnancy or within 6 months of delivery.
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Figure 6.4: Morbidity risk of PNEs by lifetime diagnosis. Vertical bars rep-
resents 99% confidence intervals. On the y axis the morbidity risk of PNEs
expressed as SO ´MR “ Ařn
i“1Dpaiq where ai is the age at the time of the in-
terview and Dpaiq is the corresponding conditional probability of being affected
by age ai, given that an individual is affected.
6.2.3 Incidence rates of perinatal episodes
Pregnancy by pregnancy information was available for 3125 pregnancies from
1441 women (table 6.3).
Table 6.3: Incidence of perinatal episodes by live birth delivery in women with
mood disorder.
LIFETIME
DIAGNOSIS
DSM-IV BD-I DSM-IV BD-II DSM-IV RMD
(N=828) (N=272) (N=327)
(Nd=1718) (Nd=598) (Nd=809)
DELIVERIES
AFFECTED
WITH:
N % 99%CI N % 99%CI N % 99%CI
PP 350 20.4 17.9-23.0 20 3.3 1.7-5.7 14 1.7 0.8-3.3
PND 433 25.2 22.5-28.0 230 38.5 33.3-43.7 315 38.9 34.5-43.5
ANY PNE 844 49.1 46.0-52.3 269 45 39.7-50.3 332 41 36.6-45.6
1
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Around 1 in 5 pregnancies in women with BD-I were complicated by a manic
episode or a psychotic depression in pregnancy or within 6 months postpar-
tum. Episodes of perinatal major depression were even more common in bipo-
lar women, affecting 1 in 4 pregnancies. Looking at broadly defined episodes of
PNE, women with BD-I had a statistically significant higher incidence of broadly
defined PNEs than women with RMD (Mantel-Haenszel χ2= 10.13, df = 1, p =
0.001). However the effect size was small (OR=1.32, 99%CI=1.06-1.66). I found
no difference in the incidence rates between BD-I and BD-II (Mantel-Haenszel
χ2= 2.43, df = 1, p = 0.12) or between BD-II and RMD (Mantel-Haenszel χ2=
1.36, df = 1, p = 0.24)
6.3 Summary
In this chapter I investigated the rates of PNEs in a large, well-characterised
clinical sample of women with mood disorders. The lifetime prevalence of PNEs
was high across all disorders, affecting more than 2 women out of 3 in all di-
agnostic groups. When information on each pregnancy was studied, women
with BD-I reported more PNEs than women with RMD. In women with BD-I
episodes of mania/psychosis affected about 1 in 5 perinatal periods and episodes
of major depression were even more common, affecting 1 in 4 perinatal periods.
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Chapter 7
Time of onset of perinatal
mood episodes
In this chapter I report the analyses I conducted on the timing of onset of PNEs.
In the background section I have argued that
• Although the majority of studies reported that episodes of postpartum
psychosis occur soon after childbirth, the presence of a free interval after
delivery and the period in which the incidence of postpartum depression
maximises are controversial
• There is a lack of information on bipolar postpartum depression and no
previous studies have compared bipolar and unipolar postpartum depres-
sion
• The literature has either focussed on episodes occurring in pregnancy or
episodes occurring in the postpartum period. Only the large retrospective
study conducted by Viguera et al that I reviewed in the background section
examined the rates of mood episodes in pregnancy and in the postpartum
period [6].
I therefore explored the time-to-onset of PNEs across the mood disorder spec-
trum. I reported the rates of episodes occurring in pregnancy and after child-
birth, using different definitions of postpartum onset. I sought to replicate
Viguera’s [6] findings on the postpartum-pregnancy risk ratio and to quan-
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tify the proportion of episodes that would be included in current definitions
of postpartum onset. Then I explored the survival curves for postnatal ma-
nia/psychosis in BD-I and for postnatal depression across the unipolar - bipolar
spectrum to test whether empirical data supported the current definitions of
postpartum onset rather than the hypothesis that different postpartum onset
criteria should be used for mania and depression.
7.1 Methods
Recruitment and assessment of participants have been already described in chap-
ter 5. Participants were included in the current analyses if they i) had a lifetime
diagnosis of DSM-IV BD-I or BD-II or RMD and ii) had at least one DSM-IV
major depressive, manic, or mixed episode in pregnancy or after a live birth.
7.1.1 Analytic plan
First I estimated the proportion of episodes occurring in pregnancy and within
6 months after childbirth by lifetime diagnosis. I also employed three mutually
exclusive definitions of postpartum onset: 4 weeks (as in the DSM-IV), 6 weeks
(as in the ICD-10) and 6 months (commonly used in the clinical practice). Then,
I used survival analyses to:
• estimate time-to-onset of i) manic or mixed episodes, ii) non psychotic
depression and iii) psychotic depression;
• compare time-to-onset of i) postnatal manic or mixed episodes, ii) post-
natal non psychotic depression and iii) postnatal psychotic depression in
women with BD-I. Given that, by definition, women with RMD do not
experience manic episodes, and there were only few episodes of psychotic
depression in the BD-II group (N= 9) and in the RMD group (N=18),
I compared survival curves according to the type of episode only in the
BD-I group.
• compare time-to-onset of postnatal depression between lifetime diagnosis
(BD-I, BD-II, RMD). I aimed to test the hypothesis that the DSM-IV
lifetime diagnosis is not associated with the time of onset of postpartum
112
depression. I limited the comparisons to the postpartum period, because
the survival curves including the entire perinatal period showed a peak
of incidence in the immediate postpartum and the majority of episodes
occurred after childbirth.
Table 7.1 lists the hypotheses I tested. I performed 3 independent groups
of tests, so the initial P value threshold using the Bonferroni correction was
0.05/3=0.0171.
Survival analyses
In order to perform any survival analysis two outcome variables are needed:
• a time variable: ti=time-to-onset of the postnatal episode
• a censoring variable: ci=1 if the postnatal episode occurred or ci=0 if the
postnatal episode did not occur by the time ti
First, I employed the Kaplan-Maier estimator to estimate the survival function.
It is a non parametric method (and thus does not require any mathematical as-
sumptions about the underlying hazards) and provides an intuitive graphical
presentation. As already discussed in previous chapters, affected pregnancies
from the same individual are not independent events. Thus, I fitted a mixed
effect Cox model to test the null hypothesis of no difference between survival
functions and to explore the influence of parity order and within subject vari-
ations. I used the coxme function of the coxme library and I compared the fit
of different models [163]. I limited these analyses to the first 2 pregnancies,
because there were not many cases among subsequent pregnancies.
1Comparative analyses on 1) episodes occurring in pregnancy v episodes occurring post-
partum 2) survival curves in BD-I 3) survival curves for perinatal depression
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7.2 Results
Information was available for 1332 affected pregnancies from 695 women (table
7.2).
Table 7.2: Sample charachteristics
LIFETIME DIAGNOSIS BD-I BD-II RMD
NUMBER OF WOMEN 421 105 169
NUMBER OF PREGNANCIES 761 190 381
N % N % N %
ORDER OF PARITY
First 421 55.3 105 55.3 169 44.5
Second 230 30.2 51 26.8 126 33.1
Third 77 10.1 22 11.6 65 17.1
Fourth 33 4.3 12 6.3 21 5.5
PERINATAL DIAGNOSIS
Mania, hypomania or mixed episodes 394 51.8 7 3.7 0
Psychotic depression 40 5.3 9 4.7 18 4.7
Non-psychotic depression 318 41.8 173 91.1 362 95.0
Polymorphic psychosis 9 1.2 1 0.5 1 0.5
7.2.1 Perinatal episodes in bipolar I disorder
Mania The vast majority (342/394, 86.8%) of manic episodes occurred within
4 weeks postpartum, about 90% (353/394) within 6 weeks. Only 5.1%
(20/394) of episodes occurred in pregnancy - test of proportion for episodes
occurring in pregnancy v episodes occurring in the postpartum χ2= 316.3,
df = 1, p ă 0.001.
Non-psychotic depression Although episodes of postpartum non psychotic
depression were still overrepresented in comparison with episodes during
pregnancy (42/318, 13.2%) , only 64.1% (204/318) occurred within 4 weeks
postpartum, while about 1 in four episodes occurred later after childbirth
(72/318, 22.5%) - test of proportion for episodes occurring in pregnancy
v episodes occurring in the postpartum χ2 = 170.7, df = 1, pă 0.001.
Psychotic depression 22.5% (9/40) episodes of psychotic depression occurred
in pregnancy, 62.5% (25/40) within 4 weeks - test of proportion χ2 = 11.0,
df = 1, p= 0.001
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Cycloid psychosis There were only 9 episodes of cycloid psychosis. All of
them occurred in the postpartum period, with 8/9 (88.9%) occurring
within 4 weeks after delivery.
Figure 7.1a displays the survival curves for perinatal episodes in BD-I according
to the type of episode (mania, psychotic depression, cycloid psychosis and non-
psychotic depression) while figure 7.1b is focused on the postpartum period.
I used Cox mixed analysis, including only first (N=379) and second deliveries
(N=204) and excluding episodes occurring in pregnancy and episodes of cycloid
psychosis, because of the small sample size. There was a significant random
effect (Integrated loglik = 65.3, df= 4,p ă 0.001; Penalized loglik= 110.4, df=
24.9, p ă 0.001), so I compared survival curves in the following model:
coxme(survival object ˜ type of episode + parity order + (1|ID))
and
survival object <- with(BD-I , Surv(t, episode))
The random effect is specified in the formula by a parenthesised expression
which contains a vertical bar separating effects on the left (in this case the
intercept) from grouping variables on the right (in this case the subject ID). I
found that survival curves for mania and psychotic depression were similar (z=-
1.63, p=0.1) while non-psychotic depressive episodes had a significantly later
onset in the postpartum (z=-6.8, p ă 0.001). Moreover, postnatal episodes
occurring in primiparae had an earlier onset than those occurring in multiparae
(z=-3.01, p ă 0.001).
116
-40 -30 -20 -10 0 10 20
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
Survival Time in Weeks
S
ur
vi
va
l r
at
e
Mania, N=394
Non psychotic depression, N=318
Cycloid psychosis, N=9
Psychotic depression,N=40
(a) Perinatal period
0 5 10 15 20 25
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
Survival Time in Weeks
S
ur
vi
va
l r
at
e
Mania, N=374
Non psychotic depression, N=276
Cycloid psychosis, N=9
Psychotic depression,N=31
(b) Postnatal period
Figure 7.1: Survival curves for perinatal episodes in BD-I according to the type
of episode. Part a) includes also pregnancy, while part b) includes only postpar-
tum episodes. Survival curves for postpartum mania and psychotic depression
were similar (z=-1.63, p=0.1) while non-psychotic postpartum depression had a
significantly later onset in the postpartum (z=-6.84, df=1, p ă 0.001).I excluded
cycloid psychosis from the analysis because of the small sample size.
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7.2.2 Perinatal non psychotic depression across the mood
disorder spectrum
Given that, by definition, women with RMD do not experience manic episodes,
and there were only few episodes of psychotic depression, further survival anal-
yses were conducted for non psychotic depressive episodes alone. I aimed to
examine the question of whether the time to onset of perinatal depression dif-
fered BD-I, BD-II and RMD.
The majority of episodes of perinatal depression occurred in the postpartum pe-
riod across all diagnostic group (figure 7.2a). However, women with BD-II had
a larger proportion of episodes occurring in pregnancy than women with BD-I
(Fisher’s Exact Test for Count Data p=0.02, OR 1.8, 99%CI 0.91- 3.49 - not
significant after Bonferroni correction) and than women with RMD (Fisher’s
Exact Test for Count Data p = 0.001, OR 2.3, 99%CI 1.17- 4.59). I summarise
the distribution of postpartum episodes, employing different definitions and ac-
cording to lifetime diagnoses in figure 7.2b.
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Figure 7.2: Part a): Staked bar plot of the proportion of perinatal non psychotic
depression occurring in pregnancy and in the postpartum period. Women with
BD-II had a larger proportion of episodes occurring in pregnancy than women
with RMD (Fisher’s Exact Test for Count Data p=0.001, OR 2.3, 99%CI 1.17-
4.59). Part b): Staked bar plot of the proportion of postpartum episodes ac-
cording to different onset definition
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Figure 7.3a shows the survival curves for perinatal non psychotic depression
according to lifetime diagnosis. I used the Cox mixed methodology to compare
survival curves for depression across lifetime diagnoses in the following model:
coxme(survival object ˜ DSM-IV diagnosis + parity order + (1|ID))
and
survival object <- with(postnatal depression, Surv(t, episode))
Including the entire perinatal period in the analysis, there were no differences
between lifetime diagnoses, nor between first and second perinatal periods (In-
tegrated loglik =18.8, df =4, p= 0.0009, Penalized loglik =389.1, df=162.85,
p ă 0.001).
I then analysed survival curves for postnatal depression (figure 7.3b). Again,
I found a within subject effect (Integrated loglik =25.1, df= 4, pă 0.001, Pe-
nalized loglik= 318.1, df=130.9, pă 0.001). Women with BD-I and RMD had
overlapping survival curves (z=0.13, p=0.9), while women with BD-II displayed
a delayed onset of non psychotic depressive episodes (z=-2.71, p= 0.007 v BD-
I). Postnatal episodes occurring in primiparae had an earlier onset than those
occurring in multiparae (z=-2.46 p=0.014).
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Figure 7.3: Survival curves for perinatal depression according to lifetime diag-
nosis Part a) includes also pregnancy, while part b) includes only postpartum
episodes. Women with BD-I and RMD had overlapping survival curves (z=0.13,
p=0.9), while women with BD-II displayed a delayed onset of non psychotic de-
pressive episodes (z=-2.71, p= 0.007 v BD-I).
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7.2.3 Was there any differences in onset between first and
subsequent pregnancies in women with more than
one episode?
I selected two sub-samples of women having both their first and second preg-
nancy affected by either perinatal mania/psychosis (N=61) or perinatal non
psychotic depression (N=135). I merged the sample with mania with that of
psychotic depression and cycloid psychosis to have a sample size suitable for
statistical inference. I labelled this category as ’affective psychosis’. I tested the
hypothesis that having an episode in the first perinatal period is associated with
a shorter latency between childbirth and the onset of a second perinatal episode.
Using Cox mixed models, there were no differences in the survival curves be-
tween first and second episode of perinatal affective psychosis (Likelihood ratio
test=0.13, df=1, p=0.7) and of perinatal non psychotic depression (Likelihood
ratio test=0.33, df=1, p=0.6).
7.3 Summary
In this chapter I explored the time to onset of perinatal episodes.
• I examined how many perinatal episodes occurred in pregnancy and how
many in postpartum and found that the majority of PNEs occurred in the
postpartum period
• I examined how many postpartum episodes met various postpartum onset
criteria and found that the majority of PNEs in women with BD-I and
RMD occurred within 4 weeks after childbirth.
• In BD-I I compared the survival curves for manic/mixed, psychotic depres-
sive, and non psychotic depressive episodes and found that there was a
correlation between the phenomenology of the episode and the time of on-
set, with a significantly shorter latency for manic and psychotic episodes.
• I compared survival curves for perinatal depression in BD-I, BD-II and
RMD. Women with BD-I and RMD had overlapping survival curves, while
for BD-II, onsets of PNEs were more spread out over the perinatal period
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with more onsets in pregnancy and later in the postpartum.
• I explored differences in onset between first and subsequent pregnancies
in women with more than one episode and found that episodes occurring
after first pregnancies had a shorter latency than episodes occurring after
subsequent pregnancies. The effect was stronger for episodes of BD-I.
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Chapter 8
Is childbirth a specific
trigger for mood disorders?
“It is certain that among furious lunatics, there are more women
than men. A new subject of research. Does this difference originate
in the sequelae of childbearing, in the nervous sensations accompa-
nying lactation?”
Jacques Tenon [164]
The high incidence rates in the perinatal period reported in chapter 6 do not
necessarily implicate that childbirth is a specific trigger, because bipolar disorder
and RMD are recurrent illnesses and high occurrence rates may be common also
outside the perinatal period. The cross-sectional observation of a PNE needs,
in fact, to be put into the context of the longitudinal lifetime course of the
disorder in order to establish the strength of the association between childbirth
and bipolar/mood disorders. Similar high rates of PNEs can have different
diagnostic validity, according to the lifetime course of the illness. Figure 8.1
and 8.2 exemplify some possible scenarios.
In this chapter I investigate the specificity of the childbirth trigger and report
the analyses I conducted in order to:
1. estimate the proportion of parous women with mood disorders who had
their first episode in relation to childbirth (as exemplified in figure 8.2)
versus women in which PNEs were recurrences of a pre-existing mood
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Figure 8.1: Perinatal recurrences of mood disorders.Red arrows represent child-
birth. Episodes occurring in temporal relation with childbirth are not neces-
sarily caused by psychological and biological changes occurring in relation to
childbirth, but may be a consequence of the recurrent course of mood disorders
and be in temporal relation to childbirth just by chance. Here I exemplify three
possible scenarios in which childbirth is not necessarily a specific trigger for an
episode. Part A Chronic illness, in which, although the participant reported
to be ill after childbirth, the episode may have been part of an ongoing episode,
or part B a relapse (i.e. a full syndrome before a full remission from a previous
episode was reached) or part C a recurrence that only by chance happened in
relation to childbirth, given the high rates of recurrence of the condition. In
fact it has been shown in a sub-sample of participant with BD-I drawn from the
mood disorder research project database that 36% of participants with an early
onset and 21.6% of those with a mid onset had rapid cycling and more episodes
and a worse course of illness than participants in the late-onset group. [165]
disorder (as exemplified in figure 8.1);
2. test the association between lifetime course of illness and PNEs and com-
pare the rates of episodes occurring in relation to childbirth with the rates
of episodes occurring at other times outside the perinatal period;
3. test whether the vulnerability was specific to postpartum mania/psychosis
(as in figure 8.2B) and postpartum non-psychotic depression or it was a
general vulnerability to PNEs in which a woman experienced mania after
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Figure 8.2: Perinatal onset of mood disorders. Red arrows represent childbirth.
Even the onset of the disorder in relation to childbirth does not necessarily imply
that childbirth is the trigger for that episode or for the disorder in general. In
fact the onset of bipolar disorder occurs in most of the cases in the reproductive
age and a first episode may occur only by chance in relation to childbirth.
In these cases women develop a bipolar illness, in which recurrences are not
related to reproductive events (part A). Among women who have episodes
only in relation to childbirth, there are three possible scenarios: 1) childbirth
is a strong and specific trigger, causing only one type of recurrence after each
pregnancy (here manic, part B), 2) it can act as a trigger after one pregnancy,
but not after other pregnancies (part C) or 3) it can act as an unspecific
trigger by triggering episodes with different phenomenology within the same
woman (part D). The latter three patterns can be identified only in women
with at least 2 deliveries.
one pregnancy and non-psychotic depression after an other (as in figure
8.2D).
8.1 Results
As I was interested in PNEs in relation to the lifetime course of illness, I in-
cluded in the current analyses only women with a lifetime history of broadly
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defined PNEs1. The sample consisted of 887 women with BD-I, 237 women with
BD-II and 314 women with RMD. The association between PNEs and lifetime
diagnoses was consistent with my findings in chapter 5 and is summarised by
the mosaic plot in figure 8.3.
1See chapter 6 for a definition of broad PNE
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Figure 8.3: History of perinatal episodes according to lifetime diagnosis. Only
women with a lifetime history of PNEs were included in the analyses (N=1438).
The total area of the mosaic plot represents the total sample size. The plot is
divided first into horizontal bars whose widths are proportional to the proba-
bilities associated with the first categorical variable (in this case the DSM-IV
diagnosis). Then each bar is split vertically into bars that are proportional to
the conditional probabilities of the second categorical variable. Colours display
the deviations (residuals) from a model in which PNEs and lifetime diagnoses
are independent events. Deep blue corresponds to residuals are greater than
+4, indicating much greater frequency in those cells than would be found if
PNE and lifetime diagnosis were independent. Deep red corresponds to the
residual lower than -4, indicating that that combination of PNE and lifetime
diagnosis is extremely rare under the hypothesis of independence. The stan-
dardized Pearson residual for a cell ij is rij “ Oij´Eij?
Eijp1`pi`qp1´p`jq where O is
the observed count, E the expected count and p the marginal proportions. The
overall Pearson χ2 statistic is just the sum of squares of the residuals. The
plot was produced using the library vcd . Abbreviations: BD-I: bipolar I disor-
der, BD-II:bipolar II disorder, RMD: recurrent major depression, PP: history of
mania or brief psychotic episode with mood symptoms within 6 weeks postpar-
tum, PND: history of postnatal depression within 6 weeks postpartum, Other:
history of mood episode in pregnancy or between 6 weeks and 6 months after
childbirth. A hierarchical approach was used
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The dataset used for the analyses reported in this chapter contained many
missing values. Figure 8.4 displays the missing values according to the pattern
of missingness. I did not identify any variable that was completely responsible
for the missing data. I therefore assumed that data were missing due both
accessible and inaccessible factors. My assumption was based on a large amount
of literature (see for example [166]), that suggested that this is the most plausible
scenario . Missing data were handled according to the algorithm presented in
chapter 5. Dealing with missing data and multiple imputation is complex and
computationally demanding, so I preferred to produce separate multiple datasets
for each hypothesis I tested. This approach allowed me a better control and
produced more stable datasets.
Figure 8.4: Missingness pattern plot obtained with the function
missing.pattern.plot in the package mi [167]. Only variables contain-
ing missing values are shown. The observed values are plotted with blue and
the missing values are in red. Variables and cases are ordered by proportion
missing and clustered by similar missingness pattern. Abbreviations: AAPNE:
age at first perinatal episode, del: number of deliveries, PNEtot: total number
of postpartum episodes within 6 weeks after childbirth, years: years of illness,
total: total number of episodes lifetime, Age1: age at first pregnancy, first:
whether perinatal episode is a recurrence or the first lifetime episode, history:
history of perinatal episodes
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8.1.1 Onset of mood disorder or recurrence of a pre-existing
disorder?
Information on whether a PNE was the first lifetime episode or a recurrence
of a pre-existing mood disorder was available for 1187/1438 (82.6%) women.
Because missing values were overrepresented in BD-I (χ2= 12.22, df = 2, p =
0.0022 and figure 8.5), the Amelia package was employed to perform multiple
imputations and the Zelig package for the inferences (please see chapter 5 for
a broader discussion on dealing with missing values).
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Figure 8.5: Association between lifetime diagnosis and first lifetime episode.
Only women with a lifetime history of PNEs were included in the analyses
(N=1438). The total area of the mosaic plot represent the total sample size.
The plot is divided first into horizontal bars whose widths are proportional to
the probabilities associated with the first categorical variable (in this case the
DSM-IV diagnosis). Then each bar is split vertically into bars that are propor-
tional to the conditional probabilities of the second categorical variable (first -
whether the PNE was the the first lifetime episode of mood disorder or a recur-
rence).Abbreviations: BD-I: bipolar I disorder, BD-II:bipolar II disorder, RMD:
recurrent major depression, FIRST:PNE as first lifetime episode of mood disor-
der, REC: PNE as a recurrence of a pre-existing mood disorder, NA information
missing
The rates of missingness for each variable inputed are listed in table 8.1, while
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graphical diagnostics to inspect the imputations are presented in figure 8.6 and
8.7.
Table 8.1: Fraction missing for individual variables in the analyses on first
episode
VARIABLE NAME FRACTION MISSING
ID No missing
History of PNE No missing
First episode in the perinatal period? 0.17
DSM-IV No missing
Age at impairment 0.03
Age at first PNE 0.86
Age at first live birth 0.68
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Figure 8.6: Overimputation diagnostic graph for multiple imputations for life-
time onset in relation to childbirth. The majority of confidence intervals fell on
the regression line and there was less than 20-40% of covariates missing for each
value imputed.
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Figure 8.7: Overdispersion diagnostic for multiple imputations for lifetime on-
set in relation to childbirth. EM chains converged. A detailed explanation of
overdispersion is provided in chapter 5.
I performed 4 independent tests, so the correct p value threshold for significance
was 0.05/4= 0.0125. The first lifetime episode was temporally associated with
childbirth in 43.1% (99%CI 38.3%-48.1%) of women with BD-I, in 37.7% (99%
CI 29.2%-46.9%) of women with BD-II and in 52.9% (99%CI 45.0%-60.7%) of
women with RMD. Postpartum depression within 6 weeks (49.3%, 99% CI 44.0%
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-54.7%) and, to a lesser extent, postpartum mania/psychosis within 6 weeks
(45.1%, 99% CI 39.3% -51.0%) were overrepresented in the group of women
with onset in the postpartum period in comparison to episodes occurring in
pregnancy or later than 6 weeks postpartum (34.8%, 99%CI 28.5%-41.6%) -
for postpartum depression estimate= -0.60, SE 0.16, t= -3.67, p= 0.0006; for
postpartum mania/psychosis estimate= -0.43, SE = 0.16, t= -2.67, p= 0.0090.
I used logistic regression to model the association between perinatal onset and
a set of explanatory variables, always including age at impairment as covari-
ate. Women with RMD reported a significantly greater proportion of first
PNEs representing the first lifetime episode (estimate: -0.41, SE: 0.13, z: -
3.08, p=0.0020), than women with BD-I, while there were no differences across
the bipolar spectrum (estimate:0.12, SE: 0.15, z=0.82, p= 0.4094). However,
the difference across mood disorder spectrum was no longer significant in the
multivariate model including age at first episode and age at first pregnancy as
covariates.
If childbirth does not represent a specific trigger, the age at the first exposure
(age at first full term delivery) should be similar in the group with a recurrence
in the perinatal period and in the group with a first episode in the perinatal
period. Women who have the first child later in their life have a longer period
at risk of developing a mood disorder before becoming mothers than those who
have their first child at a younger age. So, I expected that age at first preg-
nancy was inversely correlated with the probability of having a perinatal onset
of illness. However, in the current sample older primiparae had a greater proba-
bility of a perinatal onset than younger primiparae. Age at first pregnancy was
positively associated with the probability of having the first lifetime episode in
relation to childbirth (estimate=0.02, SE= 0.01, t=3.17, p= 0.0017). The as-
sociation between age and the probability of having a perinatal onset of illness
was significant for postpartum mania or psychosis within 6 weeks (estimate=
0.05, SE= 0.02, t= 2.78, p=0.0054 - figure 8.8, part A) and there was a trend
toward significance for depression within 6 weeks postpartum (estimate=0.02,
SE=0.01, t= 2.28, p= 0.0228, figure 8.8, part B).
In summary, about 1 in 2 women with a history of mood episodes within 6
weeks postpartum, reported the onset of the mood disorder in the postpartum
period. Women in which the first manifestation of the mood disorder was post-
partum mania or psychosis were older than those in which postpartum mania
or psychosis was a recurrence. This finding may support the hypothesis that
childbirth acts as a specific trigger for mood disorders in a subgroup of women
in which the first life-time episode occurred in the postpartum period.
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Figure 8.8: Probability of having a perinatal onset of illness as a function of
age at first pregnancy resulting in a live birth. Part A. Probability of having a
manic, mixed or psychotic episode within 6 weeks postpartum as first episode
(estimate= 0.05, SE= 0.02, t= 2.78, p=0.0054) Part B. Probability of having
a major depressive episode within 6 weeks postpartum as first episode (esti-
mate=0.02, SE=0.01, t= 2.28, p= 0.0228). Vertical bars represent simulated
confidence intervals for predicted probability of having a perinatal onset of ill-
ness over a specified range of one explanatory variable (age at first pregnancy
resulting in a live birth between 14 and 50 years of age) [168]. I used the function
plot.ci in the packageZelig to produce the graph.
8.2 Course
Analyses were performed separately for women with a lifetime history of post-
partum psychosis or mania or mixed episodes within 6 weeks and BD-I and
for those with non psychotic depression within 6 weeks of delivery. I excluded
episodes occurring in pregnancy or later in the postpartum or psychotic episodes
in BD-II and RMD because of the small samples in these subgroups. As I
wanted to explore the longitudinal course of illness, I included in my analyses
only women with at least 2 live births and who had the first mood episode at
least 5 years before the assessment by the Mood Disorder Research Group. I
used a very conservative approach and the Wilcoxon signed rank test to compare
the rates of episodes that occurred within 6 weeks after delivery with the rates
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of lifetime episodes/YEAR in a subsample of women who suffer with at least
one postpartum episode of mania, psychosis or mixed or major depression. I
conducted 2 independent tests for each diagnostic subgroup, so I used a p value
threshold for significance of p=0.05/2=0.025.
8.2.1 Postpartum psychosis in bipolar I disorder
I use here the term postpartum psychosis to label episodes of DSM-IV mania
or psychotic depression with onset within 6 weeks postpartum. 239 women met
the inclusion criteria (BD-I, at least one episode of postpartum psychosis, at
least two live births, and at least 5 years of observations after the first mood
episode). The mean period of observation was 25.2 years (SD 11.82 years).
The rates of missingness for each variable inputed are listed in table 8.2, while
graphical diagnostics to inspect the imputations are presented on figures 8.9 and
8.10. Because the variable ’total number of lifetime episodes’ was not normally
distributed, I transformed it using the natural logarithm.
Table 8.2: Fraction missing for individual variables for the analyses on bipolar
I postpartum psychosis and course of illness
VARIABLE FRACTION MISSING
ID no missing
First episode postpartum psychosis? 0.04
Age at first live birth 0.81
Total number of episodes lifetime 0.10
Total number of postpartum episodes 0.03
Deliveries no missing
Age at impairment no missing
Age at first postnatal episode 0.89
Age at interview no missing
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Figure 8.9: Overimputation diagnostic graphs for multiple imputations for bipo-
lar I postpartum psychosis in relation to lifetime course. The majority of con-
fidence intervals fell on the regression line and there was less than 20-40% of
covariates missing for the majority of value imputed.
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Figure 8.10: Overdispersion diagnostic plots for multiple imputations for bipolar
I postpartum psychosis in relation to lifetime course. EM chains converged. A
detailed explanation of overdispersion is provided in chapter 5.
Table 8.3 summarises the distribution of course of illness for each simulation.
Although the majority of women (about 58% had a recurrent course with less
than an episode every two year, a chronic/highly recurrent course was reported
by more than 15% of women).
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Table 8.3: Course of illness in women with postpartum mania or psychosis.
Only women with BD-I, at least 2 live births and 5 years of observations were
included. In each cell count (%). Y:year
Simulation Chronic ą1 episode/y 1-2 episode/2 yr ă 1 episode/2y
1 3 (1.3) 40(16.9) 54 (22.8) 140 (59.1)
2 3 (1.3) 35 (14.8) 55 (23.2) 144 (60.7)
3 3 (1.3) 37 (15.6) 55 (23.2) 142 (59.9)
4 3 (1.3) 40 (16.9) 58 (24.5) 136 (57.4)
5 3 (1.3) 37 (15.6) 61(25.7) 136 (57.4)
The proportions of deliveries affected by postpartum psychosis or mania in
women with a history of postpartum psychosis are listed in table 8.4.
Table 8.4: Proportion of live births affected by postpartum psychosis in women
with BD-I and a history of postpartum psychosis
Proportion of deliveries affected N % 99%CI
1/6 1 ă 0.1 ă 0.1´ ă 0.1
1/4 8 3.3 1.1-7.6
1/3 20 8.4 4.4-14.1
2/5 13 0.7 ă 0.1-3.2
1/2 92 38.5 30.1-46.5
3/5 1 ă 0.1 ă 0.1´ ă 0.1
2/3 10 4.2 1.6-8.7
3/4 1 ă 0.1 ă 0.1´ ă 0.1
4/5 1 ă 0.1 ă 0.1´ ă 0.1
1 101 42.3 34.4-51.2
Including any type of PNE (the concordance between PNEs occurring in the
same woman is the subject of investigation in the next section) 19.7% of multi-
parae with a history of postpartum mania/psychosis had all deliveries affected
and less than 1 recurrence every 2 years. I compared with the Wilcoxon test the
proportion of live birth affected by mood episodes within 6 weeks postpartum
with the episodes per YEAR of illness. This approach was highly conservative,
because I used a 6 weeks denominator versus a one year denominator. However,
episodes in the postpartum period were significantly overrepresented in com-
parison to episodes outside the perinatal period in multiparae with BD-I and a
history of postpartum psychosis (p ă 0.0001 in any stimulation).
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8.2.2 Postpartum depression in bipolar I disorder
166 women met the inclusion criteria (BD-I, at least one episode of non psy-
chotic within 6 weeks postpartum, at least two live births, and at least 5 years of
observations after the first mood episode).The mean period of observation was
28.7 years (SD 11.49 years). The rates of missingness for each variable imputed
are listed in table 8.5, while graphical diagnostics to inspect the imputations
are presented on figure 8.11 and 8.12. Because the variable total number of life-
time episodes was not normally distributed, I transformed it using the natural
logarithm.
Table 8.5: Fraction missing for individual variables for the analyses on bipolar
I non psychotic depression and course of illness
VARIABLE FRACTION MISSING
ID no missing
First episode postpartum psychosis? 0.14
Age at first live birth 0.65
Total number of episodes lifetime 0.06
Total number of postpartum episodes 0.11
Deliveries no missing
Age at impairment no missing
Age at first postnatal episode 0.83
Age at interview no missing
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Figure 8.11: Overimputation diagnostic graphs for the analyses on bipolar I non
psychotic depression and course of illness. The majority of confidence intervals
fell on the regression line and there was less than 20-40% of covariates missing
for the majority of value imputed.
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Figure 8.12: Overdispersion diagnostic plots for the analyses on bipolar I non
psychotic depression and course of illness. EM chains converged.
Table 8.6 summarises the distribution of course of illness for each simulation.
Compared to what I reported for postpartum mania/psychosis, a recurrent
course with less than an episode in 2 years was reported by less than 40%
of multiparae with a history of bipolar I non psychotic depression. On the
contrary, about 1 in 4 women reported a chronic/highly recurrent course.
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Table 8.6: Course of illness in women with postpartum bipolar I non psychotic
depression. Only women with BD-I, a lifetime history of postpartum non psy-
chotic depression, but not postpartum mania/psychosis, at least 2 live births
and 5 years of observations were included. In each cell count (%), y:year
Simulation chronic ą1 episode/y 1-2 episode/2y ă 1 episode/2y
1 4 (2.4) 41(24.7) 59 (35.5) 62(37.3)
2 4 (2.4) 40(24.1) 57 (34.3) 65 (39.1)
3 4 (2.4) 42 (25.3) 57 (34.3) 63 (37.9)
4 4 (2.4) 42 (25.3) 56 (33.7) 64 (38.5)
5 4 (2.4) 43 (25.9) 57 (34.3) 62 (37.3)
The proportions of deliveries affected by postpartum non psychotic bipolar I
depression in multiparae with a history of postpartum non psychotic bipolar I
depression are listed in table 8.7.
Table 8.7: Proportion of live births with postpartum non psychotic bipolar I
depression in multiparae with a history of postpartum non psychotic bipolar I
depression
Proportion of deliveries affected N % 99%CI
1/6 1 0.6 ă 0.1´ 6.4
1/5 2 1.2 ă 0.1´ 7.9
1/4 9 5.4 3.9-19.1
1/3 23 13.8 4.4-14.1
2/5 2 0.7 ă 0.1-3.2
1/2 60 36.1 26.8-46.3
3/5 1 0.6 ă 0.1´ 6.4
2/3 14 8.4 3.8-15.5
3/4 3 1.8 ă 0.1´ 6.5
4/5 1 0.6 ă 0.1´ 6.4
1 50 30.1 21.3-40.1
Only 15/166 (9.0%) of multiparae with a history of postpartum bipolar I non
psychotic depression had all deliveries affected and less than 1 recurrence every
2 years. As above for postpartum psychosis, I compared with the Wilcoxon test
the proportion of live birth affected by non psychotic depression within 6 weeks
postpartum with the episodes per YEAR of illness. There were no differences
between the rates of episodes occurring in the postpartum period and those of
episodes outside the postpartum period in multiparae with BD-I and a history of
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postpartum non psychotic depression, but not psychosis/mania (W ă 12394.5,
p ą 0.112 in any stimulation).
8.2.3 Postpartum non psychotic bipolar II depression
88 women met the inclusion criteria (BD-II, at least one episode of postpartum
depression within 6 weeks, at least two live births, and at least 5 years of obser-
vations after the first mood episode). The mean period of observation was 27.6
years (SD 11.32). The rates of missingness for each variable inputed are listed in
table 8.8, while graphical diagnostics to inspect the imputations are presented
on figure 8.13 and 8.14. Because the variable total number of lifetime episodes
was not normally distributed, I transformed it using the natural logarithm.
Table 8.8: Fraction missing for individual variables for the analyses on postpar-
tum bipolar II depression and course of illness
VARIABLE FRACTION MISSING
ID no missing
First episode postpartum psychosis? 0.06
Total number of episodes lifetime 0.09
Total number of postpartum episodes 0.06
Deliveries no missing
Age at impairment no missing
Age at interview no missing
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Figure 8.13: Overimputation diagnostic graphs for postpartum non psychotic
bipolar II depression. Although I report here the graphs also for age at first live
birth and age at first perinatal episode, these variables were dropped from the
final model because of overdispersion (see figure 8.14)
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Figure 8.14: Overdispersion diagnostic plots for multiple imputations for bipo-
lar II non psychotic depression. First I run multiple imputations on a model
including age at first live birth and age at first perinatal episode. However, in
one of the two overdispersion diagnostic plots the EM chains were not com-
pletely converging (part A), so I preferred to drop age at first birth and age at
first perinatal episode from the model (part B and C).
Table 8.9 summarises the distribution of course of illness for each simulation.The
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distribution of the course patterns was different from that observed for BD-I
(especially for women who suffered with postpartum mania/psychosis). The
majority of multiparae with BD-II (52.3%) had a chronic course and less than
1/5 (19.3%) reported less than 1 episode/ 2 years of illness.
Table 8.9: Course of illness in women with bipolar II depression within 6 weeks
postpartum. Only women with BD-II, at least 2 live births and 5 years of
observations were included. In each cell count (%), y:year
Simulation Chronic ą1 episode/y 1-2 episode/2y ă 1 episode/2y
1 13 (14.8) 33(37.5) 25 (28.4) 17 (19.3)
2 13 (14.8) 33 (37.5) 25 (28.4) 17(19.3)
3 14 (15.9) 32 (36.4) 25 (28.4) 17 (19.3)
4 14 (15.9) 32 (36.4) 25 (28.4) 17 (19.3)
5 14 (15.9) 32 (36.4) 25 (28.4) 17 (19.3)
The proportions of deliveries affected by bipolar II depression within 6 weeks
of delivery in multiparae with a history of bipolar II depression within 6 weeks
are listed in table 8.10.
Table 8.10: Proportion of live births affected by bipolar II depression within 6
weeks of delivery in multiparae with a history of bipolar II depression within 6
weeks
Proportion of deliveries affected N % 99%CI
1/6 1 1.1 ă 0.1-8.2
1/5 1 1.1 ă 0.1-8.2
1/4 2 2.3 0.1-10.2
1/3 9 10.3 3.7-21.5
1/2 40 46.0 32.2-60.2
3/5 1 1.1 ă 0.1-8.2
2/3 8 9.2 3.0-20.1
1 25 28.4 17.1-42.7
As for lifetime course, in multiparae with bipolar II postpartum depression
the distribution of live birth delivery affected differed from that in postpartum
mania/psychosis and postpartum bipolar I depression, with only 7.9% of women
having all deliveries affected and less than 1 recurrence every 2 years. Episodes in
the postpartum period were underrepresented in comparison to episodes outside
the perinatal period (W ą 1994 and p ă 0.0001 in any stimulation).
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8.2.4 Postpartum non psychotic depression in recurrent
major depression
154 women met the inclusion criteria (RMD, at least one episode of postpartum
depression within 6 weeks, at least two live births, and at least 5 years of obser-
vations after the first mood episode).The mean period of observation was 24.1
years (SD 11.73). The rates of missingness for each variable inputed are listed in
table 8.11, while graphical diagnostics to inspect the imputations are presented
on figure 8.15 and 8.16. Because the variable total number of lifetime episodes
was not normally distributed, I transformed it using the natural logarithm.
Table 8.11: Fraction Missing for individual variables for the analyses on post-
partum unipolar depression and course of illness
VARIABLE FRACTION MISSING
ID no missing
First episode postpartum psychosis? 0.03896104
Age at first delivery 0.08441558
Total number of episodes lifetime 0.02597403
Total number of postpartum episodes 0.03896104
Deliveries no missing
Age at impairment no missing
Age at interview no missing
Age at first perinatal impairment 0.90909091
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Figure 8.15: Overimputation diagnostic graphs for postpartum non psychotic
depression in RMD. The majority of confidence intervals fell on the regression
line and there was less than 20-40% of covariates missing for the majority of
value imputed.
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Figure 8.16: Overdispersion diagnostic plots for multiple imputations for non
psychotic depression in RMD. EM chains converged. See chapter 5 for details
Table 8.12 summarises the distribution of course of illness for each simulation.
There were no cases of chronic course and only one woman reported more than
1 episode/year of illness. The vast majority of multiparae with RMD (90%),
reported less than 1 episode/ 2 years of illness.
Table 8.12: Course of illness in women with RMD and history of non psychotic
postpartum depression. Only women with RMD, at least 2 live births and 5
years of observations were included. In each cell count (%), y:year
Simulation Chronic ą1 episode/y 1-2 episode/2y ă 1 episode/2y
1 - 1 137 (89.5) 15 (9.8)
2 - 1 138 (90.2) 14(9.1)
3 - 1 138 (90.2) 14(9.1)
4 - 1 138 (90.2) 14(9.1)
5 - 1 138 (90.2) 14(9.1)
The proportions of deliveries affected by postpartum non psychotic depression
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in women with a history of RMD and non psychotic postpartum depression are
listed in table 8.12.
Table 8.13: Proportion of live birth affected by non psychotic depression within
6 weeks of delivery in multiparae with a history of bipolar II depression within
6 weeks
Proportion of deliveries affected N % 99%CI
1/6 2 1.3 ă 0.1-5.9
1/5 2 1.3 ă 0.1-5.9
1/4 9 5.8 2.1-12.5
1/3 24 15.6 8.9-24.5
2/5 2 1.3 ă 0.1-5.9
1/2 55 35.7 26.0-46.3
2/3 12 7.8 3.3-15.1
3/4 2 1.3 ă 0.1-5.9
1 46 30.0 20.8-40.2
(26%) of multiparae with RMD had all deliveries affected and less than 1 recur-
rence every 2 years. Episodes in the postpartum period were overrepresented in
comparison to episodes outside the perinatal period (W ą 20895 and pă 0.0001
in any stimulation).
8.2.5 Is the postpartum trigger specific for postpartum
psychosis/mania?
In this final subsection I report the results on the analyses I conducted on a
subsample of 146 women with BD-I, 2 live births, at least one of which affected
by postpartum mania/psychosis within 6 weeks. I sought to estimate i) how
many women had both deliveries affected and ii) how many of these women had
both deliveries affected by psychosis/mania within 6 weeks postpartum.
I conducted 2 independent tests, so I considered a p value threshold for signifi-
cance of p=0.05/2=0.025.
The rates of missingness for each variable inputed are listed in table 8.14, while
graphical diagnostics to inspect the imputations are presented on figure 8.17. I
did not perform overimputations because time to onset of episode was coded as
a categorical variable (assuming values: in pregnancy, within 6 weeks postpar-
tum, later in the postpartum).
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Table 8.14: Fraction missing for individual variables for the analyses on re-
currences of postpartum mania/psychosis. Unaffected births are included (and
counted as missing for time to onsets)
VARIABLE FRACTION MISSING
ID no missing
Total number of postpartum episodes 0.02
Time to onset of first perinatal episodes 0.260
Time to onset of seconds perinatal episodes 0.34
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Figure 8.17: Overdispersion diagnostic plots for multiple imputations for the
correlation between PNEs. EM chains converged.
68/128 women had both perinatal period affected by a mood episode. There
were significantly more episodes of postpartum mania/psychosis following the
first delivery (98/128-76.6%) than the second one(78/128-60.9%)- (McNemar’s
χ2 = 20.45, df = 1, p= ă 0.0001, OR 2.1, 99%CI 1.00-4.47). 48 women (37.5% of
the total 128 women and 70.6% of the 68 with both perinatal period affected by
a mood episode) had both live births affected by postpartum mania/psychosis
within 6 weeks. 20 women (20/128=15.6%, 20/68=29.4%) had one episodes
of postpartum mania/psychosis and one episode of any other mood disorder
in pregnancy or within 6 months postpartum. I used the test of proportion
and found that the proportion of women of having both episodes affected by
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mania and psychosis was significantly higher than the proportion of women who
had one episode of postpartum mania/psychosis and one episode of any broadly
defined perinatal disorder (70.6%, 99%CI 54.29 %-83.00%, χ2 = 10.72, df = 1,
p = 0.0011, )
8.3 Summary
In this chapter I have reported the analyses I conducted on the childbirth trigger
of mood episodes in relations to the lifetime course of illness.
Episodes of mania or psychosis within 6 weeks postpartum represented
the first episode for about 45% of women who suffered from them. Women
who experienced a first mania/psychotic episode within 6 weeks postpar-
tum were significantly older than women who had a postpartum recur-
rence. The excess of episodes occurring within 6 weeks was not completely
explained by the highly recurrent nature of BD-I. There was in particular
a subgroup of 1 in 5 multiparae who reported all deliveries affected by
a postpartum episodes despite a low number of lifetime recurrences. For
70% of multiparae with BD-I suffering with more than one postpartum
recurrence the childbirth was a specific trigger for postpartum psychosis,
while 30% of them suffered with an episode of postpartum psychosis af-
ter one pregnancy and an episode of postpartum depression after another
pregnancy.
Bipolar I non psychotic depression within 6 weeks postpartum , on the
contrary, was not overrepresented compared to episodes at other times.
Women who reported non psychotic depression within 6 weeks postpar-
tum had a more recurrent pattern on average that those who reported
mania and psychosis within 6 weeks postpartum, with about 1 in 2 re-
porting at least one episode of illness/year. Less than 1 in 10 multiparae
reported all deliveries affected despite a low number of lifetime recurrences.
It seemed that in the majority of cases bipolar I non psychotic depression
occurred in relation to childbirth just by chance and that the relationship
childbirth-mood episode is just temporal, and not causal.
For bipolar II non psychotic depression within 6 weeks postpartum I
found a similar, but even more pronounced, pattern. Over 50% of women
with BD-II, in fact, had a chronic/highly recurrent course of illness with
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more that 1 episode a year, while less than 8% reported all deliveries
affected despite a low number of lifetime recurrences. There was no asso-
ciation between postpartum period and increased rates of recurrences.
Non psychotic unipolar depression within 6 weeks postpartum had a
pattern similar to postpartum mania/psychosis in BD-I: about 1 in 2
women reported the onset of the depressive disorder in the postpartum pe-
riod and postpartum episodes were overrepresented compared to episode
outside the postpartum period.
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Chapter 9
Parity: a clue to the
aetiology of the postpartum
trigger
“The study of the thing caused must precede the study of the
cause of the thing.”
Hughlings Jackson, in Brockington [77]
Understanding the childbirth triggering of severe mood episodes is of vital im-
portance. An intriguing clue that may help in this task is the greater risk
following first pregnancies that has been shown in a number of previous stud-
ies [93,169–172]. This has implications, not only for the identification of women
at risk, but also for the aetiology of PNEs. The link to primiparity may suggest
relationships with other pregnancy related disorders such as pre-eclampsia in
which parity is known to play an important role and lead to specific hypotheses
about the nature of the perinatal trigger.
In both register based [169,170] and clinical studies [80,93,171,172] postpartum
psychosis has been shown to be more common after first deliveries. The link
between first pregnancy and non-psychotic postpartum depression is more con-
troversial. The majority of studies report no effect of parity [169,173], although
one study did find an association with primiparity [174] and another found the
opposite effect [113].
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A number of methodological issues may influence the results of studies on parity.
If women suffering a postpartum episode are less likely to go on to have further
children, this will reduce rates in multiparae and may account for the association
with first pregnancies. Similarly, other demographic and obstetric variables may
also explain the excess of psychosis in primiparae. For example, first pregnancies
occur at a younger age and delivery by caesarean section has been associated
with both primiparity [175] and postpartum psychosis [169]. Another issue is the
variability in methodology in studies of postpartum mood disorder. In particular
this may account for the heterogeneous results with perinatal depression and
parity. There is a lack of consensus on the definition of postpartum depression
and it has been argued that parity itself influences the validity of rating scales
for perinatal depression [176].
Despite the potential importance of this topic, there is a paucity of large-scale
systematic studies on the effect of parity in women with severe mood disorders
and with few exceptions [93], the research to date has not considered potential
confounders. Moreover, although women with bipolar disorder experience both
postnatal depression and postpartum psychosis, no data are available on parity
and bipolar depression.
In this chapter I reported the analyses I conducted to explore the link be-
tween parity and PNEs. I tested the hypothesis that the risk of perinatal mood
episodes is greater following first pregnancies and ask whether this association:
(i) holds across the mood disorder spectrum (BD-I, BD-II and RMD); (ii) is
found for both episodes of high and low mood; (iii) applies to all perinatal
episodes or is limited to those with onset in the immediate postpartum; and
finally (iv) I investigated the impact of possible confounders, such as decisions
about having further children, age at pregnancy and method of delivery.
9.1 Methods
Recruitment and assessment of participants have been already described in chap-
ter 5. Figure 9.1 summarised the sample selection and the relationship between
samples.
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9.1.1 Analytic plan
1. First, I conducted some exploratory data analyses on the entire sample.
• I explored graphically the association between parity and mood dis-
orders across lifetime diagnoses and phenomenology of PNEs (ma-
nia/psychotic depression and non psychotic depression).
• I explored the influence of potential biases such as:
– The association between psychiatric outcome of first pregnan-
cies and the proportion of women going on to have further chil-
dren. It was, in fact, possible that any association between PNEs
and primiparity was due to women who suffer severe postpartum
episodes deciding not to have further children;
– Age at pregnancy;
– Caesarean section
2. To exclude the potential effect of the psychiatric outcome of first pregnan-
cies on reproductive decisions, I compared the rates of mood episodes in
the first perinatal period with the rates of mood episodes in the second
perinatal period in a subsample of women who were (a) multiparous and
(b) had experienced at least one delivery affected by a mood episode. I
performed the analyses on 3 mutually exclusive groups of onset: onset in
pregnancy, onset within 6 weeks postpartum, onset between 6 weeks and 6
months postpartum. Information on time of onset of PNEs was available
for 90% of deliveries affected, so I used the package Amelia to perform
multiple imputations and the package Zelig [162] to analyse the multiple
datasets (see chapter 5 for more details on dealing with missing values).
Overdispersion diagnostic plots for multiple imputations are shown in fig-
ure 9.2.
3. Pregnant women with established mood disorder may be aware of the risk
of recurrence and take medication to prevent or promptly treat an emerg-
ing postpartum episode. A reduced risk in multiparae may therefore be
due to the effects of prophylactic medication or other strategies designed
to help keep women well. I did not have detailed information on the drug
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Figure 9.2: Overdispersion diagnostic plots in the analyses on parity. On the left:
The x- axis represents the iteration number of the chain. The y-axis represents
movement in the (very high dimensional) parameter space. On the right: Two
dimensional parameter space using the first two principal components of the
end points of the EM chains. The distance between iterations is marked by the
distance between arrowheads on each chain. The EM chains converged
management of the women in subsequent pregnancies but to examine this
bias I re-ran the significant analyses including only multiparae who re-
ported their first lifetime episode in relation to childbirth. In fact, these
women were drug na¨ıve at the onset of the first postpartum episode by
definition.
In this chapter I use the term postpartum psychosis to label episodes of DSM-IV
mania, mixed episodes or psychotic depression occurring within 6 weeks after
childbirth. I performed 4 sets of independent comparison, so I considered a p
value threshold for significance of p=0.05/4=0.0125.
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9.2 Results
9.2.1 Sample characteristics
Detailed information was collected for 3174 full term deliveries from 1579 partic-
ipants, 929 with BD-I, 278 with BD-II and 372 with RMD. Sample characteris-
tics are summarised in table 9.1. The morbidity rates I report here exceeded to
some extent the figures reported in chapter 6, which focused on the prevalence
of PNEs and therefore excluded women recruited on the basis of a history of
postnatal psychosis or depression. In the analyses I present in this chapter, in-
stead, I included also women specifically recruited to the studies on postpartum
psychosis and postnatal depression, where an inclusion criterion was a history
of postnatal psychosis or depression and thus the rates of postnatal psychosis
or depression were 100%.
9.2.2 Parity
Data were available for 1579 first and 1595 subsequent pregnancies. In the BD-I
group, 304 (32.7%) women reported an episode of mania/psychotic depression
in the first perinatal period. The proportion dropped to 19.3% (109/566) in
the second perinatal period and to 14.7% (30/204) and 14.8% (12/81) in the
subsequent pregnancies (figure 9.2A). Women with BD-I reported similar rates
of perinatal depression across all perinatal periods (range 21.0%-23.5% - figure
9.2B).
Rates of perinatal depression in women with BD-II dropped between the first
(45.0%, 125/278) and the second pregnancy (33.0%, 63/191). Large confidence
intervals allowed less precise estimates for subsequent pregnancies (figure 9.2C).
An episode of perinatal depression occurred in 47.3% (176/372) primiparae with
RMD. The proportion dropped to 38.1% (105/275) in the second perinatal pe-
riod and to 37.1% (49/132) and 34.0% (16/47) in the following pregnancies
(figure 9.2D). I do not report here the estimates on pregnancies affected by de-
pressive psychosis in the BD-II group and in the RMD group because of the low
incidence rates (table 9.1).
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Figure 9.3: Proportion of live births complicated by PNEs by order of delivery
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9.2.3 Controlling for the influence of perinatal episodes
on having further children
The psychiatric outcome of first pregnancies was significantly associated with
the proportion of women going on to have further children (figure 9.3). In
the BD-I group, only 56.6% of primiparae with a PNE had further children
compared to 76.6% of those who didn’t have any PNE (OR: 2.5, 99% CI 1.70-
3.72, pă 0.0001). Similarly primiparae with either BD-II or RMD who suffered
with a PNE were less likely to have further children (respectively 69.1% v 88.5%,
OR: 3.44, 95% CI 1.46-8.81, pă 0.0001 and 70.9% v 87.4%, OR: 2.8, 95%CI
1.39-6.04, pă 0.0001).
BD-I, N=941 BD-II, N=280 RMD, N=379
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First delivery affected
Figure 9.4: Proportion of primiparae going on to have further children according
to whether they had a PNE in the first perinatal period or not. On the y axis:
proportion
It is therefore possible that any association between perinatal mood episodes
and primiparity is due to women who suffer severe postpartum episodes deciding
not to have further children. To examine this potential bias, I compared the
rates of mood episodes in the first perinatal period with the rates of mood
episodes in the second perinatal period in a subsample of women who were (a)
multiparous and (b) had experienced at least one delivery affected by a mood
episode. Information on onset of episodes occurring in relation to pregnancy
and childbirth was categorised into 3 groups: onset in pregnancy, onset within
6 weeks postpartum, onset between 6 weeks and 6 months postpartum.
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There were 183 multiparae with BD-I and at least one episode of perinatal mania
or psychotic depression. We focused our analysis on episodes occurring with
onset within 6 weeks postpartum, as the vast majority (90%) of these episodes
occurred within this time frame. Primiparity was significantly associated with
mania/ psychotic depression occurring within 6 weeks of delivery (p=0.001, OR
2.1, 99%CI 1.15-3.69). Table 9.2 shows the results of logistic regression model
for mania or psychosis within 6 weeks on each one of the 5 multiple data sets,
while table 9.3 shows the results for the combined model.
Table 9.2: Separate results of logistic regression model for mania or psychosis
within 6 weeks in BD-I on each one of the 5 imputed data sets
Coefficients Estimate Standard Error z values p value
Intercept 0.10 0.15 0.66 0.5060
Primiparae 0.72 0.22 3.30 0.0009
Intercept 0.10 0.15 0.66 0.5060
Primiparae 0.75 0.22 3.41 0.0006
Intercept 0.08 0.15 0.52 0.6049
Primiparae 0.72 0.22 3.29 0.001
Intercept 0.12 0.15 0.81 0.4164
Primiparae 0.65 0.22 2.98 0.0029
Intercept 0.05 0.15 0.37 0.7117
Primiparae 0.79 0.22 3.61 0.0003
Table 9.3: Combined results of logistic regression model for mania or psychosis
within 6 weeks in BD-I on 5 imputed data sets
Coefficients Value Standard Error t-stat p value
Intercept 0.09 0.15 0.60 0.5513
Primiparae 0.72 0.22 3.21 0.0014
No association between parity and perinatal depression was found in the group
of 93 multiparae with BD-II and at least one pregnancy affected by perinatal
depression (p=0.137 for depression in pregnancy, p=0.473 for depression within
6 weeks postpartum, p=0.096 for depression occurring between 6 weeks and 6
months postpartum).
In the RMD group (N=159), primiparity was associated with depression with
onset within 6 weeks of childbirth (p= 0.004, OR 1.9, 99% CI 1.06-3.52), but
not with onset in depression in pregnancy (p=0.653) or later in the postpartum
(p=0.447-Figure 9.4). Table 9.4 shows the results of logistic regression model
for unipolar depression within 6 weeks on each one of the 5 multiple data sets,
while table 9.5 shows the results for the combined model.
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Table 9.4: Combined results of logistic regression model for unipolar depression
within 6 weeks on 5 imputed data sets
Coefficients Value Standard Error t-stat p value
Intercept -0.35 0.16 -2.15 0.0316
Primiparae 0.66 0.23 2.85 0.00443
Table 9.5: Separate results of logistic regression model for unipolar major de-
pression within 6 weeks on each one of the 5 imputed data sets
Coefficients Estimate Standard Error z values p value
Intercept 0.39 0.16 -2.44 0.0146
Primiparae 0.71 0.23 3.12 0.0019
Intercept -0.34 0.16 -2.13 0.0331
Primiparae 0.69 0.23 3.01 0.0026
Intercept 0.076 0.15 0.52 0.6049
Primiparae 0.63 0.23 2.79 0.0052
Intercept -0.32 0.16 -1.97 0.0483
Primiparae 0.61 0.23 2.68 0.0073
Intercept -0.37 0.16 -2.29 0.0222
Primiparae 0.66 0.23 2.90 0.0037
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Figure 9.5: Time-to-onset of postpartum mania according to order of pregnancy.
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9.2.4 Controlling for the influence of age and Caesarean
section
The association between primiparity and severe mood episodes could be medi-
ated by age at pregnancy. If this were true, I would expect women to report
a younger age at delivery for pregnancies complicated by psychiatric seque-
lae. However, there were no age differences between deliveries complicated by
postnatal psychosis (mean age at delivery 26.0, sd 4.99), those complicated by
postnatal depression (mean age at delivery 26.0, sd 4.94) and those with no
psychiatric complications (mean age at delivery 26.0, sd 5.02).
In previous studies, deliveries by Caesarean section were associated with post-
partum psychosis. However, in the Mood Disorder Research Project sample
method of delivery was not associated with postpartum mania/psychosis in
BD-I (p=0.626) or with postpartum non-psychotic depression (p= 0.443).
9.2.5 Controlling for the influence of medication
Another possible factor that could lead to an increased risk in first pregnancies
is a history of previous mood episodes having an influence on further pregnan-
cies. Pregnant women with established mood disorder may be aware of the
risk of recurrence and take medication to prevent or promptly treat an emerg-
ing postpartum episode. A reduced risk in multiparae may therefore be due
to the effects of prophylactic medication or other strategies designed to help
keep women well. I did not have detailed information on the drug management
of the women in subsequent pregnancies but to examine this bias I re-ran the
analyses on only multiparae who reported their first lifetime episode in relation
to childbirth. By definition, these women were drug na¨ıve at the onset of the
first postpartum episode. In both women with BD-I (N=97, p=0.0006, OR: 2.8,
99%CI 1.29-6.28) and RMD (N=93, p=0.005, OR: 2.3, 99%CI 1.08-5.08) I again
found an association with first pregnancies. Moreover, I found an increased ef-
fect size compared to previous analyses conducted on the entire sample. The
effect of parity is, therefore, not due to women taking prophylactic medication.
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9.2.6 Are women with an onset in the postpartum a more
homogeneous group?
The latter analysis suggest that it is possible that women with an onset of mood
disorder in the perinatal period represent a more homogeneous group, especially
in relation to the increased risk in first pregnancies. To explore this hypoth-
esis I compared the effect of primiparity in the subgroup of women with an
onset within 6 weeks postpartum with the effect in those in which the postna-
tal episode was a recurrence. I found that the effect of parity on postpartum
episodes was driven by the group of women with an onset in the postpartum -
for women with BD-I and a recurrence of postpartum psychosis (p=0.248, OR
1.5, 99%CI 0.61-5.08; for RMD and a postnatal recurrence p= 0.104, OR=1.9,
99%CI 0.69-4.98).
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Figure 9.6: Primiparity effect according to lifetime course
To explore possible clinical characteristics that may differ between first onset
postnatal episodes and recurrences in the postpartum, I compared the survival
curves for postnatal episodes in women with BD-I and postpartum psychosis
and in women with RMD and postnatal depression (figure 9.6). The time of
onset of postnatal mania/psychosis did not differ between the two groups. The
same analysis was performed including only first live births. Again there were
not significant differences between women with postpartum psychosis as first
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lifetime episode (N=119) and those in which postpartum psychosis did not rep-
resent the first lifetime episode (N=123, χ2= 1.5 , df= 1, p= 0.217). The time
of onset of postnatal psychosis did not differ between the two groups (χ2= 2.2,
df=1, p= 0.135). The same analysis was performed including only first live
births. Again there were not significant differences between women with post-
partum unipolar depression as first lifetime episode (N=51) and those in which
postpartum unipolar depression was a recurrence (N=92, χ2= 0.6, df=1, p=
0.432)
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(a) Perinatal mania and psychotic depression in bipolar I disorder
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Figure 9.7: Survival curves for postpartum episodes according to lifetime course.
Part A. Survival curves for postpartum psychosis in women with BD-I and the
first lifetime episode in relation to childbirth (blue) and in women with BD-I in
which the postpartum episode represented a recurrence (red). Part B. Survival
curves for postpartum non-psychotic depression in women with RMD and the
first lifetime episode in relation to childbirth (blue) and in women with RMD
in which the postpartum episode represented a recurrence (red).
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9.3 Summary
In this chapter I explored the link between parity and PNEs.
• The results support previous research findings of an association between
primiparity and postpartum psychosis occurring soon after childbirth [93,
169–172].
• In women with BD-I, I found an excess of postpartum psychosis following
first deliveries, but no similar link to primiparity for episodes of non-
psychotic depression. In contrast I found that there was a greater risk of
a postnatal depression following first deliveries in women with RMD. I did
not find an effect of parity in women with a lifetime diagnosis of BD-II.
• The association between parity and mood episodes was significant only
for episodes occurring within 6 weeks postpartum. Episodes occurring in
pregnancy or later in the postpartum did not show a significant association
with parity.
• The excess of mood episodes in primiparae was not explained by women
with a perinatal episode not going on to have further children, by the
age at pregnancy, by method of delivery, or by the use of prophylactic
medication in subsequent pregnancies.
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Part III
A pilot prospective study
on bipolar disorder in
pregnancy and the
postpartum
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Chapter 10
Study design
Prospective design is the gold standard for observational studies. A prospec-
tive study on bipolar disorder in pregnancy and postpartum would allow i) an
estimation of the risk of perinatal recurrences i) to investigate the influence of
a range of variables on the vulnerability to develop an episode of severe illness
in pregnancy or the postpartum iii) a detailed description of the episodes oc-
curring during the time of observation. I argued in the background section that
there is a paucity of prospective studies on perinatal mood disorders. For these
reasons, with the help of the Mood Disorder Research Project team, I set up
a prospective study aimed at recruiting a large, well characterised sample of
women with bipolar disorder preconception or in early pregnancy and to mon-
itor them through pregnancy and the postpartum. The aims of the full blown
prospective study were:
• to establish the proportion of women who suffer a severe episode of psy-
chiatric illness
• to characterise the clinical features of episodes occurring in the postpartum
• to explore the influence of a range of variables on the vulnerability to
develop an episode of severe illness in pregnancy or the postpartum
In this chapter I first describe the study design and the research protocol then
the ethics procedures, finally I report the research outcomes of the pilot study
I conducted between April 2011 and June 2012.
172
10.1 Study design
The study was designed in 2010 as part of the large Mood Disorder Research
Project. When the prospective study of pregnancy was being designed, the
Mood Disorder Research Project was committed to recruiting further 4000 in-
dividuals with bipolar disorder over a three years period as part of the Bipolar
Disorder Research Network project (BDRN - see bdrn.org). I therefore design
the study to fit the BDRN research protocol to optimise the resources available.
The study had broad inclusion criteria. Women were included if i) they had
a diagnosis of bipolar disorder (DSM-IV schizoaffective disorder bipolar-type,
BD-I, BD-II, bipolar disorder not otherwise specified) and if ii) they were cur-
rently pregnant. Women with bipolar disorder planning a pregnancy were also
approached and given information on the study, in case they wanted to take
part once pregnant.
The algorithm followed by the study is presented on figure 10.1.
10.1.1 Recruitment
The BDRN project has been very successful in recruiting people with bipolar
disorder. However, the proportion of participants who were pregnant at the in-
terview was limited to sporadic cases. Moreover, recruitment of pregnant women
with severe mental disorders such as bipolar disorder is particularly challeng-
ing [177]. So, additional recruitment strategies were developed specifically to
enhance the chances of recruiting pregnant women.
BDRN Modified telephone screening Women below 45 years of age who
were willing to take part in the BDRN study were asked whether they
were pregnant or planning a pregnancy.
CUPS- Second Opinion Clinic at Cardiff University Dr Ian Jones pro-
vides second opinions in the form of single consultations including spe-
cialised information and counselling relating to the relationship of psy-
chiatric illness to childbirth - see http://medicine.cf.ac.uk/psychological-
medicine-neuroscience/cups/perinatal-psychiatry-service/. I assisted to
Dr Jones visits and approached there suitable participants.
Perinatal mental health services throughout UK Through Dr Ian Jones,
I contacted perinatal teams in Glasgow (Dr Roch Cantwell), Manchester
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Figure 10.1: Algorithm for the recruitment and assessment of pregnant women
with bipolar disorder. Women were assessed in pregnancy and 3 months after
childbirth. Information on pregnancy and the postpartum period was gath-
ered through face-to-face interview with the woman, questionnaires completed
by the woman and by GPs and psychiatrists and case notes. The study was
expressly designed to collect the same information for multiple sources. Abbre-
viations: CUPS: Second Opinion Clinic at Cardiff University, PNS: perinatal
services across the UK, BEP-C: Bipolar educational programme - Cymru , more
information at http://www.bep-c.org/
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(Dr Angelika Weik), Newcastle (Dr Hamish McAlister-Williams and Dr
Angela Walsh), Southampton (Dr Alain Gregoire), London (Dr Liz Mc-
Donald), Birmingham (Dr Floriana Coccia and Dr Giles Berrisford), Hull
(Dr Deepak Garg), Sheffield (Dr Nusrat Mir), Derby(Dr Paula Brownsett),
Edinburgh (Dr Fiona Murray), Nottingham (Dr Gopinath Narayan). All
these services manage bipolar women in the perinatal period and screen
antenatal populations for women at risk of postpartum psychosis.
Advertisements The study was advertised in the annual BDRN newsletters,
in the annual APP magazine and in the Pendulum magazine. Moreover in-
formation on the study was available on the APP website (http://www.app-
network.org/research/).
10.1.2 Assessment
Once recruited, women underwent the standard BRDN assessment and were
asked to donate a blood sample for DNA extraction. To assess potential risk
factors for perinatal recurrences not included in the BDRN assessment par-
ticipants were asked to complete an additional questionnaire. It was given to
pregnant women during the BDRN interview. Women who had already taken
part in the BDRN project before getting pregnant and, once pregnant, wanted
to take part in the prospective study, were sent the pregnancy questionnaire at
home, along with the information sheet and two copies of an additional consent
form to be signed (Appendix A and B).
The pregnancy questionnaire
Pregnant participants were asked to complete an additional self-rated question-
naire with information about their pregnancy, which took around 10 minutes to
complete. The questionnaire was left with the other questionnaires that were
part of the BDRN study and returned in the same pre-paid envelope. A copy
of the questionnaire is available in appendix C. The questionnaire was designed
in order to obtain additional information in relation to specific risk factors for
perinatal recurrences. It had 5 parts and contained questions on :
Pregnancy Expected date of delivery and week of gestation in which the ques-
tionnaire was completed.
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Psychosocial risk factors a modified version of the Pregnancy Risk Ques-
tionnaire [178]
Drug and alcohol use in pregnancy This section consists in both closed-
ended and open questions on the use and amount of drug, alcohol and
tobacco smoking.
Medications The participant was asked to indicate the daily doses of medi-
cations and when eventual changes in the prescriptions occurred from 6
months before pregnancy since the date in which the questionnaire was
filled in. Information on medications would enable to replicate and ex-
tend to the postpartum period the findings by Viguera et al [64] (see
background section).
Premenstrual symptoms screening tool [179] This questionnaire investi-
gates the presence of DSM-IV premenstrual dysphoric disorder and clini-
cally significant premenstrual syndrome. I modified it, by asking women
to recollect the presence of premenstrual symptoms before pregnancy.
10.1.3 Follow-up
Information from physicians
For pregnant women who gave consent, two months after the expected date of
delivery I contacted her GP and psychiatrist by letter (appendix D) to gather
information on pregnancy and postnatal period. They were asked to complete
a GP and psychiatrist questionnaire (appendix E and appendix F) respectively
and were asked if there was any reason not to contact the woman. If the
physicians did not reply, the form was sent a second time. GPs were asked about
obstetric complications and whether the woman had any perinatal psychiatric
complication. The psychiatrist questionnaire was more detailed and had both
open and close-ended questions on episodes occurred in pregnancy and after
childbirth and medications prescribed in the perinatal period.
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Follow-up telephone interview
Following this contact with her GP and psychiatrist, the participant was con-
tacted three months after the expected date of delivery to arrange an additional
telephone interview asking about symptoms experienced in relationship to preg-
nancy and childbirth (appendix G). The interview took about 20 minutes and
repeated the relevant sections of the SCAN interview [142], modified from the
BDRN interview and the following additional features:
• Structured questions on obstetric variables, including pregnancy and de-
livery complications, method of delivery, hour of birth.
• Open question about psychological stressors in pregnancy and the post-
partum period
• Closed-ended questions on breastfeeding and sleep
• Life chart of pregnancy and the postpartum period. Questions on stres-
sors and medication during pregnancy included in the questionnaire were
reviewed and women who did not completed the questionnaire were asked
about medications at this stage.
The study was expressly designed to collect the same information from multiple
sources in order to compare the consistency across sources and to minimise the
chances of missing information. Table 10.1 summarises the principal variables
investigated, the sources from which information was collected and the rationale
behind the choice of each variable.
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Table 10.1: Potential risk factors for postpartum episodes
1st column: potential risk factors (grouped by the bio-psycho-social
paradigm), 2nd column: source from which data were gathered; 3dr
column: previous studies.
FACTOR SOURCE PREVIOUS STUDIES
FH BDRN Association with general family history of psychiatric disorders
[77] and [180] Only a FH of perinatal episodes predicts PP [59,
87]
Age BDRN NS [77] [169]*; Postpartum mental illness patients are older [76]*
Current SUD PQ Differential diagnosis, + [180]
Medications PQ, PsychQ,
Follow-up
interview, CN
Increased risk of pregnancy and postpartum recurrence after
(rapid) lithium discontinuation [58,64]*
Premenstrual syndrome PSST [179] + [77]
Previous PP/PND BDRN 57% PP recurrence [100]
1st episode puerperal BDRN NS [100]
Length of time since last deliv-
ery
BDRN a gap of at least 5 years [181]*; 3y for psychotic mothers v 2.5y
for controls [76]*
First pregnancy (nulliparity) BDRN + [76,93,169,170,180,182]*; Marce, Winter: NS [77]; confound-
ing factors in the old studies: high parity, relative risk higher
late in reproductive life [93,170,180]
Continued on next page
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Table 10.1 – Continued from previous page
FACTOR SOURCE PREVIOUS STUDIES
Obstetric complications GPQ, follow-up
interview, CN
pregnancy complication NS; caesarian section [93] [169]*, no
birth complication [170]; induction, foetal distress, instrumental
delivery, abnormalities [183]; hypertension, respiratory illness,
cephalopelvic disproportion, uterine dysfunction [76]*; need for
intensive medical care for the baby or death of the baby [180]
Short gestation GPQ, follow-up
interview, CN
++ [76]*, [170]
Low birth weight Follow-up inter-
view
’If episodes were more frequent after short gestation, the ob-
stetric reasons for early delivery might provide a clue to the
aetiology of the psychosis’ [77]; NS [93]
Previous miscarriage rate BDRN inter-
view
[169]* : lower rate of miscarriage, higher rate of for termination
Sex Follow-up inter-
view
NS [93]; Excess of females [184], [169]*
Breastfeeding Follow-up inter-
view
NS PAFFENBARGER:1964mi*
Sleep loss during delivery Follow-up inter-
view
+ [185]
Sleep loss because of the baby Follow-up inter-
view
+ [185]
Continued on next page
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Table 10.1 – Continued from previous page
FACTOR SOURCE PREVIOUS STUDIES
Personality Questionnaires Marks: NS EPQ [186]
Polarity at the onset BDRN, CN NS [186], + time since last admission [186]
Illness severity (comorbidity,
age at onset, course of disor-
der, deterioration from premor-
bid level of function)
BDRN, CN [64]*
Predominance mixed BDRN, CN
Periodicity BDRN, CN
Affective vs psychotic features BDRN, CN
Time since last illness BDRN, CN
Time since last discharge BDRN, CN
Social Class BDRN ’modern controlled studies have shown little social class differ-
ence’ [77]; higher social class [187]; NS [186]
Interpersonal difficulties BDRN , PQ + [186,187]
Single BDRN, PQ Nguni, South Africa: 80% unmarried [188]* , Edinburgh: un-
married, widows , separated, divorced [169]* , [76]*: NS; inter-
action w/ primiparity [189]
Continued on next page
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Table 10.1 – Continued from previous page
FACTOR SOURCE PREVIOUS STUDIES
Material situational problems BDRN inter-
view, preg-
nancy question-
naire
- (more positive life situation) [187], NS (SPQ) [186]
Attitude toward the pregnancy PRQ [187]
Marital relationship PRQ + (MAMA) [186] , [190]: NS
Support PRQ + [186,187]; [190]:NS
Life events PRQ No [186,190,191]
Stillbirth GPQ + [77]
0Symbols and abbreviations *: not specific for puerperal psychosis, non psychotic postpartum episodes included; + positive association, - negative association,
AFF: affective disorders; BDRN: BDRN interview; CN: case notes; FH: family history; GPQ: questionnaire for GP; LEDS: Life Events and Difficulties Schedule
[192], MAMA:Maternal Adjustment and Maternal Attitudes [193]; NS:non significant, PN: perinatal episodes, PP puerperal psychosis, PND, postnatal depression;
PQ: pregnancy questionnaire, PsychQ: questionnaire for psychiatrist, PSST: premenstrual symptoms screening tool [179], part of the pregnancy questionnaire,
SPQ: Social Problem Questionnaire [194], SUD: substance use disorde
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10.2 Ethics procedures
Part of the sample was recruited sistematically through NHS across UK, thus
the study was subject to local and national level ethical review. The Mood
Disorder Research Project had Local Research Ethics Committee approvals and
held Multi-Centre Research Ethics Committee approval from the West Midlands
Research Ethics Committee. However, for my research project it was necessary
to obtain the MREC approval and my research passport.
10.2.1 MREC approval
The study required that the West Midlands Research Ethics Committee ap-
proved an amendment to the Mood Disorder Research protocol1 in order to
conduct the prospective assessment. The following amendments to the research
protocol were proposed by the Mood Disorder Research Team and approved by
the West Midlands Research Ethics Committee:
• Pregnancy questionnaire
• GP and psychiatry questionnaire
• Follow up interview (it was not necessary to submit the text of the follow-
up interview.
• Modification to the participant information sheet (appendix B) and to
the consent form (appendix A) in order to add information about the
additional part of the study for pregnant women
10.2.2 NHS research passport
The research passport is a document issued (in my case) by Cardiff University
that allowed me to obtain honorary research contracts in any NHS organisation,
although I did not have any contractual arrangements with NHS. Although the
1The full title of the study conducted by the Mood Disorder Research team is ’Molecular
genetic investigation of bipolar disorder and related mood disorders’, REC reference number
MREC/97/7/0, commenced on 22 December 1997
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research passport was design to simplify the administrative procedures, it took
me more than 6 months to obtain it.
10.3 Summary
In this chapter I described the methodology of the research protocol of a longitu-
dinal study on bipolar disorder in pregnancy and the postpartum period aimed
to i) establish the proportion of women who suffer a severe episode of psychiatric
illness, ii) characterise the clinical features of episodes occurring in the postpar-
tum and iii) explore the influence of a range of variables on the vulnerability to
develop an episode of severe illness in pregnancy or the postpartum.
The study was conducted as part of the Mood Disorder Research Project. Preg-
nant women with bipolar disorder were recruited through mental health services
and by non-systematic means throughout UK.
In pregnancy participants were interviewed with a modified SCAN interview.
A number of questionnaires were also completed that included measures
of current mood, life events prior to onset, personality and temperament,
alcohol and illicit drug use, childhood life events and information about
the current pregnancy.
Two months after the expected date of delivery the woman’s GP and psy-
chiatrist were contacted to gather information on the pregnancy and post-
natal period. They were asked to complete a short questionnaire, which
took less than 5 minutes to complete, and if there was any reason not to
contact the woman.
Three months after the expected date of delivery the woman was con-
tacted to arrange an additional telephone interview asking about symp-
toms experienced in relationship to pregnancy and childbirth. The in-
terview took about 20 minutes and repeated the relevant sections of the
SCAN. Case notes were also reviewed by the research team.
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Chapter 11
Pilot study
I report here the results of the pilot study, that was conducted between April
2011 and June 2012. The aims of the pilot study were:
• to establish the effectiveness of the recruitment methods
• to test the adequacy of the assessment tools
• to estimate the variability in the outcomes to calculate the sample size
that would be needed in further studies
• to assess the feasibility of the large scale study and to modify the current
research protocol in order to increase the chance of success in recruiting
and following-up women
Over 15 months I was in contact with 66 women. Because it took about 10
months to finalise the protocol and obtain the necessary documentation, includ-
ing my research passport (this was the longest step), 5 women assessed before
the beginning of the study by Dr Jones at the CUPS clinic were also included.
Figure 11.1 and table 11.1 show the flow-chart of the inclusion process.
Only 38/71(60.6%) women met the inclusion criteria, gave their consent, were
interviewed by the BDRN team and thus included in the prospective study.
Women planning a pregnancy or in the postpartum period were included in
the BDRN general study, but were excluded from the current research project.
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Pendulum 
N=9 
BDRN 
Newsletter 
N=5 
APP 
Newsletter 
N=8 
Telephone screening N= 57 
 
BDRN 
pregnant 
participant 
N=10  
BDRN INTERVIEW N=38  
PREGNANCY QUESTIONNAIRE N=14 
QUESTIONNAIRE TO GP N=8 & 
PSYCHIATRIST N=6 
FOLLOW-UP INTERVIEW N=16 
CUPS 
N=17 
PNS 
N=17 
BEP-C 
N=1 
Follow-up 
information 
available for 19 
women 
Drop-
out 
N=2 
Gave informed consent N= 31 
Inclusion criteria –YES  N = 38 	  
Refused 
N=7 
Inclusion criteria 
– NO N=19 
Refused 
N=1 
Miscarriage 
N=2 
Figure 11.1: Flow chart including information on the sample sizes. Abbrevia-
tions and notes:CUPS: Second Opinion Clinic at Cardiff University, PNS: peri-
natal services across the UK, BEP-C: Bipolar educational programme - Cymru
, more information at http://www.bep-c.org/. d from the current research
project. To date16/38 (42.1%) women have already completed the follow-up, in-
cluding the telephone interview, 1/38 woman was not available for the telephone
in interview, because moved abroad, but she was interviewed by the BDRN team
after delivery and the GP questionnaire was available, 19/38(50.0%) still need
to complete the follow-up assessment (for 3 of them information through the
GP and/or the psychiatrist is already available) and 2/38 (5.3%) dropped-out.
Overall 10 pregnant women initially contacted/ indicated refused or were not
available for the initial BDRN interview:
• 1 woman contacted me via e-mail to have more information, saying she
wanted to be contacted only via e-mail and never got back to me
• 1 woman, initially recruited through Manchester PNS in her 3rd trimester
was not available for the telephone screening, despite 5 phone calls over 2
months
• 1 woman recruited through Manchester PNS in her 2rd trimester refused
her consent at the initial telephone screening, without giving any expla-
nation
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• 1 women recruited though the BDRN, 2 recruited through the APP newslet-
ter initially accepted to be interviewed, but then procrastinated the inter-
view until the postpartum period. To date they have still not arranged
the interview with the team
• 2 women recruited through the CUPS clinic were not interview, one be-
cause declined the interview in a second moment saying she was too
stressed, another one did not turn up at the interview and was not avail-
able to arrange a further appointment.
• Despite giving their consent to the interview, additional 2 women were
not interviewed because they had a miscarriage (1 women in the first
trimester, one during the second trimester, both recruited through the
CUPS) before the interview. For these women information are available
through case notes.
To date 16/38 (42.1%) women have already completed the follow-up, including
the telephone interview, 1/38 woman was not available for the telephone in
interview, because moved abroad, but she was interviewed by the BDRN team
after delivery and the GP questionnaire was available, 19/38(50.0%) still need
to complete the follow-up assessment (for 3 of them information though the GP
and/or the psychiatrist is already available) and 2/38 (5.3%) dropped-out. For
the 2/38 women who dropped out information on the postpartum period was
not available, either because they never sent back the consent to take part to
the follow-up study, despite a written reminder (1 woman recruited though the
BDRN), or because they were not available for the telephone follow-up interview
and were not in contact with the services (1 woman recruited through the BDRN
had the landline interrupted).
11.1 Effectiveness of the recruitment methods
The majority of women screened were recruited through the CUPS clinic and
through the PNS. However, the ratio women recruited/women screened was the
lowest for PNS with less than 30% of the initial contacts actually recruited, half
of the proportion actually recruited thought the CUPS clinical. Moreover, the
recruitment through the PNS, despite being effective in generating contacts on
paper, required lot of effort in engaging the clinicians and, although I have been
repeatedly in contact with 13 services, women were referred only by 5 services
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and only 2 services referred women who met inclusion criteria and accepted to
take part.
Considering the number of women who were interviewed for the initial assess-
ment, the best recruitment methods were the CUPS clinic and BDRN. However,
women recruited through CUPS were more likely to complete the follow-up than
women recruited through BDRN. The entire cohort of women recruited through
the CUPS clinic completed the follow-up versus 1/3 of those recruited through
the BDRN. These statistics were drawn from a small sample and 1 in 2 partic-
ipant was still in the follow-up stage of the study. However, beside statistics, it
was my personal experience that it was much easier to remain in contact with
women recruited through the CUPS clinic rather than through other methods.
I think it was because the clinician recruiting through the CUPS clinic was Dr
Jones, the supervisor of my research project, who was very committed to the
research. Moreover, I assisted to all consultations and thus I met in person all
participants recruited through the CUPS clinic.
Another effective method of recruitment was Bipolar UK through advertise-
ments in the Pendulum magazine. It is worth to notice that within the group
of 10 women recruited thorough the BDRN, 1 heard about the study at the
Bipolar UK conference.
In summary, considering both the absolute number of women who completed
the follow-up and the proportion of women initial contacted who completed the
study, the recruitment through the CUPS clinic was the most effective method
of recruitment, followed by the advertisements in the Pendulum magazine.
These findings overlapped to what was found in previous studies. Peindl and
Wisner [177] reported on the effectiveness of recruitment strategies in two trials
on prevention and treatment of postpartum depression and found that recruit-
ment through physicians was difficult and time consuming, requiring more than
one year to develop relationships and to establish a referral network.
11.2 Adequacy of the assessment tools
I present here the statistics including only the 19 women for whom I had infor-
mation on the postpartum period. The pregnancy questionnaire was completed
during the clinical interview with Dr Jones for 5 women recruited before the
beginning of the study, 9/19 completed it in their own time during pregnancy
and 5/19 did not return the questionnaire during pregnancy and were asked
the questions during the postpartum telephone interview. Pregnancy question-
naires were completed in median 11 weeks before childbirth (range 2-25 weeks).
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Contact details were available for 12 GPs and 12 psychiatrists. The follow-up
questionnaires were sent back by 8/12 GPs (66.7%) and 6/12 (50%) psychia-
trists. For 3/19 (15.8%) women the physicians questionnaires were the only
source of follow-up information. The median time of follow-up was 15 weeks
(range 2-174 weeks). In one case the GP reported a delivery affected by ’bipo-
lar disorder’, while the woman reported euthymia during pregnancy and the
postpartum period. In another case the psychiatrist did not report any episode,
while the woman reported a depressive episode (developed after the appointment
with the psychiatrist). A woman reported that she discontinued the medications
in the first trimester of pregnancy, despite the medical prescription.
For episodes occurring in pregnancy and in the postpartum period, diagnoses
were made by Dr Jones and myself independently by DSM-IV criteria. We
then met and reviewed the diagnoses. There was perfect agreement between Dr
Jones and me on the perinatal diagnoses. Interestingly, women who were not
available for the follow-up telephone interview were all reported to be affected
by a manic/mixed episode after childbirth (in 2 cases a new onset episode, in 1
case the continuation of a previous episode).
11.2.1 Medications
A major limitation was that in my study I did not collect information on the
drug concentration in blood. My approach had two major problems: i) the
compliance to the prescribed treatment and ii) the physiological changes in
drug metabolism during pregnancy. Alterations in the absorption, distribution,
metabolism, and excretion can modify the necessary dose. It should be noticed
that other physiological alterations, not related to the pharmacokinetics, can
alter the efficacy of the drugs, for example lower protein binding, higher sen-
sitivity to nausea and vomiting, altered glucose metabolism. The latter needs
to be acknowledged in pregnant women who take drugs known to be associ-
ated with metabolic syndrome and glucose resistance, such as olanzapine and
quetiapine. Although pharmacokinetics changes are often a major concern for
clinicians, the most important issue is probably compliance. In fact, about one
in two woman does not take the medications as prescribed [195]. In the pilot
study there was only one woman who reported discontinuing medications while
her doctor reported she continued the therapy.
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11.2.2 Refusal and dropout mechanisms
It has been suggested that response rates of at least 70% are necessary to infer
that the sample group is sufficiently representative of the target population from
which it is drawn [196]. Excluding women who had a miscarriage, 10/46 (21.7%)
women who met the inclusion criteria either refused of take part to the study
(8/10) or were not available for the follow-up interview (2/10). Thus, a rate
of completion of 78.3% is satisfactory. Unfortunately I did not have systematic
information on women who refused to take part to the study. However, it is
interesting to point out that all 3 women who were not available for the follow-
up telephone interview were, according to their GP and psychiatrist, ill after
childbirth with a manic or mixed episode. Considering that there were overall
4 women who had a manic or mixed episode after childbirth (in one case it was
a continuation of a previous episode), 3/4 (75%) severe episodes were detected
only thanks to the collaboration with the woman’s GP and psychiatrist.
11.3 Preliminary data for sample size calcula-
tion
The selection of an appropriate sample size is a crucial aspect of any experi-
mental design problem. However, before performing any sample size calculation
it is vital to have a clear idea of the aim of the study. As I have already men-
tioned, the aims of the full-blown longitudinal study were to estimate the rates
of perinatal recurrences and to explore the risk factors of a perinatal recurrence.
I focussed my analyses on women who have already completed the follow-up.
Sample characteristics are summarised on table 11.2.
Table 11.2: Sample characteristics. Only women who completed the follow-up
were included.
N %
DSM-IV LIFETIME DIAGNOSIS
BD-I 13 68.4
BD-II 5 26.3
SAD-BT 1 5.3
MEDIAN RANGE
PREGNANCIES 1 0-4
DELIVERIES 1 0-3
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11.3.1 Selection of the response variable
In the next two pages I report the a schematic summary of the PNEs that were
identified through i) the BDRN face-to-face interview in pregnancy, ii) the ques-
tionnaires for the physicians and ii) the telephone interview I conducted in the
postpartum period. In 2 cases the diagnosis made by physicians differed from
that obtained during the telephone interview. I recorded 14 DSM-IV episodes in
10 women, 2 cases of prodromal manic symptoms soon after childbirth (colour
orange in figure 11.2) that were promptly treated, while 1 woman experienced
mixed features after lithium discontinuation (colour yellow in figure 11.2), that
did not meet the severity criterion for a DSM-IV mixed episode. The symp-
tomatology reported varied across women and within a woman over the time
of observation. Only 2 episodes met the DSM-IV criteria for a mixed episode
(criteria for a manic episode and for a major depressive episode - except for du-
ration). However, mixed features during depressive episodes (colour purple in
figure 11.2) were present in 3/4 episodes of depression occurring in pregnancy.
In 2 cases the onset of manic symptoms during the depressive episode followed
the introduction/increased of an antidepressant. Interestingly, none of the 3
major depressive episodes reported in the postpartum had mixed features. One
woman, however, reported a dissociative episode during postpartum depression.
While depressive and mixed episodes were common across the entire perinatal
period, all 3 manic episodes and 2 cases of prodromic manic symptoms occurred
in the first week postpartum. One woman reporting mania after childbirth ex-
perienced transitory auditory and visual hallucinations (colour grey in figure
11.2) in pregnancy that become more prominent after childbirth with the onset
of manic symptoms. Interestingly I did not identify any episodes of hypomania.
Main issues in selecting the response variable were:
large variability between subjects symptomatology varied largely between
subjected, leading to a large variance. The larger the variance , the larger
sample size is required. Which is a good compromise between detailed
information and small variability?
within- subject, across- time variability there were women who experienced
more than one episode during the period of observation. Is a single vari-
able defining a single episode the best approach? If so, which episode
should be rated?
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Figure 11.2: Chart of perinatal period for each woman who completed the
follow-up and had manic (red), mixed (violet), major depressive episodes with
(purple) or without (blue) manic symptoms, or prodromic symptoms (orange)
or swings in relation to lithium discontinuation (yellow). Psychotic symptoms
in grey. Euthymia is represented by the bold line. The high of the coloured
bar symbolises the severity of the symptomatology: 2 rows: episode with severe
impaired functioning, 1 row:episode with mild-moderate impaired functioning
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definition of a mood episode in the cases in which women started a medi-
cation immediately after the onset of early symptoms of a severe episode
and did not develop any full-blown severe episode, it is likely that the med-
ications interfered with and modified the natural course of illness. How
should these episodes be rated?
Table 11.3 shows how different definitions of PNE impacted on the estimates of
recurrence rates. As discussed in the next paragraph on the choice of factors,
levels and range, the definition of the outcome depends on the research question.
To estimate the burden of bipolar disorder in the perinatal period, a broad
definition, including all episodes occurring in pregnancy and in the postpartum
period should be used. On the contrary, to assess the effect of medications on
the risk of postpartum psychosis, a narrow definition of postpartum psychosis
should be used, excluding those women with a postpartum episode that was the
continuation of a previous episode.
Table 11.3: Rates of perinatal recurrences according to different definitions of
the outcome variable
Outcome Proportion
Proportion of deliveries affected by a DSM-IV manic or mixed
episode or psychotic depression with onset within 6 weeks post-
partum
3/19 = 15.8%
Proportion of deliveries affected by a DSM-IV manic or mixed
episode or psychotic depression or hypomanic or prodromic symp-
toms of a manic or mixed episode or psychotic depression with
onset within 6 weeks postpartum that required medications
4/19 = 21.0%
Proportion of deliveries affected by any DSM-IV episode with on-
set within 3 months postpartum
5/19 = 26.3%
Proportion of deliveries affected by any DSM-IV episode or pro-
dromic symptoms that required medications with onset within 3
months postpartum
7/19=36.8%
Proportion of perinatal periods affected by any DSM-IV episode
with onset in pregnancy or within 3 months after childbirth
9/19=47.4%
Proportion of perinatal periods affected by any DSM-IV episode or
prodromic symptoms that required medications. Episodes could
be the continuation of an episode
12/19=63.2%
11.3.2 Choice of factors, levels and range
As shown on table 10.1, there are many factors that can be explored and tested
for an association with perinatal recurrences. However, the more independent
variables are included in a model the larger sample size is required. I limited my
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sample size calculation to the simplest case of one predictor. I ran the analyses
for 2 predictors:
1. lifetime diagnosis, because it was associated with the type of perinatal
recurrence in the retrospective study (see chapter 6 and figure 8.3);
2. pharmacological treatment, because it was the major source of complexity
and variability (table 11.3).
The questions I needed to answer were:
1. Which is the best definition of the independent variable/s?
2. How large a shift in the parameter I wish to detect in the full-blown
longitudinal study?
3. How much variability is present in the population - i.e. how much vari-
ability did I find in the pilot study?
4. What size errors am I willing to take in the full-blown longitudinal study?
In order to deal with the complex data structure, the formulation of clear specific
research hypotheses is vital. Table 11.4 shows the sample size needed accord-
ing to different research questions. In each analysis I set α=0.05, β=0.20 and
power=1´ β=0.8. I assumed that χ2 test would be run to test any association
between PNEs and categorical independent variables such as lifetime diagnosis
and medications. Calculations were performed using the functions ES.w2 and
pwr.chisq.test in the package pwr [197]. ES.w2 computed effect size w for a
two-way probability table corresponding to the alternative hypothesis in the χ2
test of association in two-way contingency tables. The effect size w is the square
root of the standardised χ2 statistic. The formula in terms of population values
pi0 and pi1 is:
w “
dÿ ppi0 ´ pi1q2
pi0
(11.1)
with w “ 0.1, w “ 0.3 and w “ 0.5 suggesting respectively a small, a medium
and a large effect size. To calculate the effect size I used the data from the pilot
study. However, when cell counts were ď 1, I assumed w “ 0.1. Table 11.4
reported also the sample size I calculated from the data of Viguera et al. [64]
and that I report in the table as a reference.
As a reference book for power calculations I used [198]
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Which is the best definition of the independent variable ’medica-
tions’?
The variable ’medications’ presented:
1. great variability between subjects, and
2. within- subject, across- time variability
4/19 (21.0%) were treated with more than one drug and 4/19 (21.0%) changed
the therapy at least once during pregnancy. Interestingly only 7/19 (36.8%)
women did not take any medications during pregnancy and even less 4/18
(22.2%) in the postpartum period. However, when only mood stabilising drugs
were taken into account, only 1 woman took lithium during pregnancy, 1 arip-
iprazole, 1 quetiapine and 1 olanzapine (only in the second part of the preg-
nancy), while 2 started quetiapine soon before childbirth. I did not consider
chlorpromazine a mood stabiliser. In summary, only 3 women (15.8%) reported
a mood-stabilising therapy all through pregnancy, while 6 women (31.6%) took
an antidepressant alone, without any mood stabiliser, for at least 8 weeks during
pregnancy. Despite recent reports (reviewed in [199]) challenged the safety of
tricyclic antidepressants in pregnancy, 2/6 women on antidepressants (33.3%)
were treated with dosulepin. To summarise, with the exception of 4 women who
did not take any medication in pregnancy and in the postpartum period, there
were 15 different therapeutic regimens, one for each woman and only 2 women
maintain the same therapy all through pregnancy and the postpartum period.
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Table 11.5: List of medications taken in the perinatal period by
each woman
ID PRECONC 1-8 weeks 9-16 weeks 17-24
weeks
25-32
weeks
33-
40weeks
1week 2week 3-4weeks 5-8 weeks 9-16 weeks
1 Lithium CLPRZ 50
mg
CLPRZ 50
mg
CLPRZ 50
mg
Citalopram
(non effec-
tive¿stop)
Venlafaxine
150 mg+
Quetiapine
200 mg
Quetiapine
500 mg
Quetiapine
500 mg
Quetiapine
300 mg,
Lithium
600 mg
Quetiapine
100 mg,
Lithium
800 mg
Quetiapine
100 mg,
Lithium
800 mg
CLPRZ 50
mg
Venlafaxine
150 mg+
Quetiapine
100 mg
Stop Ven-
lafaxine
1 week
before
delivery
2 Venlafaxine
150 mg
Venlafaxine
150 mg
Venlafaxine
150 mg
Venlafaxine
150 mg
Venlafaxine
185 mg
Venlafaxine
150 mg
Venlafaxine
150 mg
Venlafaxine
150 mg
Venlafaxine
150 mg
Venlafaxine
150 mg
Venlafaxine
150 mg
3 Quetiapine
800 mg
H H Olanzapine
20 mg
Olanzapine
20 mg
Olanzapine
20 mg
Olanzapine
20 mg
Olanzapine
20 mg
Olanzapine
20 mg
Olanzapine
20 mg
Olanzapine
20 mg
Citalopram
40 mg
Fluoxetine
20 mg
Fluoxetine
20 mg
Fluoxetine
40 mg
Fluoxetine
40 mg
Fluoxetine
40 mg
Fluoxetine
40 mg
Fluoxetine
40 mg
Fluoxetine
40 mg
Lamotrigine
100mg
Lamotrigine
25 mg
Lamotrigine
50 mg
Lamotrigine
50 mg
Lamotrigine
50 mg
Lamotrigine
50 mg
Lamotrigine
50 mg
Continued on next page
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Table 11.5 – Continued from previous page
ID PRECON 1-8 weeks 9-16 weeks 17-24
weeks
25-32
weeks
33-
40weeks
1week 2week 3-4weeks 5-8 weeks 9-16 weeks
4 Quetiapine
200mg
Quetiapine
200mg
Quetiapine
200mg
Quetiapine
200mg
Quetiapine
200mg
PRETERM
DELIV-
ERY 31/40
Quetiapine
400 mg,
Sertraline
50 mg
Quetiapine
1200 mg,
Sertraline
50 mg
Quetiapine
1200 mg,
Sertraline
50 mg
Quetiapine
150 mg,
Sertraline
50 mg
NA
5 H H Sertraline Sertraline Sertraline Sertraline Sertraline Sertraline Sertraline Sertraline Sertraline
6 Fluoxetine
40 mg
Fluoxetine
40 mg
Fluoxetine
40 mg
Fluoxetine
60 mg,
briefly on
Olanzap-
ine 10mg,
briefly on
haloperi-
dol 5
mg
Flouxetine
60 mg
NA NA NA NA NA
7 Quetiapine
200 mg
H H H H H Quetiapine
200 mg
Quetiapine
600 mg
Quetiapine
600 mg
Quetiapine
600 mg
VLP 500 VLP 1000
Continued on next page
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Table 11.5 – Continued from previous page
ID PRECON 1-8 weeks 9-16 weeks 17-24
weeks
25-32
weeks
33-
40weeks
1week 2week 3-4weeks 5-8 weeks 9-16 weeks
8 H H H H H H Quetiapine
100-300
mg
Quetiapine
300 mg
Quetiapine
300 mg
Quetiapine
300 mg
Quetiapine
300 mg
9 Aripiprazole
15 mg
Aripiprazole
15 mg
Aripiprazole
15 mg
Aripiprazole
15 mg
Aripiprazole
15 mg
Aripiprazole
15 mg
Aripiprazole
15 mg
Aripiprazole
15 mg
Aripiprazole
15 mg
Aripiprazole
20 mg
Aripiprazole
20 mg
Citalopram
20 mg
Citalopram
20 mg
10 H H H H H H H H H H H
11 Dosulepin
75mg
Dosulepin
75mg
Dosulepin
75mg
Dosulepin
75mg
Dosulepin
75mg
Dosulepin
75mg
Quetiapine
600 mg
Quetiapine
600 mg
Quetiapine
600 mg
NA NA
Dosulepin
75mg
Dosulepin
75mg
Dosulepin
75mg
12 NA Thyroxine Thyroxine Thyroxine Thyroxine Thyroxine Thyroxine Thyroxine Thyroxine Thyroxine Thyroxine
13 H H H H H H H H H H H
14 Stop
lithium
H H H H H H H H H H
15 Citalopram
20mg
Citalopram
20mg
Citalopram
20mg
Citalopram
20mg
Citalopram
20mg
Quetiapine
200 mg
Quetiapine
200 mg
Quetiapine
200 mg
Quetiapine
200 mg
Quetiapine
200 mg
Quetiapine
200 mg
Continued on next page
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Table 11.5 – Continued from previous page
ID PRECON 1-8 weeks 9-16 weeks 17-24
weeks
25-32
weeks
33-
40weeks
1week 2week 3-4weeks 5-8 weeks 9-16 weeks
Citalopram
20mg
Citalopram
20mg
Citalopram
20mg
Citalopram
20mg
Citalopram
20mg
Citalopram
20mg
16 Dosulepin
150mg +
Lithium
Dosulepin
150mg
Dosulepin
150mg
Dosulepin
150mg
Dosulepin
150mg
Dosulepin
150mg
Dosulepin
150mg
Dosulepin
150mg
Dosulepin
150mg
Dosulepin
150mg
Dosulepin
150mg
17 Lithium
800mg
Lithium
800mg
Lithium
800mg
Lithium
800mg
Lithium
800mg
Lithium
800mg
Lithium
800mg
Lithium
800mg
Lithium
800mg
Lithium
800mg
Lithium
800mg
18 H H H H H H Sertraline
75mg
Sertraline
75mg
Sertraline
75mg
Sertraline
75mg
Sertraline
75mg
19 Quetiapine
75 mg
H H H H H H H H H H
1
1Abbreviations and symbols:H:no medications, CLPRZ: chlorpromazine, NA: information non available
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11.4 Feasibility of a large scale study and mod-
ifications to the current research protocol
“If we want more evidence-based practice, we need more practice-
based evidence.”
Lawrence W. Green @ http://www.lgreen.net/
The analyses of the data collected in the pilot showed a great variability, es-
pecially in the pharmacological treatment. A study aimed to investigate the
effect of pharmacological treatment on the risk of perinatal recurrences would
need a large sample size of at least 280 women. However, to replicate the find-
ings of my retrospective analyses in a longitudinal study a much smaller sample
size of about 60-100 women would be required. Over 14 months of recruit-
ment 19 women completed the longitudinal study (16 with, 3 without telephone
interview) and other 16 completed the initial assessment and are due to be in-
terviewed in the next couple of months. Assuming a conservative drop-out rate
of 50% , 8 women would complete the follow-up within 4 months. Therefore,
assuming a constant rate of recruitment and follow-up completion, it would re-
quire about 3 years to recruit and follow-up other 60 women.
The major finding of this pilot study is that the collaboration with GPs
and psychiatrists is essential. In the pilot study I would have missed 75%
of severe episodes occurring after childbirth without the information gathered
through physicians. Moreover, the response rate of GPs and psychiatrists was
better than that I had expected, with 12/14 participants (excluding women
recruited before I had ethical approval to contact physicians- 85.7%) having in-
formation from at least one of the two.
• I would suggest that a larger amount of resources should be put in es-
tablishing effective collaborations not only with PNS, but also with GPs
and general adult psychiatrists. Although I did not have any element to
justify the involvement of obstetricians, it would be interesting to explore
it.
Although the difficulties in recruiting women systematically through PNS
(in addition to the difficulties in establishing effective contacts with the
services, there were the efforts to obtain honorary contracts in the health
boards involved), this method should not be dismissed and has got a great
potential. Not only it would assure a large number of potential partici-
pants entering in the study, but it would also allow to have a more repre-
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sentative sample of women with bipolar disorder who are pregnant in the
general community. As observed by Peindl and Wisner [177], it may re-
quired time to establish an effective network and my discouraging findings
may be due to the short period of time. The commitment of time and en-
ergy involved in the recruitment in the two studies reported by Peindl and
Wisner [177] was greater than my commitment. For me, coming from a
clinical background (but I suspect also because of my temperament), ask-
ing potential participants/potential collaborators for help with the study
was the major challenge of the PhD. In my clinical experience, in fact, I
was used to be contacted and to be asked for help and not vice versa. So,
perhaps, future recruitment and follow-up could benefit from the help of
more perseverant researchers. Peindl and Wisner [177] suggested monthly
contacts with physicians in order to ’keep the studies fresh in the minds
of health professionals’, weekly meetings with specialists and their staff,
giving informative talks to service users, carers and the general public,
also after office hours. The talks should be not only about perinatal men-
tal health, but also about the importance of research in improving the care.
• Another suggestion can be drawn from the high rates of missing interviews
among women with postpartum psychosis: it is likely that women were
still ill/recovering three months after childbirth and probably 6 months
to 1 year follow-up for these women would be a more sensible option (es-
pecially because for the majority of women earlier information would be
provided by physicians 2 months after childbirth).
• A third suggestion coming from the high rates of non response among
women with postnatal psychosis is that it may be useful to make sure
that case notes for the postpartum period are provided. At the moment,
in fact, case notes are requested by the BDRN team after the face-to-face
interview in pregnancy to assess lifetime course and severity of the illness.
I would suggest that case notes could also be used to integrate detailed
information on the postpartum period.
• Psychiatrists are currently asked about mania, without any reference to
psychotic features2. Given that the psychiatrist questionnaire is vital for
the assessment of episodes occurring in the postpartum period, I would
2In the questionnaire for psychiatrists, on page 2: Did she experience an episode of mania,
hypomania or a mixed affective episode following this delivery?
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propose the additional question: Were psychotic symptoms present?
In summary, I would not make any major modifications to the current research
protocol, but I would focus the resources in engaging the services involved in
the care of the woman during pregnancy and postpartum.
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Part IV
General discussion
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Chapter 12
12.1 Summary of the findings
In the first part of my PhD I explored the link between childbirth and mood
disorders in a large retrospective sample of women with mood disorders. Because
it is likely that unipolar and bipolar disorder are on a continuum, without points
of rarity, I investigated the childbirth trigger across the entire mood disorder
spectrum (BD-I, BD-II, RMD). The main findings of my PhD are:
• Around two thirds of all diagnostic groups reported at least one episode
of illness during pregnancy or the postpartum.
• Women with BD-I reported an approximately 50% risk of a perinatal
major affective episode. Risks were lower in RMD and BD-II at around
40%.
• Mood episodes were significantly more common in the postpartum than
outside the postpartum period in both BD-I and RMD, but not in BD-II.
• The majority of PNEs in women with BD-I and RMD occurred within
4 weeks of childbirth. In BD-I episodes of mania or psychosis had an
earlier onset than those of depression. For BD-II, onsets of psychiatric
episodes were more spread out over the perinatal period with more onsets
in pregnancy and later in the postpartum.
• In women with BD-I, episodes of mania/psychosis within 6 weeks post-
partum were associated with first live delivery. Episodes of depression in
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the postpartum were associated with primiparity only in mothers suffer-
ing from RMD and I did not find any effect of parity on perinatal bipolar
II depression. The primiparity effect was not due solely to women with
postpartum episodes not going on to have further children or driven by
the use of prophylactic medication in subsequent pregnancies.
• The effect of parity on postpartum mania/psychosis and unipolar postpar-
tum depression was driven by women who experienced their first lifetime
episode within 6 weeks postpartum.
In the second part of my PhD I designed and piloted a prospective study. I
sought to test the feasibility and the validity of a study that aimed to recruit a
large, well characterised sample of women with bipolar disorder in early preg-
nancy and to monitor them through pregnancy and the postpartum. The full-
scale study aimed i) to replicate and ii) to extend the findings on the retrospec-
tive sample, exploring the influence of a range of variables on the vulnerability
to develop an episode of severe illness in pregnancy or the postpartum. The
main findings of the pilot phase of the study were:
• Over 14 months of recruitment 19 women completed the follow-up assess-
ment. Excluding women who had a miscarriage, the rate of completion
was 78%, with 8/10 women who met the inclusion criteria refusing to take
part to the study and 2/10 not available for the follow-up interview.
• The recruitment through PNS, despite the high number of contacts gen-
erated, was not effective. Considering the number of women who were
interviewed for the initial assessment, the best recruitment methods were
the CUPS clinic and BDRN.
• The analyses of the data collected in the pilot showed a great variability,
especially in the pharmacological treatment.
• The response rate by GPs and psychiatrists was better than that I had
expected, with 85.7% participants having information from at least one
of the two. The collaboration with physicians was essential. Without the
information gathered through them, I would have missed 75% of severe
episodes occurring after childbirth.
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12.2 Previous research
12.2.1 Rates of perinatal episodes in women with mood
disorders
Despite differences in inclusion criteria, assessment and phenotypic definitions
that make direct comparisons of studies difficult, findings of the current study
corroborate and extend previous research that has reported high rates of peri-
natal mood disturbances in relation to childbirth (chapter 3, table 3.1).
Robust evidence of an association between a history of bipolar disorder and in-
creased risk of severe postpartum episodes has been previously reported. In the
Danish population-based cohort study the cumulative incidence of readmission
0 to 3 months postpartum was 22% for first time mothers with bipolar disor-
der [65]. Similar rates were reported in a previous analysis of smaller numbers
of bipolar women from the Mood Disorder Research Project sample, where 26%
of deliveries in familiar bipolar disorder were affected by a severe episode [59].
Consistent with previous research, in the present study I found that in women
with BD-I more than 1 in 5 pregnancies was complicated by psychosis or mania
with onset within 6 weeks of delivery - episodes that correspond to the concept
of postpartum psychosis.
Munk-Olsen [65] reported that less than 5% of first time mothers with a history
of unipolar affective disorders were admitted with an episode within 6 months
of childbirth. I found low rates (1.4%) of psychotic postpartum depression in
women with RMD but these rates are considerably lower than the rates of non
psychotic depression that complicated about 40% of pregnancies of women with
RMD .
In these analyses I excluded women recruited on the basis of being recruited
because of a perinatal episode and a proportion was recruited systematically.
Thus, the sample was representative of women with mood disorders in contact
with psychiatric services and there was no selection on the basis of having an
episode in relation to childbirth. This represents an advantage over previous
studies [6], where participants were drawn from perinatal psychiatry programs
and subject to selection bias potentially raising the rates of PNEs.
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12.2.2 Time of onset of perinatal episodes
Consistent with previous reports, in the current analyses the incidence of mood
episodes was considerably lower in pregnancy than in the postpartum. My find-
ings also corroborated the evidence of a strong link between mania or affective
psychosis and the first postpartum weeks.
Contrary to expectation, however, I didn’t find any differences between the BD-I
and RMD groups in the time of onset of postpartum non psychotic depression.
In the Danish population-based cohort study [65], the risk of admission for
unipolar depression was spread out over 5 months, while first time mothers
with bipolar disorder had the highest risk of readmission within the first three
weeks postpartum. However, there are important methodological differences
between the Danish study and the current report. The Danish study was based
on hospital admissions and did not discriminate between bipolar depression and
mania. My results on mothers with BD-I showed that the onset of bipolar de-
pressive episodes is more spread out in the postpartum than manic episodes.
This finding suggests that rather than a difference between lifetime unipolar or
bipolar diagnosis, the latency of onset after childbirth is associated with the
phenomenology of the puerperal episode itself. This hypothesis may explain
differences with the Danish study.
There is a paucity of studies that discriminate between bipolar depression and
mania in relation to childbirth. Bergink et al [80] 1 found that psychotic depres-
sion had a significantly later onset than psychotic mania. This contrasts with
my findings of an overlapping survival distribution between mania and psychotic
depression. Differences in the methodology and sample characteristics may ac-
count for this discrepancy.
In the Mood Disorders Project dataset, BD-II showed a pattern of onset sur-
prisingly different from BD-I and RMD. As I analysed episodes of different po-
larity separately, it is unlikely that the different proportion of perinatal manic
and depressive across mood disorders can be an explanation for this difference.
However, there is a lack of studies on the differences between BD-II and other
mood disorders in the perinatal period and my findings need to be replicated.
1I discussed this study in the background section
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12.2.3 Childbirth as a trigger for episodes of mood disor-
der
The registry studies that I largely discussed in the background section used ei-
ther women as their own control or the general population as control to test
the hypothesis that childbirth is a period of increased risk of mood episodes
(table 12.1). In my research I selected women with at least 5 years of illness and
compare the rates of postpartum periods affected by postpartum psychosis or
postpartum depression with the rates of episodes per years of illness. Compared
to registry studies, my approach gave a more general picture of the childbirth
trigger in relation to bipolar disorder, because it considered a broader period
of observation: from the onset of the mood disorder to the interview. Again,
comparisons with registry studies are difficult because of the differences in the
methodology. However, my findings replicated previous findings of an associa-
tion between childbirth and BD-I and extend the findings to episodes of RMD,
that probably do not require admission and thus were not included in the reg-
istry studies.
12.2.4 Primiparity
In table 12.2 I summarise the results of previous studies on parity and mood
disorders. For each pertinent analysis reported in previous studies I calculated
the effect size ES using the arcsin transformation of the probabilities [198].
2 My finding of an association between first delivery and postpartum psychosis
replicated previous findings of both register based and clinical studies. A num-
ber of methodological issues may influence the results of studies on parity. If
women suffering a postpartum episode are less likely to go on to have further
children, this will reduce rates in multiparae and may account for the association
with first pregnancies. Similarly, other demographic and obstetric variables may
also explain the excess of psychosis in primiparae. For example, first pregnancies
occur at a younger age and delivery by caesarean section has been associated
with both primiparity [175] and postpartum psychosis [169]. Only one previous
study took into account the possible effect of postpartum psychosis on further
pregnancies [93] and was conducted on a subsample of women that I included
in my analyses.
2I compute effect size h for two proportions using the function ES.h in the package pwr
h “ 2 arcsin?p1 ´ 2 arcsin?p2 (12.1)
where p1 is the first proportion and p2 the second proportion
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Table 12.1: Studies investigating the risk of mood episodes in the postpartum
compared to other times
Study Subject Comparison
group
Outcome Risk
Munk Olsen
et al 2009
[65]
Primiparae with
history of psychi-
atric admission
who had given
birth 0 to 6 months
previously
Primiparae with
psychiatric ad-
mission who had
given birth 6 to 11
months previously
Readmission Ò Mania
Munk Olsen
et al 2009
[65]
Primiparae with
history of psychi-
atric admission
who had given
birth 0 to 6 months
previously
Nulliparae with
mood disorder
Readmission Ò Mania
Munk Olsen
et al 2006
[68]
Primiparae without
previous admission
who had given birth
0 to 11 months pre-
viously
Primiparae without
previous admission
who had given birth
11 to 12 months
previously
1st admis-
sion
Ò Mania
Munk Olsen
et al 2006
[68]
Primiparae without
previous admission
who had given birth
0 to 11 months pre-
viously
Nulliparae without
previous admission
of the same age
1stadmission Ò Mania in
age groups ă
26 and ą 30
Terp &
Mortensen
1998 [67]
Parous women 0-3
months after deliv-
ery
General Danish fe-
male population
Admission Ò 1st admis-
sion, but not
readmission
mania
Kendell et al
1987 [52]
Parous women 0-90
days after delivery
2 y before and the
2 y after delivery
aged 15-44
Average
monthly
admissions
Ò
Current
study
Women with mood
disorders and his-
tory of PNE
Episodes/year PNE 6 weeks
postpar-
tum/delivery
retrospec-
tive Ò in BD-
I and RMD,
but not BD-
II
I also found an effect, although of smaller magnitude, for non-psychotic unipo-
lar postpartum depression. Differences in the definition and assessment criteria
could account for the differences between my results and those of previous stud-
ies, that did not report any effect of parity [169,186], or even found the opposite
effect [113]. Moreover, it has been argued that parity itself influences the validity
of rating scales for perinatal depression [176].
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12.3 Limitations
12.3.1 Retrospective study on mood disorders in preg-
nancy and the postpartum period
My results need to be interpreted in the light of several limitations:
• Information on PNEs was collected retrospectively and therefore the rates
I reported may not equate exactly with the risk of PNEs to women with
an existing mood disorder who become pregnant. This is for two reasons:
– A small number of pregnant women with a previous diagnosis of BD-
II or RMD may go on to develop a postpartum episode of mania and
therefore switch diagnosis to BD-I. As I pointed out in the introduc-
tion, it has recently been reported that about 14% of women having
a first psychiatric admission soon after childbirth developed bipolar
disorder during a 15-year follow-up period [7]. In my analyses these
women would be included in the BD-I group.
– Some pregnancies may have been prior to the first episode of mood
disorder. It is possible that having non-postpartum episodes of mood
disorder raise the risk of an episode following childbirth.
For these reasons, prospective longitudinal studies of women with a range
of mood disorder diagnoses are necessary. They would allow to quantify
the risk of developing PNEs. However, the retrospective design allowed a
greater insight into the overall lifetime course and is, in general, a more
cost effective method than the longitudinal design.
It is also worth noting that these limitations are likely to mean that the
high rates of PNEs I reported are likely to underestimate, to some extent,
the true risk to women with mood disorders, particularly those with BD-II
and RMD. Moreover, this represented a conservative bias also in the parity
analyses, making it less likely that I would find an effect of primiparity.
• Individuals in the RMD group were excluded from the study if they had
ever experienced mood incongruent psychosis or psychosis outside of mood
episodes, thus the rates of postpartum psychotic illness in women with
RMD may be underestimated.
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• A further issue is the reliability of the women’s recollections of PNEs. It
should be noted, however, that the reporting of episodes at interview was
in agreement with the medical records and the recollection of episodes of
illness in relation to childbirth has been shown to be excellent [200].
• In the analyses on the course of illness in relation to the childbirth trigger,
information on age at first pregnancy and age at first PNE was missing
for the majority of women. Data for first episode in relation to childbirth
were also missing for more than 10% of the sample. Despite the good
performances of multiple imputed datasets, the analyses including these
variables need to be interpreted with caution.
• It is possible that women with mood episodes only in relation to child-
birth represent a separate nosological entity from those who experience
recurrences both in the perinatal period and outside it. In the Mood
Disorder Research Project dataset there were 16 women who had only
episodes in relation to childbirth: 5 with unipolar postpartum depression,
1 with bipolar II postpartum psychosis and 10 with bipolar I postpartum
psychosis. I did not conduct any analyses to estimate the rates of women
who had only PNEs nor I explored the differences between this subgroup
and women with episodes both in the perinatal period and at other times.
Because of the methods of recruitment, it is likely that the Mood Disorder
Research Project dataset underestimated the actual prevalence of women
with only postpartum recurrences. Women who suffered with mania only
after childbirth could in fact have a diagnosis of postpartum psychosis
and not be aware of the link between postpartum psychosis and bipolar
disorder. These women were very likely to be missed by the BDRN study.
• I did not provide an accurate description of symptoms. In the Mood Disor-
der Research Project dataset episodes of postpartum mania were recorded
without any specification for psychotic features, so I was not able to per-
form separate analyses for psychotic mania and mania without psychotic
features. Moreover, given that survival curves for postpartum mania and
for postpartum psychotic depression overlapped, I merged mania with and
without psychosis with psychotic depression in a unique category (post-
partum psychosis), including also cycloid psychosis.
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12.4 Implications for nosology
12.4.1 Bipolar II disorder
In the retrospective sample, the patten of findings for BD-II was surprisingly
different from the patterns for BD-I and RMD:
• The onsets of PNEs in the BD-II group significantly differed from those
in the BD-I and RMD groups. In women with BD-II episodes were more
spread over the pregnancy and 12 months postpartum period.
• I did not find any relationship between parity and PNEs of any type in
women with BD-II. In this regard, BD-II appeared to have a different
relationship to childbirth than BDÐI and RMD.
• Although PNEs occurred in relation to 40% of pregnancies in women with
BD-II and approximately 70% of parous women with BD-II experienced
at least one PNE, childbirth did not seem to be a specific trigger for
DSM-IV mood episodes. Over 50% of women with BD-II, in fact, had a
chronic/highly recurrent course of illness with more than 1 episode a year.
In this group of women it is likely that perinatal recurrences happen in
concomitance with puerperium only by chance and are not causally related
to it. On the opposite side, less than 8% reported all deliveries affected by
PNE and a low number of lifetime recurrences. This small sub-group, with
the majority of lifetime recurrences occurring in the perinatal period can
represent a more homogeneous sub-group of women in which childbirth
represents a specific trigger for mood episodes. However, considering the
overall group of women with BD-II, there was no association between
postpartum period and increased rates of recurrences.
My interpretation is that women with BD-II had many recurrences in the peri-
natal period because they suffered from a highly recurrent disorder and thus
many episodes may not be causally related to childbirth but happen in con-
comitance with puerperium by chance.
There is a lack of studies on the differences between BD-II and other mood
disorders in the perinatal period and my findings need to be replicated. Further
work is needed to clarify the relationship of episodes of BD-II to childbirth. In
general, the construct of BD-II is controversial. On one hand, there is the view
that bipolar features/bipolar disorder are under-diagnosed and that at least 1
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in 5 patients in primary care in the UK suffers with unrecognised bipolar disor-
der [201]. On the other hand, there is a paucity of evidence on the validity of
the BD-II construct and clinicians have criticised its utility [202]. 3
12.4.2 Possible bipolar features in women with postpar-
tum major depression
I demonstrated an influence of parity on postpartum mood episodes in women
with both BD-I and RMD - the effect was not found only in the former con-
dition. In women with BD-I, however, the effect was limited to episodes of
manic/mixed polarity. In RMD, in which by definition episodes of high mood
have not occurred, there was an influence on episodes of depression with early
onset following delivery. An interesting question for further work is whether
these early onset depressive episodes in RMD, while not meeting criteria for
hypomania, show evidence of bipolar features. Indeed previous work by Munk-
Olsen et al found that episodes of depression with onset within 4 weeks of
delivery are a marker of underlying bipolarity with a higher risk of subsequent
conversion to a bipolar diagnosis [7].
The rates of hypomania in the perinatal period were surprisingly low (2.6% in
the BD-I group and 4.0% in the BD-II group). It may be due to the difficul-
ties in recollecting minor episodes and in differentiating hypomania from the
extreme happiness following motherhood. In addition, mixed states may be
common in the postpartum and it is possible that women focused on depressive
symptoms when asked retrospectively about postpartum episodes. As discussed
in the background section, mood swings are highly prevalent after childbirth in
the general population. It is possible that childbirth is more likely to trigger
a full-blown mood episode in women with a vulnerability to mood disorder,
whereas in the general population, who do not have an underlying diathesis for
major psychiatric illness, more minor mood symptoms are triggered.
3For example, Spence [202] argued that there are economical implications and perhaps
there is an economical interest in widening the spectrum of bipolar disorder to BD-II. He
focused its claims on the BOLDER studies on the efficacy of quetiapine on bipolar depression,
that were supported by AstraZeneca Pharmaceuticals and reported the data from the NHS
Business Services Authority that the prescription of quetiapine has increased by 160% since
2005
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12.4.3 Postpartum onset criterion
The decision about where to set the postpartum onset criteria is difficult. On
one hand a broader definition may be of benefit in clinical practice, where the
treatment of mothers who experience an onset within a few months of deliv-
ery should be informed by the postpartum context. On the other hand, onsets
later in the postpartum are likely to be less related to childbirth as a trigger
and a broad definition may be a problem for studies examining the aetiology
of postpartum triggering. In my analyses over 90% of episodes of postpartum
psychosis met the DSM-IV diagnostic criterion of 4 weeks, while it was the case
for less than 34 of episodes of postpartum depression.
Despite previous work suggesting differences between bipolar and unipolar dis-
orders, I found that in BD-I and RMD, episodes of depression had a very similar
pattern of onset following childbirth. When postpartum episodes in women with
BD-I were analysed according to episode type, postnatal depression with psy-
chotic features and mania had an overlapping pattern of onset, while the onset of
non psychotic depression was later in the postpartum. Together, these findings
suggest that if different postpartum onset criteria are to be employed this may
be more appropriate according to the phenomenology of the episode rather than
according to the lifetime diagnosis. There is no justification here for separate
onset criteria for bipolar and unipolar disorders.
In the analyses on primiparity I refined the definition of PNE to better estab-
lish the relationship between parity and mood disorders. In women with both
BD-I and RMD, the relationship with parity was only significant for episodes
with onset within 6 weeks of delivery. Episodes with onset in pregnancy or
later in the postpartum did not show any relationship with parity. My study
therefore, provides empirical support for an onset specifier for research limited
to the first few weeks following delivery. My findings are in agreement with pre-
vious studies that have found that the risk of mania is highest within 4 weeks
of childbirth [65, 68] and that an onset of any psychiatric symptoms but manic
within 2 weeks after delivery predicts subsequent conversion to bipolar disorder
(relative risk = 4.26; 95% CI =3.11-5.85) [7]. Similarly, Forty et al [84] found
evidence for familial aggregation of unipolar PND only for episodes with onset
within 4 weeks of delivery but not for those occurring within 6 months of deliv-
ery. In this study, however, the familiarity for postpartum unipolar depression
maximised when a postpartum definition of 6-8 weeks was applied, suggesting
that a 4-week postpartum onset specifier may be too narrow in the study of
postpartum unipolar depression. In summary, in clinical practice there may be
good reasons for extending the definition of postpartum episode but research
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aimed at uncovering the aetiology of postpartum triggering should be focused
on episodes with early onset.
12.5 Clinical implications
12.5.1 Burden of perinatal episodes
The present findings emphasise the high rates of PNEs for women with a broad
range of mood disorders. My results indicated that more than 70% of parous
women with mood disorders will experience at least one perinatal episode in
relationship to pregnancy and childbirth. The importance of pregnancy and
childbirth for women with mood disorders should therefore not be underesti-
mated.
For women with BD-I, approximately 20% of deliveries were associated with
a postpartum episode of mania or psychosis, a further 25% of deliveries were
associated with an episode of non psychotic major depression and almost 50%
of deliveries were associated with a PNE of major mood disorder of some de-
scription. Women with a lifetime diagnosis of BD-II or RMD by definition will
not have suffered an episode of mania in relation to childbirth. It would be
wrong, however, to underestimate the importance of PNEs to women in these
diagnostic groups. Although showing lower rates of broadly defined PNE than
women with BD-I, still approximately 40% of deliveries are associated with a
PNE of major mood disorder.
In discussing the risk of a PNE in women with BD-I, it is therefore important
to consider the risk of a postpartum depression in addition to the risk of post-
partum psychosis. For these women there is a 1 in 2 risk of an episode of major
mood disorder in relationship to pregnancy and childbirth.
The risk of PNEs, while highest in BD-I disorder, extends also to women with
BD-II and RMD. The high rates of perinatal mood disorder across the mood
disorder spectrum should be recognised and discussed with women and their
partners.
It has been estimated that more than 40% of the approximately 23 million preg-
nancies occurring each year in high-income countries are unplanned. Thus, the
risk of illness in the puerperium should be discussed with all women of child-
bearing age who have a personal history of mood disorders, even with those
who are not currently planning a pregnancy. Given that women might not be
in contact with mental heath services it is important that all healthcare pro-
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fessional that look after pregnant women including midwifes, family physicians
and obstetricians are aware of this increased risk.
In summary, for research into aetiology all evidence points to early onset, more
severe and manic / mixed episodes being of primary importance and research
strategies may be better focussing on these episodes. However, the clinical bur-
den of PNEs is extended to include other less severe episodes of mania and
non psychotic depressive episodes occurring in pregnancy and in the postnatal
period. All these episodes in relation to childbirth are clinically important.
12.5.2 Parity
For women with mood disorders, particularly for those with bipolar disorder,
difficult decisions need to be made in relation to pregnancy and childbirth. Any
information that can help to individualise the risk of illness may be useful. For
women with BD-I, the odds of postpartum psychosis following a first pregnancy
are double those for further deliveries. If a woman has remained well after her
first baby, this provides some reassurance in subsequent pregnancies. However,
it is important to remember that the risk of postpartum recurrence is very high
(ą 60%) in women who have already experienced an episode of postpartum
psychosis [100].
12.6 Implications for further research
Brockington defined postpartum psychosis as a ’relatively sharply phenomenon’
that offers an ’exceptional opportunity for clinical observation’ [77]. Moreover,
the study of postpartum episodes could have implications for mood disorders
in general. However, my research found that it is likely that postpartum mood
disorders are complex entities and that research into the causes of these episodes
should take into account this complexity.
12.6.1 Longitudinal studies
Although my analyses provided some insight in the complexity of the childbirth
trigger of mood disorders, only large longitudinal studies could capture the great
variability between subjects and provide detailed information on risk factors
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and clinical features of PNEs. My findings on the lack of specificity of the
childbirth trigger in BD-II particularly need to be replicated, as there have
been no previous studies on BD-II in the perinatal period.
The pilot longitudinal study I conducted showed a great complexity in the course
of illness during pregnancy and the postpartum period, with women suffering
from multiple episodes and becoming ill at many different stages in the perinatal
period. The major source of variability was medications that included poly-
pharmacy and changing of medications and dosage at different occasions during
the perinatal period.
The main finding on the feasibility of a longitudinal study was the importance
of the collaboration with the NHS, that is vital not only to provide generalizable
results, but also to get information about the most severe cases. A large-scale
longitudinal study (¿200 women) that captures at least part of the complexity of
the clinical course of bipolar disorder in pregnancy and after childbirth would be
feasible only with the collaboration of PNS, GPs and general adult psychiatrists.
However, establishing an effective network of collaborators in the NHS requires
lot of time and resources.
12.6.2 Clinical phenotypes for biological studies
A consistent conclusion from all my analyses was that the current classification
systems may not provide adequate definitions of postpartum episodes for bio-
logical studies, because they are too general. I propose the following suggestions
for future biological studies on postpartum mood disorders:
• Postnatal episodes in women with BD-II should be excluded, because it
is likely that in this subgroup most episodes occurred only by chance in
the postpartum period, with no specific association with the childbirth
trigger.
• Women with BD-I who experienced their first manic/psychotic episode
within 6 weeks after the first delivery are likely to be a more homogeneous
group.
• Studies on postnatal depression should be conducted separately for unipo-
lar and bipolar depression. Although episodes of bipolar I depression
and unipolar depression had overlapping survival curves, only episodes
of unipolar depression were overrepresented after childbirth and associ-
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ated with primiparity. However, more clinical studies on bipolarity and
postpartum depression are needed.
• Although in my research there were not many women who had only
episodes in relation to childbirth, attention should be paid on the lon-
gitudinal course of recurrences. Women with few recurrences and the ma-
jority of recurrences occurring soon after deliveries are likely to be more
vulnerable to the childbirth trigger than those who have the same number
of postpartum episodes, but in the context of a highly recurrent/rapid
cycling disorder. Interestingly, the association between bipolar postpar-
tum psychosis and the VNTR polymorphism of the serotonin-transporter
gene, found by Coyle et al [88] on a sub-sample of women that was in-
cluded also in my analyses, was stronger when the phenotype was narrowed
to women who had experienced multiple postpartum episodes (OR=9.2,
95%CI=1.2-73.1).
12.6.3 What accounts for the influence of parity?
There are both psychosocial and biological differences between first and sub-
sequent pregnancies that might underpin the association with parity. Women
having their first child experience higher levels of stress and the concerns of
motherhood are different for first and subsequent deliveries [203]. However,
while undoubtedly important for postpartum mood disorders in general, in the
case of severe postpartum episodes, there is a lack of evidence implicating psy-
chosocial factors [173, 190, 191]. This suggests the potential importance of bi-
ological differences, immunological or hormonal for example, between first and
subsequent pregnancies.
My findings raise the possibility of a relationship between postpartum mood
disorders and other disorders influenced by parity. Pre-eclampsia has robustly
been associated with primiparity [204], while more controversial findings have
reported that autoimmune disorders [205–207] and gestational diabetes [208]
are overrepresented in multiparous women.
There are a number of important overlaps in the clinical presentation and epi-
demiology of pre-eclampsia and postpartum psychosis and this relationship has
been recognised for over 160 years [209] (figure 12.1) . Associations between
pre-eclampsia and mood episodes have been described [210], and psychosis can
be a dramatic feature of eclampsia [211]. It is of interest that psychotic symp-
toms occurring in this condition are not merely a post-ictal phenomenon but
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rather occur prior to this end stage and are therefore thought to be part of the
systemic effects of pre-eclampsia on the central nervous system [211]. It is also
worth noticing that, although eclampsia is considered a disorder of the late stage
of pregnancy, a multicenter study found that 33% of women with eclampsia had
onset in the postpartum period [212].
Molecular studies have also shown possible similarities between the pathogenesis
of eclampsia and that of postpartum psychosis. The isoprenoid pathway synthe-
sizes from the acetil-coenzimA metabolites such as digoxin, dolichol, ubiquinone,
and cholesterol. Alterations in the isoprenoid pathway have been reported in
both pre-eclampsia and postpartum psychosis [213]. Magnesium sulfate, a drug
commonly used to prevent and treat eclamptic seizures, has antimanic-like ef-
fects in this animal model [214].
Primiparity 
  
Eclamptic psychosis sine 
convulsions [210] 
 
Efficacy of magnesium sulphate 
(for mania in animal models 
[213]) 
 
Isoprenoid pathway and 
hypothalamic digoxin [212] 
 
Immunological dysfunction 
[214, 215] 
POSTPARTUM PSYCHOSIS PRE-ECLAMPSIA 
Usually in 
pregnancy,	  
but 33%of 
eclampsia 
postpartum  
[211]	  
Usually 
within 
days after 
delivery 
[78]	  
Figure 12.1: Overlap between preeclampsia and postpartum psychosis
The primiparity effect in pre-eclampsia supports an immunological aetiology of
this complex condition [215], and my findings suggest immunological factors
may similarly play a role in postpartum triggering of mood episodes. Interest-
ingly, Bergink et al [216] reported a 4 fold increase in the rates of autoimmune
thyroid disease in primiparae with de novo postpartum mania/psychosis com-
pared to new mothers without psychiatric complications.
The primiparity effect in unipolar depression within 6 weeks postpartum needs
to be investigated further. Studies on unipolar postpartum depression have
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shown great heterogeneity. The aetio-pathology of postnatal depression is prob-
ably complex and multifactorial, including biological and psycho-social factors
(I briefly overviewed them in chapter 2). However, it is of interest that immu-
nity has been implicated in the pathogenesis of major depression [217]. Maes et
al [218] comparing non-pregnant healthy women with healthy pregnant women
found that plasma tryptophan and the tryptophan/CAAs4 ratio were signifi-
cantly lower at the end of term and even lower 1-3 days after childbirth and
that women with an history of major depression had an enhanced inflammatory
response 1 and 3 days postpartum compared to women without a history of
major depression [219]. It is therefore possible that immune activation close
to delivery increases tryptophan metabolism to kynurine, reducing tryptophan
availability. However, the decreased availability of plasma tryptophan was not
related with psychometric measures of depression or anxiety [219].
My findings give clues, therefore, to the pathogenesis of the postpartum trig-
ger and, perhaps, to the causation of mood disorders more generally. Future
studies are needed to clarify the role that biological and psychosocial differ-
ences between first and subsequent pregnancies on the postpartum triggering
of mood episodes. Studies exploring the relationship of perinatal mood disor-
ders and other conditions associated with parity such as pre-eclampsia may also
prove fruitful.
12.7 Conclusion
The research on perinatal mood disorders relies mostly on arbitrary definitions
of postpartum disorders, while more evidence-based criteria are needed. Confu-
sion in the nosology has probably prevented firm and consistent conclusions on
the nature of the postpartum trigger. My PhD project sought to address these
deficiencies.
In the first part of this thesis I explored the link between childbirth and mood
disorders in a retrospective sample of over parous 1500 women with mood disor-
ders, recruited as part of ongoing molecular generic studies. Because it is likely
that unipolar and bipolar disorder are on a continuum I included a sample of
women with RMD as a comparison group. I found that PNEs are highly preva-
lent across the mood disorder spectrum. Primiparity is associated with bipolar I
mania and psychosis and unipolar major depression within 6 weeks postpartum.
Childbirth does not seem to be a specific trigger for episodes of BD-II.
4CCAs are the amino acids valine, leucine, tyrosine, phenylalanine and isoleucine that are
known to compete with tryptophan for the same cerebral uptake mechanism
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In the second part I designed and piloted a prospective study to follow-up women
with bipolar disorder in pregnancy and the postpartum period. From the pi-
lot study a great variability emerged , especially in the course of illness and in
medications, between women and within the same woman over time.
To conclude, the association between childbirth and mood episodes may be
specific only for mania/psychosis and unipolar depression occurring soon after
childbirth. These episodes are associated with first deliveries and are important
candidates for further biological studies. To capture the clinical complexity
of bipolar disorder in pregnancy and the postpartum period very large scale
longitudinal studies are needed. These studies must be based on a strong col-
laboration with the NHS.
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 Department of Psychiatry, University of Birmingham, The Barberry, 25 Vincent Drive, Birmingham  B15 2FG 
Tel: +44(0) 121 301 2361 Fax: +44(0) 121 301 2351 Email: moodresearch@contacts.bham.ac.uk 
   
 
  Version 5 – 12.12.10 
      
 
 
 
 
AGREEMENT TO TAKE PART IN THE STUDY OF MOOD DISORDERS 
 
                                      Please initial box 
 
1. I have read the attached information sheet  (version 5,  dated 12.12.10) on the above project and have  
been given a copy to keep.  I have had the opportunity to ask questions about the project and understand          
why the research is being done.          
 
2. I agree to give a sample of blood for research in the above project.   
 
3.    I agree to part of the interview being audio recorded.  
  
4.    I understand that participation in this project is voluntary and that I am free to withdraw from the study  
without giving a reason and without my medical treatment being affected.                                                  
 
5.  I give permission for my medical records to be looked at in strict confidence by responsible people from  
the Mood Disorders Research Group, Birmingham University.       
 
6. I understand that the tests done as part of this research are not clinically diagnostic and I will not be  
informed of any specific results. 
 
7. I understand that I will not benefit personally from taking part in this research. 
 
8. I understand that the information and blood sample I have donated for this study will be held in a  
confidential and anonymised form by the research team and may be made available to researchers at other  
centres who are carrying out similar work. 
 
9. I agree that I may be contacted again, in connection with the research, in the future. 
 
10. I know how to contact the research team if I need to. 
 
If you are pregnant: 
 
11. I give permission for my GP and psychiatrist to be contacted 2 months after my expected delivery date 
 to request information about the pregnancy and postnatal period. 
 
12. I agree to be contacted 3 months following my expected delivery date to be invited to take part in a 
telephone interview about my pregnancy and the postnatal period. I understand that I am free to  
decline this invitation. 
 
 
NAME ____________________ SIGNED ______________________ DATE ___________________ 
 
WITNESSED _______________ SIGNED ______________________ DATE ___________________ 
 
THANK YOU FOR PARTICIPATING IN OUR RESEARCH 
YOU WILL BE GIVEN A COPY OF THIS CONSENT FORM TO KEEP 
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INFORMATION ABOUT RESEARCH INTO MOOD DISORDERS 
 
INTRODUCTION 
We are a team of psychiatrists and psychologists who work in the Department of Psychiatry at the 
University of Birmingham and the Department of Psychological Medicine at Cardiff University. We are 
conducting research (funded by the Wellcome Trust) into the causes of mood disorders and work closely 
with other research groups both in Europe and the United States. We would like to ask you if you would be 
willing to take part in our research.  Before you decide whether or not you would like to take part, please 
take the time to read the following information carefully.   
 
WHAT IS THE PURPOSE OF THE RESEARCH? 
Mood disorders sometimes run in families but in other cases only one member of a family is affected. 
Unfortunately no-one understands enough about the illnesses to know what causes particular individuals to 
become unwell. The main aim of our research is to look for genes and other factors, such as stressful life 
events, which make some people more likely than others to become ill. We hope that our study will 
improve understanding of mood disorders and help other workers find better treatments in the future.  
 
WHO IS BEING ASKED TO TAKE PART IN THE STUDY? 
Over 3000 individuals have already taken part in our ongoing research into mood disorders. It is important 
for us to see many more people in order that we can get the best possible understanding of the causes of 
mood disorders. We are hoping to recruit individuals who have experienced one or more episodes of high 
mood (often called mania, hypomania or bipolar disorder) at some point in their lives and would be 
extremely grateful if you would be kind enough to help with this study. 
 
WHERE DOES THE STUDY TAKE PLACE? 
If you agree to take part, a member of our research team will arrange a suitable time to visit you in your 
home or at another place convenient for you.  
 
WHAT DOES TAKING PART INVOLVE? 
Taking part involves: 
• An interview by a trained member of our research team who will spend around an hour and a half 
asking you about your experiences and the kinds of symptoms you have had in the past. If you are 
willing we would like to audio record part of the interview for consistency and training purposes. 
• Completing a set of questionnaires (which will take around half an hour). 
• Giving a blood sample from your arm (2 standard blood tubes). 
 
With your permission, we would like to look at your medical records in strict confidence in order to gain 
further information about the kinds of symptoms you have experienced. We only need to see you once but 
may contact you again in the future if we need to collect more information for the research. However, you 
will be free to decline if you do not want to participate further. Once you have agreed to take part in the 
study we will ask you to sign a consent form and will give you a copy to keep along with this information 
sheet. 
 
If you are pregnant, we will also ask you to complete an additional questionnaire about your 
pregnancy (which will take around 10 minutes). With your permission, two months after your 
expected date of delivery we would like to contact your GP and psychiatrist to request information 
about the pregnancy and postnatal period.  Unless your doctors advise us otherwise, will then 
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arrange an additional telephone interview with you (which will take about 20 minutes) to ask about 
any symptoms you may have experienced in relationship to pregnancy and childbirth.  
You can decline to participate in this part of the study. You do not have to take part when contacted 
after the delivery and this will not affect the care you receive. 
 
WHAT ARE THE POSSIBLE BENEFITS OF TAKING PART? ARE THERE ANY RISKS? 
• By taking part in the study you will not gain any direct benefit. However, your help will be of great 
value in allowing us to learn more about the causes of mood disorders and we hope this will lead to 
important advances in the treatment and prevention of mood disorders.  
• This study does not include any treatment changes or invasive techniques. Some people experience 
mild discomfort when giving a blood sample and sometimes there is mild bruising afterwards. 
• Most people find talking about their illness beneficial, but some may find it distressing. If at any time 
during the interview you feel distressed, you can ask the interviewer to move onto another question, 
take a break or end the interview. 
• If you have a concern about any aspect of this study, please speak to Katherine Gordon-Smith. Her 
contact details are provided at the end of this information sheet. 
 
DECLINING AND WITHDRAWING FROM THE STUDY  
• You do not have to take part in this study. If you do decide to take part you are still free to withdraw at 
any time and without giving a reason.  
•  A decision to withdraw at any time, or a decision not to take part, will not alter the care you receive. 
• If you decide to withdraw from this study, all information and samples you have provided will be 
destroyed and not used further in the research. 
 
DATA CONFIDENTIALITY  
• All interviews and results will be strictly confidential. 
• The interview data, audio recordings of interviews and blood samples will be stored in accordance 
with the Data Protection Act. The data will be stored for a minimum of 10 years, but probably for 
longer as this is an ongoing long-term programme of research. 
• The blood sample you provide will be coded and stored safely in a laboratory.  It will be analysed to 
identify genetic variations that might cause some people to develop mood disorders. The results of 
your blood test are for research purposes only and will not be available to anybody on an individual 
basis. 
 
WHAT WILL HAPPEN TO THE RESULTS OF THE RESEARCH STUDY? 
• It is our intention to publish the results of this study in academic journals. Participants will not be 
identifiable in any report or publication. 
• We will keep in touch with you by sending a regular newsletter to let you know how our research is 
progressing and to ask you to let us know about any important changes in your health since we last 
saw you. 
 
FURTHER INFORMATION AND CONTACT DETAILS 
If you have any further questions about this research, please contact the Mood Disorders Research Team 
and ask for Dr Katherine Gordon-Smith (Research Psychologist). Our address appears below, our 
telephone number is 0121 301 2361, and our e-mail address is moodresearch@contacts.bham.ac.uk 
                                        
This study was given a favourable ethical opinion for conduct in the NHS (or other) by the West 
Midlands Multi-centre Research Ethics Committee (MREC/97/7/01). 
 
Department of Psychiatry, University of Birmingham, The Barberry, 25 Vincent Drive, Birmingham  B15 2FG 
Tel: +44(0) 121 301 2361 Fax: +44(0) 121 301 2351 Email: moodresearch@contacts.bham.ac.uk 
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Page 01
PART D
QUESTIONNAIRE 8. PREGNANCY QUESTIONNAIRE
D D
/
M M M
/
Y Y
Date of Completion
OFFICE USE
-STUDY ID
Initials
/ /
Date of Birth
Part A Questions about your pregnancy:
D D
/
M M M
/
Y Y
What date is your baby due?
How many weeks 
pregnant are you ?
Part B  Questions about your feelings about your pregnancy and the support you are 
receiving
Please only answer the items in this section if you are past 24 weeks pregnant. If you are up to 24 
weeks pregnant, please go to Part E on page 4 and we will ask you about this when we contact you 
again in the future.
1. Overall, has this pregnancy been a positive experience for you? (please cross one)
1
Not at all
2 3
Somewhat
4 5
Very much
2. Do you feel you will have people you can depend on for emotional support when you go home 
with your baby? (please cross one)
1
Not at all
2 3
Somewhat
4 5
Very much
3. Have you a partner in this pregnancy? (please cross one) Yes No
If yes, is your relationship with your partner an emotionally supportive one? (please cross one)
1
Not at all
2 3
Somewhat
4 5
Very much
If YES, please describe briefly:
4. Have you had any major stresses, changes or losses in the course 
of this pregnancy (e.g. separation, moving house, domestic violence, 
bereavement)? (please cross one)
Yes No
Page 02
If YES, on average, how many cigarettes a day have you smoked?
1. In this pregnancy have you smoked cigarettes? 
 (please cross one)
Yes No
Part C Questions about smoking, drugs and alcohol in pregnancy
2. In this pregnancy, have you drunk alcohol regularly? Yes No
If YES, how many units of alcohol have you consumed on average per week? (1 unit of alcohol is equal to
 one small glass of wine, a single measure of spirits or half a pint of beer/lager/cider)
Sedatives
Cannabis
Speed
Ecstasy
Glue
Solvents
Cocaine
Heroin
Methadone
Other non prescription/over the counter drugs
Yes No
3. During this pregnancy have you used any of the following substances when they have
 not been prescribed by a doctor?
If yes please give brief details
Page 03
1. What drug treatments (medications) as prescribed by your doctor did you take in the 6 months before
 you became pregnant? 
(If you can, please indicate daily doses and say when any changes were made)
Part D Questions about medications
2. What drug treatments (medications) as prescribed by your doctor have you been taking during 
your pregnancy? 
(If you can, please indicate daily doses and say when any changes were made)
Page 04
1. Anger/irritability
2. Anxiety/tension
3. Tearful/increased sensitivity to rejection
4. Depressed mood/hopelessness
5. Decreased interest in work activities
6. Decreased interest in home activities
7. Decreased interest in social activities
8. Difficulty concentrating
9. Fatigue/lack of energy
10. Overeating/food cravings
11. Insomnia
12. Hypersomnia (needing more sleep)
13. Feeling overwhelmed or out of control
14. Physical symptoms: breast tenderness, 
headaches, joint/muscle pain, bloating, weight gain
Not at all Mild Moderate Severe
1. Do you experience some or any of the following premenstrual symptoms which start before 
your period and stop within a few days of bleeding?
Part E Questions about your periods
These questions refer to your periods (menstrual cycle) before your pregnancy.
Please mark an X in the appropriate box (mark one for each symptom)
15.  Your work efficiency or productivity
16.  Your relationships with coworkers
17.  Your relationships with your family
18.  Your social life activities
19.  Your home responsibilities
Not at all Mild Moderate Severe
2. Have your symptoms, as listed above, interfered with:
Thank you very much for completing this questionnaire. Arianna Di Florio will 
arrange to contact you again by telephone following your delivery.
Appendix D
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Dear 
Re:	  Participation	  in	  Mood	  Disorders	  Research	  Study	  (Name	  and	  DOB)	  
  
The above named woman has very kindly taken part in our research study into the causes of mood 
disorders, based at the University of Birmingham and Cardiff University. She has given us 
permission to write to you as her doctor to request information about her recent pregnancy and post 
natal period.  
Please find enclosed with this letter an information sheet with further details about the study which 
has been approved by the West Midlands Multi-centre Research Ethics Committee and a copy of 
your patient’s signed consent form. 
We would be very grateful if you would be kind enough to complete the attached questionnaire, 
with questions about her pregnancy and post partum period, and return it in the free post envelope 
provided. 
We plan to re-contact your patient with the next few weeks by telephone or by e-mail to arrange a 
brief telephone interview, which will take about 20 minutes. If you know any reason why we 
should not re-contact her, or require any further information about the research please do not 
hesitate to contact us, our contact details appear below.  
  
Yours sincerely   
  
Mood Disorders Research Team 
  
 
Appendix E
Postpartum General
Practitioner
Questionnaire-to be sent
with postpartum letter 2
months after due date
237
Version 1 12.12.10 
 
Appendix F - Postpartum General Practitioner Questionnaire-to be sent with post 
partum letter 2 months after due date 
 
 
Pregnancy and Childbirth Questionnaire 
 
 
Q 1.  Date of delivery     
 
Q 2. Pregnancy outcome    Q 3.  Delivery modality  
Live birth     Normal vaginal delivery  
Stillbirth    Elective caesarean section  
Termination     Emergency caesarean section  
Miscarriage     Forceps / Ventouse   
 
Q. 4  Baby heath status: 
Healthy   
Minor problem    
Major problem    
 
Please give brief details of any problems: 
 
 
Q 5.  Has she suffered an episode of psychiatric illness in this pregnancy or post-
partum period? 
Yes          No       
 
If yes please give brief details: 
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Completed by: 
 
Name 
 
 
Position 
 
 
 
Date  
 
 
 
 
Address 
 
 
E-mail address 
 
 
Telephone number 
 
 
 
 
 
 
 
 
Please send completed questionnaire in the pre-paid envelope provided 
 
 
 
 
Thank you for your time 
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Pregnancy and Childbirth Questionnaire 
 
 
Q1. Episodes of psychiatric illness during pregnancy 
 
Did she experience an episode of depression during the pregnancy?    
 
Yes          No      Unknown  
 
Did she experience an episode of mania, hypomania or a mixed affective episode 
during the pregnancy?  
 
Yes          No      Unknown  
 
Did she experience another form of psychiatric episode during the pregnancy?       
 
Yes          No      Unknown    
 
If yes please give brief details: 
 
If yes to any of the above, was the onset of the episode; 
 In the first trimester of pregnancy          Yes          No 
 In the second trimester of pregnancy                 Yes          No 
 In the third trimester of pregnancy                     Yes          No 
 A continuation of an episode from before pregnancy       Yes          No  
 
Was she admitted to hospital?             
Yes          No   
 
 
Q 2.   Episodes of psychiatric illness in the postpartum period 
 
Did she experience an episode of depression following this delivery?     
 
Yes          No           
 
Did she experience an episode of mania, hypomania or a mixed affective episode 
following this delivery?  
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Yes          No   
 
Did she experience another form of psychiatric episode following this delivery?       
 
Yes          No       
 
If yes please give brief details: 
 
 
If yes to any of the above, was the onset of the episode: 
 the continuation of an episode from pregnancy        Yes          No  
  an onset following delivery                                 Yes          No  
 
 
If a postpartum onset, when was the onset in relationship to delivery? 
 
 
days    Or    weeks    following delivery 
 
 
Was she admitted to hospital? 
Yes          No  
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Q 3.  Medication in relationship to the pregnancy 
 
What prescribed medication did she take in the 6 months before pregnancy? 
(Please indicate daily doses and say when any changes were made) 
 
  
 
What prescribed mediation did she take during the pregnancy?  
(Please indicate daily doses and say when any changes were made)  
 
  
 
What prescribed medication did she take in the postpartum period? 
(Please include daily doses and say when any changes made) 
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Completed by: 
 
Name 
 
 
Position 
 
 
Date  
 
 
 
 
Address 
 
 
E-mail address 
 
 
Telephone number 
 
 
 
 
 
 
Please send completed form in the pre-paid envelope provided 
 
 
 
 
 
Thank you for your time 
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ID  
INITIALS 	  
TIMELINE 
BDRN interview ____________________ 
Questionnaire _______________________ 
Consent to the follow-up interview ______________________ 
Follow-up interview _____________________ 
 
IF THE QUESTIONNAIRE HAS NOT BEEN COMPLETED, FILL IT 
ID  
INITIALS 	  
OBSTETRIC RISK FACTORS 
 
Expected date of delivery ________________________ 
Date of delivery ______________ Time______________ 
Length of gestation (weeks) __________________ 
Parity and gender___________ 
Birth status 
O Stillbirth (a birth after a gestation period of 24 weeks (168 days) where 
the baby shows no sign of life when delivered) 
O Alive 
Method of delivery 
O Spontaneous –Spontaneous cephalic vaginal delivery, Normal delivery 
and Other breech delivery 
O  Instrumental –Forceps cephalic delivery, Vacuum delivery and Breech 
extraction delivery 
O Caesarean –Elective caesarean delivery and Other caesarean delivery 
(includes emergency caesarean delivery)  
O Other – Caesarean hysterectomy  
O Unknown  
Method of onset of labour 
O Spontaneous – includes spontaneous onset only 
O Induced – includes surgical induction, medical induction and 
combination of surgical and medical induction 
O Caesarean – includes caesarean section only 
O Method of onset not applicable or not known 
Normal delivery (without induction, without the use of instruments, not by caesarean 
section and without general, spinal or epidural anesthetic before or during delivery. 
Procedures related to assisted deliveries are excluded, except repair of laceration) 
O Yes 
O No 
Length of labour (in hours)_________ 
Postnatal days of stay ____________ 
 
Complication during pregnancy (maternal or fetal medical condition severe 
enough to warrant treatment by the antenatal healthcare provider, either as an 
outpatient or through hospital admission - antepartum hemorrhage, gestational 
diabetes and pre-eclampsia) 
O Yes 
O No 
Delivery complications (breech presentation, fetal distress and cord accidents) 
O Yes 
O No 
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COMMENTS: 
ID  
INITIALS 	  
Edema, proteinuria and hypertensive disorders in pregnancy, childbirth and the 
puerperium: 
O NO 
O Pre-existing hypertension  
O Pre-existing hypertension with pre-eclampsia/eclampsia (please, rate 
also one of the following) 
O Gestational edema and proteinuria without hypertension (Development 
of significant proteinuria (>=0.3 g/l) after 20 weeks of gestation or 
during labor and/or within 48 hours of delivery) 
O Gestational hypertension without significant proteinuria (Hypertension 
without the development of significant proteinuria (<0.3 g/l), after 20 
weeks of gestation or during labor and/or within 48 hours of delivery) 
O Pre-eclampsia (Development of gestational hypertension and 
significant proteinuria after 20 weeks of gestation or during labor and/or 
within 48 hours of delivery) 
O Eclampsia (Convulsions ante, intra- or postpartum) 
O Unspecified maternal hypertension (Hypertension found when blood 
pressure is recorded for the first time after 20 weeks of gestation or 
during labor and/or within 48 hours of delivery) 
ID  
INITIALS 	  
PSYCHOLOGICAL STRESSORS 
 
 
 
 
BREASTFEEDING and SLEEP 
Length of breastfeeding (weeks) _______________ 
Frequency of breastfeeding______________________ 
Sleep pattern_________________________________ 
Comments 
 
 
ID  
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   LIFE
 C
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BRIEF HISTORY OF ILLNESS IN PREGNANCY AND POSTPARTUM 
 
Have you experienced during pregnancy or after childbirth periods of 
depression when you may have felt sad, been unable to positively enjoy 
things, had less energy than usual or had thoughts that life was not worth 
living? 
 
If yes 
• Approximately when did these episodes occur?  
 
• Were you able to take care of your child? 
 
• Did you receive treatment for these periods of low mood? (such as 
counselling, antidepressants by GP or psychiatrist, ECT or admission 
to hospital) 
 
Have you experienced during pregnancy or after childbirth periods of high or 
irritable mood when you may have experienced your thoughts racing through 
your mind, been more active and energetic than usual or felt especially 
efficient at work or in your daily activities? 
 
If yes 
 
• Approximately when did these episodes occur? 
 
• Were you able to take care of your child? 
 
• Have you received treatment for these periods of high mood (such as 
Lithium, Depakote, Olanzapine, Haloperidol by GP or psychiatrist or 
admission to hospital)? 
 
DEPRESSION 
 
Since pregnant.. 
  
• 6.001 Depressed mood  
Have you ever felt sad, downcast, gloomy, despairing or deeply depressed? 
                        
• 7.004 Loss of interests 
Have you lost interest in work, your recreations, and appearance? 
Check this was a definite loss compared from normal 
       
• 6.004 Capacity for enjoyment  
Have you ever lost the ability to positively enjoy things like working at your 
hobbies or interests, having a nice meal with friends?  
         
• 6.012 Tedium vitae 
Have you ever thought that life was not worth living, or you didn’t care if you 
wake up?   
Have you ever wished you had a fatal disease?       
 
• 6.011 Suicide or self-harm  
Have you ever thought about harming yourself or even made an attempt at 
suicide? 
 
• 6.009 Morning depression 
At what time of the day does the depression feel worse? 
         
• 6.017 Loss of self-esteem 
Have you felt less competent, inferior or worthless compared to other people?  
     
• 6.013 Pathological guilt  
Have you tended to blame yourself for things you had done? Or have you felt 
guilty or ashamed of yourself?   
     
• 6.015 Loss of self confidence with other people 
How confident have you felt in yourself- in talking to others and managing 
relationships with others?  
     
• 6.016 Social withdrawal 
Have you ever wanted to stay away from other people?  Have you answered 
the door or telephone?  Or have you tried to avoid company of others?  
 
• 7.002 Loss of concentration  
Has your concentration been as good as usual or has your attention 
wandered?  
    
• 7.003 Subjectively inefficient thinking 
Have simple decisions been hard to make? Have you found your thoughts 
have been much slower?   
 
• 7.005 Subjective feeling of retardation  
Have you felt as though you are slowed down in your movements, as though 
everyone and everything is moving much faster? 
    
• 7.006 Loss of energy  
Have you ever felt as though you have lost energy or vigour?  
Check this was a definite loss compared from normal   
 
• Agitated anxiety (in the context of depression) 
Were you so fidgety and restless that you couldn’t sit still?  
 
• Mixed episodes 
During episodes of depression, have you also experienced (even for brief 
periods) manic-type symptoms such as elevated mood, increased energy, 
racing thoughts and increased self esteem? 
 
 
MANIA 
 
Since pregnancy…. 
 
• 10.001 Expansive (elevated) mood   
Have you ever felt intensely happy or elated? 
 
• 10.002 Irritable mood  
Have you found that you were easily irritated? 
   
• 10.004 Pressing and racing thoughts 
Have you ever found your thoughts crowded into and raced through your 
mind- as though they were speeded up?      
 
• 10.005 Over-talkativeness 
Have people said that you talked too fast and too much so that they couldn’t 
understand you? Did you feel a pressure to keep talking?   
 
• 10.006 Distractibility 
Have you found that you could not keep your attention on one subject long 
enough to deal with it properly? 
   
• 10.007 Self-reported over activity 
Have you ever been more active than usual- so active that you or other 
people thought something was wrong? 
   
• 10.010 Exaggerated self esteem  
Have you ever felt especially efficient at work or in your daily activities- as 
though you had super powers or talents?       
 
• 10.012 Actions based on expansive mood 
Have you ever done anything that you wouldn’t normally do, like spend a lot of 
money, gamble, give inappropriate gifts, drive recklessly?    
 
• 10.013 Decreased need for sleep 
Are you able to manage with far less sleep than usual without seeming to get 
tired? 
 
• 10.014 Socially embarrassing behaviour 
Have you been more sociable than usual?  Were you ever over-familiar or 
inappropriate?   
   
• 10.015 Increased sexual drive or activity 
Have you found that your sex drive or interest in sex increased?   
   
• Dysphoric Mania 
During episodes of high mood, did you ever also experience (even for brief 
periods) depressive-type symptoms such as low mood, loss of energy, 
hopelessness or suicidal feelings? 
 
 
HALLUCINATIONS, THOUGHT DISORDER, REPLACEMENT OF WILL & 
DELUSIONS 
..Since pregnancy 
 
• Probe question: Hearing noises/voices     
   
Have you ever heard noises or voices when there was nobody around 
and no ordinary explanation seemed possible?      
IF YES 
17.009 Third person Auditory Hallucinations      
Did you ever hear voices talking about you between themselves or did you 
ever hear a single voice talking about you?   
17.008 Voice(s) commenting on thoughts or actions  
Did a voice comment on your thoughts or actions?   
 
• Probe question: Visual Hallucinations 
   
Have you ever had visions or seen things other people couldn’t see? 
 
• Other hallucinations (17.022, 17.026, 17.028) 
Have you ever noticed any unusual smells that you couldn’t account for or any 
unusual sexual sensations or noticed any other strange or inexplicable 
sensations of touch, taste, or temperature, or pain, or floating?  Or like a 
crawling sensation under the skin?        
                                           
  
• Probe Question: Interference with thoughts     
  
Have you ever felt some outside force or person was interfering with or 
controlling your thoughts or felt that your thoughts were being read?  
 
• Probe Question: Experience of Replacement of Will 
   
Have you ever felt some outside force or person was controlling your 
actions?  
 
19.004 Delusions of reference 
Have you ever felt the TV, radio or newspaper were talking about you? or 
giving messages to you? Have people ever seemed to drop hints meant for 
you, or say things with double meanings?                                
 
• 19.003 Delusions of being spied upon  
Have people seemed to talk about you, check up on you, or follow you about, 
or record your movements?                                           
 
• 19.012 Delusions of persecution 
Have you ever experienced the feeling that someone or some organisation 
was trying to harm you? 
 
• 19.021 Religious delusions 
Have you ever been unusually preoccupied with religious ideas for example 
thoughts about God or the Devil?        
 
 
• 10.016/19.029 Delusions of grandiose ability or 10.017/19.030 identity  
Have you ever felt that you or your baby have had special powers? or thought 
you were somebody special?  
               
 
• Delusions of guilt or worthlessness ( 6.018/19.025)  
Have you ever felt responsible for a crime, evil or harm to others?   
 
 
• (OPCRIT item 57) Delusions of poverty  
Have you ever believed that you have lost all of your money or property? 
                                      
 
• (OPCRIT item 58) Nihilistic delusions  
Have you ever felt that part of your body had disappeared or was rotting away 
or was affected by some devastating or malignant disorder or did you ever 
believe that you were dead?                                                                                                               
 
General probe question 
Have you ever had any other unusual or abnormal experiences when 
your mind has played tricks on you that looking back now seems 
strange or unusual? 
 
DURING: Mania   Depression   At other times    UK 
 
MATERNITY RELATED SYMPTOMS 
 
 
Have you ever had any unwanted thoughts about the baby? 
 
 
 
 
 
 
 
 
Have you ever had any excessive worries about the baby? 
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